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ABSTRACT 
Calorie restriction (CR), defined as reduced calorie intake without causing 
malnutrition, is the best-known intervention to increase life span and slow aging-related 
diseases in various species.  However, current knowledge on the exact mechanisms of 
aging and how CR exerts its anti-aging effects is still inadequate.  The detoxification 
theory of aging proposes that the up-regulation of xenobiotic processing genes (XPGs) 
involved in phase-I and phase-II xenobiotic metabolism as well as transport, which 
renders a wide spectrum of detoxification, is a longevity mechanism.  Interestingly, bile 
acids (BAs), the metabolites of cholesterol, have recently been connected with longevity.  
Thus, this dissertation aimed to determine the regulation of xenobiotic and BA 
metabolism by the well-known anti-aging intervention CR. 
First, the mRNA expression of XPGs in liver during aging was investigated.  The 
age-dependent mRNA profiles of 101 XPGs was determined in livers of male and female 
mice at 3, 6, 9, 12, 15, 18, 21, 24, and 27 months of age.  Gender differences across 
the lifespan were observed for 52 XPGs.  The mRNAs of 40 XPGs were lower in aged 
than young male mice, and 43 XPGs were lower in aged than young female mice.  
More XPGs with higher expression with age were observed in female (21 XPGs) than 
male (4 XPGs) mice. 
To characterize BA profiles during aging, an ultra-performance liquid 
chromatography-tandem mass spectrometry (UPLC-MS/MS) method recently developed 
by our laboratory was applied to quantify 20 individual BAs in serum and livers of male 
and female mice from 3 to 27 months of age.  Total BAs remained constant with age in 
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liver, but increased 340% from 3 to 27 months in serum of female mice.  In contrast, in 
male mice, BAs did not change in serum or liver.  The higher concentrations of BAs in 
serum of aged female mice were likely due to female-specific increased expression of 
BA uptake transporters Ntcp and Oatp1b2 in liver as well as the rate-limiting enzyme for 
BA synthesis Cyp7a1. 
Previous reports on regulation of gene expression in CR mice were inconsistent, 
mainly due to the large variation of diets, feeding regimes, as well as age and strain of 
the mice.  Utilizing a "dose-response" model (0, 15, 30, or 40% CR for one month), the 
present dissertation investigated the regulation of XPG expression in livers by graded 
CR in male mice under the same study design.  In general, CR (30 and 40%) altered 
the mRNA levels of over half of the 98 XPGs quantified (32 increased and 29 decreased).  
CR up-regulated some phase-I enzymes (such as Cyp4a14, Nqo1, Fmo2, and Fmo3) 
and numerous phase-II enzymes (many Sults, some Ugts, and most Gsts), as well as 
uptake transporter Oatp1a4.  Furthermore, over half of the CR-induced alterations of 
XPG mRNA profiles appeared to be attributable to feminization of the liver. 
To innovatively investigate the regulation of BA homeostasis by CR, individual 
BAs were quantified by UPLC-MS/MS in various compartments of the enterohepatic 
circulation using the "dose-response" model of CR.  CR (40%) increased the BA pool 
size (162%).  CR "dose-dependently" increased many individual BAs in serum.  
Notably, 40% CR increased tauro-deoxycholic acid (TDCA) over 10-fold in serum, liver, 
and gallbladder.  The increase in BAs correlated with increased expression of 
BA-synthetic (Cyp7a1) and conjugating enzymes (BAL) and the ileal BA-binding protein 
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(Ibabp) by 40% CR.  Improved glucose tolerance and lipid parameters in the CR mice 
correlated with altered BA composition of increased proportion of 12-hydroxylated BAs 
(cholic acid and DCA) but decreased muricholic acids.  
In summary, this dissertation identified female-specific age-dependent changes of 
XPG expression and elevation of total BA concentrations in serum during aging, as well 
as the feminization effects of the expression of many XPGs by CR, all of which 
interestingly correlate with the phenomenon that females generally have longer life span 
than males.  The current findings provide new evidence for the detoxification theory of 
aging and promote a better understanding of BAs as potential longevity signaling 
molecules, and may provide insight into drug elimination pathways that one should 
monitor in the elderly as well as people on diets. 
  
 
 
vi 
 
ACKNOWLEDGEMENTS 
First of all, I would like to acknowledge my Ph.D. mentor Dr. Curtis Klaassen.  He 
introduces me to the field of pharmacology and toxicology, and provides me a wonderful 
opportunity to join an internationally-known laboratory, learn basic concepts in the field 
systematically, develop scientific thinking, learn cutting-edge techniques, and to conduct 
exciting research.  I am very grateful to him for the time and efforts he spends on 
discussion about my research projects, rehearsal of my talks, as well as numerous 
rounds of editing of my abstracts, seminar slides, and manuscripts.  He always gives 
me the freedom to have my own scientific ideas and supports my research projects and 
attending to scientific meetings with his full ability.  He teaches me how to be a better 
scientist by setting a role model to me, and I am sure I will benefit a lot in my future 
career development by learning from his diligence, positive attitudes, and scientific 
philosophy.  I would like to thank him for his guidance, support, understanding, 
encouragement, and suggestions throughout my Ph.D. study. 
I would like to thank my graduate student committee, Drs. Udayan Apte, Wen-Xing 
Ding, Thomas Pazdernik, and Hao Zhu, as well as a previous committee member Dr. 
James Luyendyk, for their generous support and inspiring advice on the progress of my 
dissertation projects.  They have made every committee meeting a pleasant experience 
of learning and discussion.  I would not have completed my Ph.D. study with success 
without their help. 
 
 
vii 
 
I would also like to thank all current and past faculty, students, fellows, and staff in    
the Department of Pharmacology, Toxicology, and Therapeutics, for their help and 
support which makes my graduate study a little bit easier.  
I appreciate the support and friendship from current and past lab members, 
especially Dr. Yue Cui, Dr. Youcai Zhang, Dr. Kai Wu, Dr. Jie Liu, Dr. Ivan Csanaky, Dr. 
Rachel Chennault, Dr. Yu-kun Zhang, and Felcy Selwyn.  I would like to thank all of the 
lab members for making our lab a pleasant place to work all the time.  
Last but not least, I would like to especially thank my parents for their unconditional 
love, understanding, support, and encouragement all the time. 
 
 
 
 
 
  
 
 
viii 
 
TABLE OF CONTENTS 
Chapter 1: INTRODUCTION AND BACKGROUND  .....................................................1
1.1 Introduction to aging  ................................................................................2 
1.2 Models for aging research  .......................................................................9 
1.3 Aging liver and xenobiotic metabolism  ...................................................14 
1.4 Aging liver and nutrient homeostasis  .....................................................14 
1.5 Calorie restriction as an anti-aging intervention  .....................................16 
1.6 Important mediators and signaling pathways during aging and  
calorie restriction  ..............................................................................................22 
1.7 Calorie restriction mimetics  ....................................................................26 
1.8 Overview of xenobiotic-processing genes in liver  ..................................30 
1.9 Introduction to bile acids and the enterohepatic circulation  ....................33 
1.10 Bile acids as signaling molecules  ..........................................................35 
Chapter 2: STATEMENT OF PURPOSE  ....................................................................38 
Chapter 3: EXPERIMENTAL MATERIALS AND METHODS  ......................................43 
3.1 Chemicals and Reagents  ......................................................................44 
3.2 Animals and Husbandry  .........................................................................44 
3.3 Glucose Tolerance Test (GTT)  ..............................................................45 
3.4 Sample Collection  ..................................................................................48 
3.5 Total RNA Isolation  ................................................................................48 
3.6 Multiplex Suspension Assay  ..................................................................49 
3.7 Branched DNA Assay  ............................................................................50 
 
 
ix 
 
3.8 Reverse Transcription and Real-time PCR Analysis  ..............................50 
3.9 BA Extraction  .........................................................................................55 
3.10 BA Quantification by Ultra-performance Liquid Chromatography-Tandem 
 Mass Spectrometry (UPLC-MS/MS)  ...............................................................55 
3.11 Plasma and Liver Lipid Parameters  .......................................................55 
3.12 Preparation of Crude Membrane Fractions  ............................................55 
3.13 Western Blot Analysis  ............................................................................56 
3.14 Statistical Analysis  .................................................................................56 
3.15 Hierarchical Clustering Analysis  ............................................................57 
Chapter 4: REGULATION OF XENOBIOTIC PROCESSING GENE EXPRESSION 
 IN LIVER OF MICE DURING AGING  .............................................................58 
4.1 Abstract  .................................................................................................59 
4.2 Introduction  ............................................................................................60 
4.3 Results  ...................................................................................................62 
4.4 Discussion  .............................................................................................84 
Chapter 5: REGULATION OF BILE ACID HOMEOSTASIS DURING AGING 
 OF MICE  .........................................................................................................90 
5.1 Abstract  .................................................................................................91 
5.2 Introduction  ...........................................................................................93 
5.3 Results  ..................................................................................................96 
5.4 Discussion  ...........................................................................................115 
 
 
x 
 
Chapter 6: CALORIE RESTRICTION FEMINIZES THE HEPATIC EXPRESSION OF 
XENOBIOTIC METABOLIZING ENZYMES AND TRANSPORTERS IN MICE  .........121 
6.1 Abstract  ...............................................................................................122 
6.2 Introduction  .........................................................................................109 
6.3 Results  ................................................................................................126 
6.4 Discussion  ...........................................................................................150 
Chapter 7: REGULATION OF BILE ACID ENTEROHEPATIC CIRCULATION 
 BY GRADED CALORIE RESTRICTION IN MICE  ........................................159 
7.1 Abstract  ...............................................................................................160 
7.2 Introduction  .........................................................................................161 
7.3 Results  ................................................................................................163 
7.4 Discussion  ...........................................................................................178 
Chapter 8: CONCLUSIONS AND DISCUSSION  ......................................................183 
Chapter 9: REFERENCES  ........................................................................................192 
  
 
 
xi 
 
LIST OF ABBREVIATIONS 
Abbreviation Full name 
Abc ATP-binding cassette 
Adh alcohol dehydrogenase 
AhR aryl hydrocarbon receptor 
AL ad libitum 
Aldh  aldehyde dehydrogenase 
AMPK AMP-activated protein kinase 
ANOVA analysis of variance 
Asbt apical sodium-dependent bile acid transporter 
BA bile acid 
BAL bile acid-CoA ligase 
BAT bile acid-CoA: amino acid N-acyltransferase 
Bcrp breast cancer resistant protein 
Bsep bile salt export pump 
CA cholic acid 
CAR constitutive androstane receptor 
CDCA chenodeoxycholic acid 
Ces carboxylesterase 
Comt catechol-O-methyl transferase 
DCA deoxycholic acid 
EHC enterohepatic circulation 
Ent equilibrative nucleoside transporter 
Fgf fibroblast growth factor 
Fmo  flavin-containing monooxygenase 
Fox forkhead box protein 
FXR farnesoid X receptor 
Gapdh glyceraldehyde 3-phophate dehydrogenase 
GB gallbladder 
GH growth hormone 
Gst  glutathione S-transferase 
HDCA hyodeoxycholic acid 
HNF  hepatocyte nuclear factor 
Ibabp ileal bile acid binding protein 
IGF-1 insulin growth factor-1 
LCA lithocholic acid 
LI large intestine 
Mate multidrug and toxin extrusion 
MCA muricholic acid 
MDCA murideoxycholic acid 
 
 
xii 
 
Abbreviation Full name (Con'd) 
Mdr multidrug resistance protein 
Mgst microsomal glutathione S-transferase 
Mrp multidrug resistance-associated protein 
mTOR mammalian target of rapamycin 
Nat N-acetyltransferase 
Nqo1 NAD(P)H: quinone oxidoreductase 
Nrf2 nuclear factor E2-related factor 2 
Ntcp Na+/taurocholate cotransporting polypeptide 
Oat organic anion transporter 
Oatp organic anion-transporting polypeptide 
Oct organic cation transporter 
Ost organic solute transporter 
P450  cytochrome P450 
Papss 3'-phosphoadenosine 5'-phosphosulfate synthetase 
PGC1α peroxisome proliferator-activated receptor γ coactivator 1-alpha 
Pon paraoxonase 
Por cytochrome P450 reductase 
PPAR peroxisome proliferator-activated receptor 
PXR pregnane X receptor 
RXR retinoid X receptor 
SHP small heterodimer partner 
SI small intestine 
Sirt Sirtuin (silent mating type information regulation 2 homolog)  
Slc solute carrier 
Sult sulfotransferase 
T-BA taurine-conjugated bile acid 
U-BA unconjugated bile acid 
UDCA ursodeoxycholic acid 
Ugdh UDP-glucose-6-dehydrogenase 
Ugp UDP-glucose pyrophosphorylase 
Ugt UDP-glucuronosyltransferase 
UPLC-MS/MS ultra-performance liquid chromatography-tandem mass spectrometry
XPG xenobiotic processing gene 
 
 
  
 
 
xiii 
 
LIST OF TABLES 
Table 1.1.  The impact of aging on multiple organs and systems.  ..............................3 
Table 1.2.  Main theories of aging.  ..............................................................................8 
Table 1.3.  Some long-lived mice models with decreased GH/IGF-1  
signaling.  ..........................................................................................................13 
Table 1.4.  Comparison between two calorie restriction (30% CR) studies in rhesus 
monkeys.  ..........................................................................................................18 
Table 1.5.  Evidence of beneficial effects of calorie restriction in healthy humans......19 
Table 1.6.  The theories of life span extension by calorie restriction.  ........................21 
Table 1.7.  Some compounds in testing for extending the longevity of mice.  ............28 
Table 3.1.  Scheme of the CR Study.  ........................................................................46 
Table 3.2.  Custom Diet Formula.  ..............................................................................47 
Table 3.3.  Summary of XPGs quantified by multiplex suspension assay 
in mice liver.  .....................................................................................................52 
Table 3.4.  Oligonucleotide probes for quantifying mouse Comt mRNA  
by the branched DNA assay.  ............................................................................53 
Table 3.5.  Sequences of Real-Time PCR primers. .....................................................54 
Table 4.1.  Summary of three patterns of age-dependent mRNA changes of  
XPGs in livers of male and female mice.  .........................................................83 
Table 6.1.  CR (30 and 40%) feminizes the mRNA profiles of over half of  
the XPGs that are altered in livers of male mice.  ...........................................158 
  
 
 
xiv 
 
LIST OF FIGURES 
Figure 1.1.  The role of liver in "xenobiotic processing".  ............................................32 
Figure 1.2.  Scheme of the enterohepatic circulation of BAs in mice.  ........................37 
Figure 4.1.  The mRNA profiles of uptake transporters with aging in livers of  
male and female mice.  ......................................................................................64 
Figure 4.2.  The mRNA profiles of major cytochrome P450s (P450s), P450 reductase 
(Por), and NAD(P)H:quinone oxidoreductase (Nqo1) with  
aging in livers of male and female mice.  ...........................................................67 
Figure 4.3.  The mRNA profiles of flavin-containing monooxygenases (Fmos) 
 with aging in livers of male and female mice.  ..................................................68 
Figure 4.4.  The mRNA profiles of alcohol dehydrogenases (Adhs) with aging 
 in livers of male and female mice.  ...................................................................69 
Figure 4.5.  The mRNA profiles of aldehyde dehydrogenases (Aldhs)  
with aging in livers of male and female mice.  ...................................................70 
Figure 4.6.  The mRNA profiles of carboxylesterases (Cess) and paraoxonases (Pons) 
with aging in livers of male and female mice.  ....................................................71 
Figure 4.7.  The mRNA profiles of sulfotransferases (Sults) and 3'-phosphoadenosine 
5'-phosphosulfate synthetase (Papss) enzymes with aging in livers of male and 
female mice.  .....................................................................................................74 
Figure 4.8.  The mRNA profiles of UDP-glucuronosyltransferase (Ugts) 
 and UDP-glucose pyrophosphorylase (Ugp2) with aging in livers of male 
 and female mice.  ............................................................................................75 
 
 
xv 
 
Figure 4.9.  The mRNA profiles of glutathione S-transferases (Gsts) with 
 aging in livers of male and female mice.  ........................................................76 
Figure 4.10.  The mRNA profiles of N-acetyltransferases (Nats) and  
catechol-O-methyl transferase (Comt) with aging in livers of male 
 and female mice.  ............................................................................................77 
Figure 4.11.  The mRNA profiles of efflux transporters with aging in livers 
 of male and female mice.  ...............................................................................79 
Figure 4.12.  The mRNA profiles of major transcription factors with aging 
 in livers of male and female mice.  ..................................................................80 
Figure 4.13.  Hierarchical cluster analysis of the mRNA profiles of XPGs 
 during aging in livers of male and female mice.  .............................................82 
Figure 5.1.  Total BA concentrations in serum during aging of male and 
 female mice.  ...................................................................................................97 
Figure 5.2.  Concentrations of conjugated BAs in serum during aging 
 of male and female mice.  ...............................................................................98 
Figure 5.3.  Concentrations of unconjugated BAs in serum during aging 
 of male and female mice.  .............................................................................101  
Figure 5.4.  Total BA concentrations in liver during aging of male 
 and female mice.  ..........................................................................................104 
Figure 5.5.  Concentrations of conjugated BAs in liver during aging 
 of male and female mice.  .............................................................................105 
Figure 5.6.  Concentrations of unconjugated BAs in liver during aging 
 
 
xvi 
 
 of male and female mice.  .............................................................................108  
Figure 5.7.  The mRNA and proteins of BA transporters in livers during aging of male 
and female mice.   ..........................................................................................111 
Figure 5.8.  The mRNA profiles of BA synthetic enzymes in livers during aging of male 
and female mice.  ............................................................................................113 
Figure 5.9.  The mRNA changes of regulators of Cyp7a1 transcription during aging of 
male and female mice.  ...................................................................................114 
Figure 6.1.  The body weight changes by graded CR.  ............................................127 
Figure 6.2.  The mRNA changes of CR-responsive target genes in livers 
by graded CR.  ................................................................................................128 
Figure 6.3.  The mRNA changes of uptake transporters in livers 
by graded CR.  ................................................................................................131 
Figure 6.4.  The mRNA changes of P450s, Por, and Nqo1 in livers 
by graded CR.  ................................................................................................132  
Figure 6.5.  The mRNA changes of Fmos in livers by graded CR.  ..........................135 
Figure 6.6.  The mRNA changes of Adhs in livers by graded CR.  ...........................136 
Figure 6.7.  The mRNA changes of Aldhs in livers by graded CR.  ...........................137 
Figure 6.8.  The mRNA changes of Cess and Pons in livers by graded CR.  ...........138 
Figure 6.9.  The mRNA changes of Sults and Papss in livers by graded CR.  ..........142   
Figure 6.10.  The mRNA changes of Ugts and Ugdh in livers by graded CR.  ..........143 
Figure 6.11.  The mRNA changes of Gsts in livers by graded CR.  ..........................144 
Figure 6.12.  The mRNA changes of Nats and Comt in livers by graded CR.  ..........145   
 
 
xvii 
 
Figure 6.13.  The mRNA changes of efflux transporters in livers by graded CR.  .....147 
Figure 6.14.  The mRNA changes of several transcription factors in livers 
 by graded CR.  ...............................................................................................149 
Figure 6.15.  Hierarchical clustering of the mRNA profiles of XPGs in livers 
 by graded CR.  ...............................................................................................151   
Figure 7.1.  Body weight, glucose, and lipid parameters in CR mice.  ......................165 
Figure 7.2.  Effect of graded CR on total BAs in various compartments 
 of the enterohepatic circulation.  ....................................................................166 
Figure 7.3.  Individual BAs in various compartments of the enterohepatic 
 circulation in CR mice.  ..................................................................................169 
Figure 7.4.  Altered enterohepatic BA composition by 40% CR.  ..............................172  
Figure 7.5.  Expression of BA-synthetic and conjugating enzymes 
 in CR mice.  ...................................................................................................175 
Figure 7.6.  Expression of Cyp7a1 transcription regulatory factors 
 in liver and ileum of CR mice.  .......................................................................176 
Figure 7.7.  Expression of BA transporters in the enterohepatic 
 circulation in CR mice.  ..................................................................................177 
Figure 8.1.  The regulation of BA and xenobiotic metabolism by CR.  ......................184 
 
 
 
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1: INTRODUCTION AND BACKGROUND  
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1.1   Introduction to aging 
Aging is characterized as a progressive decline of physiological functions in various 
organs that ultimately leads to the functional decline or death of the whole organism.  
Aging is thought to be a universal, intrinsic, progressive, and deleterious process (Vina et 
al., 2007).  The elderly, with a chronological age of 60 years and older, are expected to 
reach 22% of the global population by 2050, with 38% in Southern Europe and 27% in 
United States (United Nations Population Ageing and Development 2012).  Due to this 
rapid increase, aging has become an important global issue.   
Physiological functions lose efficiency with aging in various organs.  When 
interacting with external insults from the environment, the elderly have a decline in 
capability to endure various stresses and maintain homeostasis.  As listed in Table 1.1, 
the elderly have declined neural and cardiovascular functions, sarcopenia, cataracts, 
osteoporosis, declined vision, hearing, and fertility.  The functions of liver, kidney, lung, 
and GI tract also are affected with aging.  Moreover, the elderly have impaired glucose 
tolerance and more prone to develop type 2 diabetes.  With an dysregulated immune 
system, the elderly have increased risks of auto-immune diseases and susceptibility to 
infections.  What's more, the incidence of cancer increases exponentially with age. 
Aging is a very complicated and fascinating process, which attracts numerous 
scientists to investigate its mechanisms and possibly interventions to slow or even 
reverse aging.  As early as 1990, more than 300 theories of aging were raised 
(Medvedev, 1990).  Some theories are more favored because more and more 
experimental evidence have been found in various species.  Others are abandoned due  
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Table 1.1.  The impact of aging on multiple organs and systems. 
Targets Impact by aging 
Nervous system neurodegeneration (decline in memory, cognition etc) 
Heart cardiac arrhythmia, arterial wall stiffening, 
arthrosclerosis, decrease blood flow through heart 
Skeletal muscle loss in motor co-ordination, sarcopenia 
Liver 
decrease in liver mass and hepatic blood flow, slow bile 
production and flow, impaired metabolism of some 
drugs 
Kidney lower glomerular filtration 
Lung decrease in pulmonary ventilation 
Eyes cataracts, loss in vision 
Ears loss in hearing 
Bone osteoporosis 
Immune system autoimmune, decrease inflammation 
Reproductive system infertility 
Glucose-responsive organs impaired glucose tolerance 
Many organs cancer 
Skin wrinkles, dermal thinning, impair wound healing 
Hair hair loss 
Digestive system decrease in stomach capacity and empty, lactose 
intolerance, bacterial overgrowth in small intestine 
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to a lack of experimental support.  It is still considered unrealistic to have one theory 
that can explain all puzzles of aging.  The main theories of aging are listed in Table 1.2. 
The free radical theory.  As one of the most prominent theories, the free radical 
theory is also called the oxidative stress theory, or mitochondrial theory.  It is proposed 
that oxidative stress induced by highly reactive free radicals is responsible for oxidative 
damages associated with aging (Harman, 1956; Rattan, 2006; Oliveira et al., 2010).  
These reactive oxygen species (ROS) are generated from the electron transport chain in 
the mitochondria on a regular basis.  Therefore, the importance of mitochondria in aging 
is proposed. Specifically, senescence results from damage caused by ROS to the 
mitochondrial genome when large amounts of ROS saturate the antioxidant capabilities 
of the cells (Miquel et al., 1980).  
Immune senescence.  The immune theory is becoming a popular theory of aging.  
The immune system plays critical roles in distinguishing self antigens from exogenous 
insults, and elimination of foreign pathogens.  Immune senescence in the elderly makes 
them increasingly susceptible to infectious diseases such as influenza and pneumonia, 
as well as infection by Clostridium and Staphylococcus, which contribute to morbidity 
and irreversible frailty and dependency (Boraschi et al., 2010).  In addition to increased 
susceptibility to infectious diseases, the elderly have increased risks for autoimmune 
diseases (Franceschi et al., 1995; Franceschi et al., 2000). 
Telomere shortening.   Telomeres at the end of chromosomes with repeated DNA 
sequences get shorter with each cell division due to problems with end replication.  
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Telomere shortening leads to replicative senescence and is thought to be a marker of 
aging (Olovnikov, 1992; De Meyer et al., 2011).  Telomerase, the reverse transcriptase 
that specifically replicates shorter telomeres, is generally not able to counteract telomere 
shortening in normal somatic cells, and health life styles is associated with increased 
telomerase activity (De Meyer et al., 2011). 
DNA damage and repair theory.  Oxidative stress-induced accumulation of DNA 
damage can cause deleterious effects such as dysregulated gene expression and cell 
function, cell cycle arrest and apoptosis, as well as impaired tissue homeostasis 
(Smith-Sonneborn, 1979; Skinner and Turker, 2005).  Although oxidative stress also 
damages lipids and proteins, DNA damage is especially critical for aging, due to its role 
as genetic material that cannot be replaced.  Several DNA repair pathways have 
decreased efficiency with aging, such as nucleotide excision repair and non-homologous 
end joining repair.  Moreover, impaired DNA repair pathways are associated with 
human progeriod syndromes (Freitas and de Magalhaes, 2011).  
Antagonize pleiotropy theory.  Antagonize pleiotropy indicates that genes may be 
selected for their beneficial effects at early stages of life, but later become deleterious 
with aging (Williams, 1957).  It is also known as reproductive-cell cycle theory, because 
reproduction, as a typical example, is thought to be a costly process ensured for 
development, yet may be bad for longevity.  Antagonism of reproduction and longevity 
has been supported by some evidence. For example, destroying germ-line cells can 
increase life span in Drosophila (Sgro and Partridge, 1999) and elegans 
(Arantes-Oliveira et al., 2002).  In humans, androgen is important for the development 
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and function of the male reproductive system, however, prostate stimulation by testicular 
hormones also significantly contributes to the development of benign prostatic     
hyperplasia as well as aging-related prostate pathology, such as prostate cancer.  In 
addition, correlation between castration and longevity has been identified in male pet 
dogs and humans (Waters et al., 2000).  However, the relation of longevity and 
reproduction is not absolute (Weinert and Timiras, 2003).  A clear-cut example of 
antagonistic pleiotropic gene is mammalian target of rapamycin (mTOR), the master 
regulator of protein synthesis, which drives development as well as aging (Blagosklonny, 
2010). 
Detoxification theory.  A modern theory suggests that aging results from a 
progressive decline in detoxification of a broad spectrum of toxic metabolites generated 
by both xenobiotic and endobiotic metabolism (Gems and McElwee, 2005).  It is coined 
detoxification theory in this dissertation.  Longevity assurance mechanisms are 
proposed to primarily involve the removal of various toxic molecules that cause damage 
and cannot be repaired under normal conditions.  The up-regulation of genes involved 
in phase-I and phase-II metabolism renders broad spectrum detoxification, which may be 
one of the best longevity assurance processes.  This theory was raised upon the 
findings in long-lived mutants of C. elegans (McElwee et al., 2004), and is supported by 
accumulating evidences in Drosophila (Iqbal et al., 2009) and rodents (Amador-Noguez 
et al., 2007; Steinbaugh et al., 2012). 
Hormesis theory.  About 500 years ago, Paracelsus, the father of Toxicology, 
raised "the dose makes the poison".  The finding of "hormesis" (Southam and Ehrlich, 
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1943), a biphasic dose response characterized with a low dose stimulation and a high 
dose inhibition, challenged the central dogma of toxicology.  Low doses of drugs, toxins, 
and natural substances trigger multiple adaptive stress defense pathways, such as 
kinases, protein chaperons, phase-II enzymes, anti-oxidative and other cytoprotective 
proteins, which could provide protection against aging-related diseases (Calabrese et 
al., 2012; Calabrese, 2013). 
These various theories are not completely independent of each other.  For instance, 
mitochondrial function declines during aging, generating large amounts of free radicals 
and oxidative stress and thus DNA damage.  DNA damage accumulation and declined 
DNA repair capabilities contribute to aging.  Thus, the free radical theory and the DNA 
damage and repair theory are closely connected.  Another example is the connection 
between detoxification theory and hormesis theory.  The hormesis effects provided by 
some compounds are mediated by the induction of various signaling pathways, which 
could elicit detoxification and defense responses.  
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Table 1.2. Main theories of aging. 
Theories Description References 
Free radical/ 
Oxidative 
stress 
Oxidative metabolism produces reactive 
free radicals that cause oxidative 
damage. 
(Harman, 1956)          
(Rattan, 2006)           
(Oliveira et al., 2010) 
Immune 
senescence 
Aging-related decline of immune 
functions. 
(Franceschi et al., 1995) 
(Franceschi et al., 2000) 
(Boraschi et al., 2010) 
Telomere 
shortening 
Telomere loss leads to cellular 
senescence. 
(Olovnikov, 1992)           
(De Meyer et al., 2011) 
DNA damage 
and repair 
Oxidative damage to DNA and reduced 
mismatch repair lead to mutation events, 
and hence cancer, with aging. 
(Smith-Sonneborn, 1979)     
(Skinner and Turker, 2005) 
Antagonize 
pleiotropy 
Genes that are beneficial during 
development become deleterious during 
aging. 
(Williams, 1957)          
(Waters et al., 2000) 
(Blagosklonny, 2010) 
Detoxification 
theory 
Decline in detoxification abilities of a 
broad spectrum of damaging species 
generated by both xenobiotic and 
endobiotic metabolism 
(Gems and McElwee, 2005) 
(Amador-Noguez et al., 
2007) (Iqbal et al., 2009) 
(Steinbaugh et al., 2012) 
Hormesis 
Hormetic dose of xenobiotics lead to 
adaptation and activation of stress 
responsive signalings that ensure 
longevity. 
(Calabrese et al., 2012) 
(Calabrese, 2013) 
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1.2   Models for aging research 
Aging research has been promoted by various experimental models with 
naturally-occurring or genetically-modified mutations that lead to longevity.  Drosophila 
and C. elegans are frequently used by gerontologists for research on the molecular 
mechanisms of aging, because they have short life cycle and are relatively easy for 
genetic modification.  Recent discoveries in long-lived mutant mice have significantly 
promoted the area of aging research.  Because it is generally thought that the most 
fundamental mechanisms of aging are evolutionarily conserved among species, the 
findings in rodents may contribute significantly to our understanding of the causes of 
aging and how longevity could possibly be increased in humans.  Common models for 
aging research are explained below, with a main focus on rodents.   
Dietary models.  The diet known as calorie restriction (CR; also known as dietary 
restriction) is the most reproducible way to extend life span in mammals.  As early as in 
Ancient Greece and Rome, the health benefits of food limitation were appreciated 
(Dehmelt, 2004).  At the turn of the 20th century, Professor Maurice Gueniot, president 
of the Paris Medical Academy, is famed for living on a restricted diet and for dying at the 
age of 102 (Sinclair, 2005).  In 1935, the first widely recognized scientific article of 
restricted diets and their ability to extend life span was published in rats (McCay et al., 
1935).  Since then, CR has been found to be effective in extending life span of various 
species including mammals without genetic alterations (Masoro, 2000).  Similar to CR, 
healthy dietary patterns are effective in reducing risk for chronic diseases diets with 
"health" nutrition components could have beneficial effects against age-related diseases.  
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A classic example is the Okinawan diet, the diet of the world's longest-lived people.  
The traditional Okinawan diet is low in calories yet nutritionally dense with high-quality 
carbohydrates mostly from vegetables and fruits.  Residents of Okinawa in Japan are 
known for their long life expectancy, high numbers of centenarians, and low risk of 
age-related diseases, which is thought to be related to a healthy life style, particularly the 
traditional low-calorie but nutritious Okinawan diet (Willcox et al., 2009).  This suggests 
that such healthy diets may help to slow aging (Willcox et al., 2007). 
Genetic models.  The growth hormone/insulin-like growth factor 1 (GH/IGF-1) 
signaling is associated with longevity regulation.  GH is secreted by the anterior pituitary 
gland, secreted into blood, and stimulates liver to produce IGF-1.  As a primary 
mediator of the effects of GH, IGF-1 regulates cell growth and development.  In addition 
to its structural similarity with insulin, IGF-1 has insulin-like effects, as it binds to the 
insulin receptor, at a lower affinity than IGF-1 receptor.  The original finding about the 
connection of IGF-1 pathway and aging is in C. elegans with mutations in daf-2, which 
encodes the worm's unified insulin/IGF1 receptor (Dorman et al., 1995).  Mutations that 
disrupt GH/IGF-1 signaling can extend life span in mice, and many have 
gender-divergent effect on life span (Table 1.3).  For example,  Ames dwarf mice with 
a mutation in the prophet of pituitary factor-1 (Prop1) are deficient in GH and IGF-1, and 
have 50-70% longer mean life span (Brown-Borg et al., 1996).  Snell dwarf mice with a 
mutation of pituitary specific transcription factor 1 (Pit1) have deficiencies in GH/IGF-1 
signaling and live about 30-40% longer (Flurkey et al., 2002).  In addition, Little mice, 
which have a mutation of GH-releasing hormone receptor, have decreased GH 
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production and over 20% longer life span (Flurkey et al., 2001).  More evidence on the 
connection of GH deficiency and longevity is derived from Laron dwarf mice, which are 
GH receptor/GH-binding protein knockout (GHR/GHBP-KO) mice with 40-55% longer life 
span (Coschigano et al., 2000), and GH transgenic mice, which have increased 
circulating IGF-1 levels and shorter life span (Bartke et al., 2002).  The critical role of 
IGF-1 in life span regulation is supported by long-lived IGF-1 receptor heterozygous 
(IGF-1R +/-) mice (Holzenberger et al., 2003) and Klotho (a hormone that represses 
insulin and IGF-1 receptors thus inhibiting intracellular insulin and IGF-1 signaling) 
transgenic mice (Kurosu et al., 2005). 
Some insulin signaling mutant mice have a longer life span, such as the fat-specific 
insulin receptor knockout (FIRKO) mice (Bluher et al., 2003) and the insulin receptor 
substrate 1 (IRS-1) KO mice (Selman et al., 2008).  The over-expression of antioxidant 
enzymes and proteins are also linked with longevity, such as the mitochondria-targeted 
calatase (MCAT) transgenic mice (Schriner et al., 2005) and metallothionein transgenic 
mice (Yang et al., 2006).  Moreover, long-lived mice models with mutations in other 
pathways include p66shc (a 66kD isoform of Shc oncogene) KO, AC5 (adenylyl cyclase 
type 5) KO, αMUPA (urokinase-type plasminogen activator) transgenic, RIIβ (a 
regulatory subunit of protein kinase A) KO, Surf1 (a putative cytochrome c oxidase 
assembly factor) KO, PEPCK-C (cytosolic form of phosphoenolpyruvate carboxykinase) 
muscle-specific transgenic, UCP2 (uncoupling protein 2) hypocretin neuron-specific 
transgenic, S6K1 (ribosomal protein S6 kinase 1) KO, Agtr1a (angiotensin II receptor 
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type 1a) KO, and Mclk1 (mitochondrial clock abnormal protein 1) +/- mice etc (Chen et 
al., 2010).    
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Table 1.3.  Some long-lived mice models with decreased GH/IGF-1 signaling. 
 
Mice models Genotype 
Body 
weight 
Longevity 
(mean life 
span) 
References 
Ames dwarf 
mice 
Prop-1 mutant ↓ (~67%) 
↑ (♂: 49%; 
♀: 68%) 
(Brown-Borg et al., 1996) 
Snell dwarf mice Pit-1 mutant ↓ (~67%) 
↑ (♂: 26%; 
♀: 42%) 
(Flurkey et al., 2002) 
Little mice Ghrhr mutant ↓ (~33%) 
↑ (♂: 23%; 
♀: 25%) 
(Flurkey et al., 2001) 
Laron dwarf 
mice 
GHR/GHBP 
knockout 
↓ (~57%) 
↑ (♂: 55%; 
♀: 38%) 
(Coschigano et al., 2000) 
IGF-1R +/- mice 
IGF-1 receptor 
heterozygous  
↓ (<10%) 
↑ (♂: 16%; 
♀: 33%) 
(Holzenberger et al., 
2003) 
Klotho mice 
Klotho 
overexpression
N.D. 
↑ (♂♀: 
~20-30%) 
(Kurosu et a., 2005) 
 
Ghrhr: GH-releasing hormone receptor 
GHBP: GH-binding protein 
WT: wild-type 
N.D.: no difference 
♂: male 
♀: female   
 
 
14 
 
1.3   Aging liver and xenobiotic metabolism 
The elderly exhibit increased susceptibility to xenobiotics and often consume large 
amounts of drugs.  Therefore, polypharmacy and high incidence of adverse drug 
interactions can complicate drug therapy in the elderly.   
Aging is associated with multiple physiological changes, leading to pharmacokinetic 
changes.  Liver is a major metabolic organ of the body, playing key roles in drug 
metabolism and detoxification.  Decrease in liver mass during aging is thought to be 
responsible for the decline in hepatic drug metabolism, especially for low extraction 
drugs like phenytoin, alcohol, and theophylline, and the decrease in clearance of high 
extraction drugs such as hydralazine, nitrates, lidocaine, verapamil, propranolol, and 
morphine correlates with the decline in hepatic blood flow (Woodhouse and James, 
1990).  Therefore, alteration of drug metabolism likely results from physiological 
changes in the elderly. 
1.4   Aging liver and nutrient homeostasis 
Liver is the major organ of glucose and lipid metabolism.  In addition, neural and 
hormone signals, which are presumably derived from hepatic metabolism, or metabolites 
themselves, markedly influences extrahepatic glucose/lipid utilization (Langhans, 2003).  
Overexpression of hepatic glucokinase, the key enzyme in glycolysis, can alleviate some 
of the metabolic disturbances triggered by insulin deficiency.  This emphasizes the 
importance of improving hepatic glucokinase activity in diabetes (Jackerott et al., 2002).  
Hepatocyte nuclear factor-4 and 6 appear to play a role in activation of glucokinase 
(Roth et al., 2002).  In addition, members of protein targeting to glycogen (PTG) family 
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(Gasa et al., 2000) can be used to increase glycogenic signals and lower blood glucose 
levels in diabetes.  PPARγ coactivator 1-alpha (PGC1α) is a key modulator of hepatic 
gluconeogenesis (Yoon et al., 2001), and recently was shown to be involved in activation 
of carnitine palmitoyl-transferase-1 (CPT-1) by cAMP (Louet et al., 2002).  Therefore, 
PGC1α is a key regulator of both glucose and lipid utilization and their coordination in 
liver.  PGC1α is suggested as a candidate for susceptibility for type 2 diabetes (Hara et 
al., 2002).  There is a connection of over-consumption of dietary carbohydrates and 
hepatic lipogenesis, involving more than 15 genes responsible for conversion of glucose 
to fat.  A recently discovered transcription factor (Yamashita et al., 2001), called 
carbohydrate responsive element-binding protein (ChREBP), is activated in response to 
high glucose levels and it up-regulates the expression of pyruvate kinase and lipogenetic 
enzymes.  Another fork-head box transcription factor FoxO1 is a negative regulator of 
insulin sensitivity in liver (Nakae et al., 2002). 
Altered glucose and lipid metabolism occurs during aging.  The accumulation of 
advanced glycation end (AGE) products generated endogenously at higher rates in 
diabetics due to altered glucose metabolism, may accelerate multisystem decline that 
occurs with aging (Semba et al., 2010).  In regards to lipid metabolism, the levels of 
plasma high-density lipoprotein (HDL) cholesterol in elderly men are higher than those in 
middle-aged men (Schaefer et al., 1989; Schleich and Legros, 2004).  Plasma total and 
low-density lipoprotein (LDL) cholesterol levels as well as triglyceride levels increase 
slightly after puberty and until about 50 year-old and then stabilize for the remaining 
years.  The hepatic synthesis of very low-density lipoprotein (VLDL) and their 
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conversion to LDL particles is likely to increase, and the catabolism of VLDL and LDL 
particles is likely to decrease with age due to reduced expression of LDL receptors and 
activity of lipoprotein lipase (Li et al., 2008).  Recently, it was reported that aging can 
increase the inflammatory response to excess nutrients and the vulnerability to free fatty 
acid-induced insulin resistance associated with aging (Einstein et al., 2010). 
1.5   Calorie restriction as an anti-aging intervention 
CR, defined as reduced calorie intake without causing malnutrition, is the 
best-known intervention that reproducibly increases both mean and maximum life span 
in a variety of species ranging from single cell organisms to mammals.  Approximately 
80 years ago, Clive Maine McCay first observed the effect of CR on life span extension 
in rats, promoting CR as a productive research topic in the multidisciplinary science of 
gerontology (McCay et al., 1935).  CR increases life span in S. cerevisiae (Lin et al., 
2000), C. elegans (Schulz et al., 2007), Drosophila (Mair et al., 2003), fish (Comfort, 
1963), as well as in mammals (such as rodents and dogs) (McCay et al., 1935; 
Weindruch and Walford, 1982; Kealy et al., 2002).  The amount by which CR extends 
life span in rodents depends on the extent, onset, and duration of restriction, and 
whether enriched diets are provided to restricted animals.  Life span is progressively 
increased with progressive reductions in energy intake from the ad libitum amount up to 
approximately 50% reduction, beyond which further CR results in increased mortality 
(Mattson, 2005). 
For non-human primates, a study using rhesus monkeys at the Wisconsin National 
Primate Research Center (WNPRC) showed that CR can blunt aging and significantly 
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delay the onset of age-related diseases, such as diabetes, obesity, cancer, autoimmune 
diseases, sarcopenia, and cardiovascular disease (Colman et al., 2008; Colman et al., 
2009).  In contrast, a CR study implemented in young and old age rhesus monkeys at 
the National Institute of Aging (NIA) showed no improvement in survival outcomes 
(Mattison et al., 2012).  One needs to be cautious when drawing conclusions from these 
two studies.  As described in details in Table 1.4, the differences in results are likely 
due to variations in study design, diet composition, minerals and vitamin 
supplementation, and genetic origins of monkeys (Ingram et al., 1990; Kemnitz et al., 
1993; Ramsey et al., 2000; Kemnitz, 2011; Mattison et al., 2012).  
Whether the beneficial effects of CR in lower organisms can be extrapolated to 
humans has been debated.  Recent studies have also demonstrated beneficial effects 
of CR in healthy humans (as detailed in Table 1.5).  However, much longer studies are 
needed to evaluate whether CR also increases the lifespan of humans.  CALERIE 
(Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy) is a 
National Institute on Aging (NIA)-sponsored trial, and conducted at three clinical sites, 
namely Pennington Biomedical Research Center, Tufts University, and Washington 
University School of Medicine.  The phase 2 study, which started in 2007 and ended in 
2012, is the first randomized controlled trial that systematically investigated sustained 
CR on aging in relatively healthy, non-obese humans. 
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Table 1.4.  Comparison between two calorie restriction (30% CR) studies in 
rhesus monkeys. 
Differences WNPRC NIA 
Monkeys Origins: Indian Origins: both Indian and Chinese 
Sex M F M M M M M M M F F F 
Sample # 30 30 16 12 12 6 8 8 14 20 20 20 
Age (yrs) 8-14 8-14 6-14 
0.5-
1 
3-5 18-25 1-4 5-9 >20 1-3 6-14 
16-
21 
Entry year    
(19xx) 
89 94 94 
86- 
87 
86-
87 
86-87 88 88 88 92 92 92 
Diet 
composition 
Purified diet 
(15% protein, 
10% fat, 5% 
cellulose). 
Source of 
nutrients: protein 
from lactalbumin; 
fat from corn oil; 
carbohydrate 
from corn starch 
and sucrose. 
NIA-1-87 diet (15% protein, 5% fat, 5% fiber). 
Source of nutrients: protein from wheat, corn, 
soybean, fish and alfalfa meal; fat from soybean oil 
and fish meal; carbohydrates from ground wheat, 
corn, and lesser sucrose. NIA diet contains 
components that may have an impact on health 
such as phytochemicals (e.g. flavonoids), 
ultra-trace minerals, and other unidentified 
elements. 
Minerals and 
vitamin 
supplement 
Two different 
diets fed to CR 
and control. Only 
CR monkeys 
were 
supplemented 
with vitamin and 
minerals by 30%.
One diet fed to both CR and control. The diet was 
supplemented with additional 40% of the 
daily-recommended allowance of vitamin and 
minerals. Thus, the control monkeys were 
over-supplemented. 
Conclusions 
CR improves 
survival 
outcomes; CR 
decreases the 
incidence of 
diabetes, cancer, 
cardiovascular 
disease, and 
brain atrophy. 
CR implemented at young and older ages does not 
improve survival outcomes. Young-onset CR 
decreases the incidence of neoplasia. Old-onset 
CR is beneficial on metabolic parameters. 
 
M: male; F: female.   
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Table 1.5.  Evidence of beneficial effects of calorie restriction in healthy humans. 
Study 
(References) 
Description Conclusion 
Okinawan diets 
(Kagawa, 1978) 
Nutritious, low-calorie, high in 
vegetables and 
carbohydrates. ~20% fewer 
calories than the average of 
Japan. 
Death rates from malignancy, 
brain and heart disease in 
Okinawa were 30-40% lower than 
the rest of Japan.  
Fasting on 
alternative days 
(Vallejo, 1957; 
Stunkard, 1976) 
60 healthy seniors (aged 72 
yrs on average), ~35% CR for 
3 yrs. Average 1500 (CR) vs 
2300 (cont) kcal/day.  
CR lowers hospital admissions 
(123 vs 219 days) and deaths (6 
vs 13). 
Biosphere 2 
(Weyer et al., 
2000; Walford et 
al., 2002) 
8 healthy humans (7 aged 
27-42 yrs and 1 aged 67 yrs; 
4 men and 4 women), for 2 
yrs. 1750-2100 (CR) vs 2500 
(cont) kcal/day.  
About 50 CR-related changes in 
physiologic, hematologic, 
hormonal, and biochemical 
parameters, which resemble 
findings in rodents and monkeys. 
Serum IGF-1 not changed. 
Long-term CR 
(Fontana et al., 
2004) 
18 CR+18 cont (aged 25-82 
yrs, 15 men and 3 women) 
~20% CR for 3-15 yrs. Cont: 
typical American diets. 
CR improves biochemical 
parameters in blood and 
decreases risk factors for 
cardiovascular diseases. 
Long-term CR 
(Meyer et al., 
2006) 
25 CR+25 cont (aged 35-82 
yrs, 21 men and 4 women) 
CR for 3-15 yrs. Cont: 
western diets. 
CR decreases risk factors for 
cardiovascular diseases and 
systemic inflammation. 
CALERIE-Phase 1 
(Heilbronn et al., 
2006; Redman et 
al., 2007; Redman 
and Ravussin, 
2009) 
23 healthy but overweight 
(BMI: 25-30 kg/m2) humans 
(aged 25-50 yrs; 11 men and 
12 women), ~25% CR for 6 
mons 
CR decreases abdominal visceral 
fat, but does not alter fat 
distribution. CR decreases body 
temperature, energy expenditure, 
serum T3, and plasma DNA 
damage. Serum IGF-1 not 
changed. 
CALERIE-Phase 2 
(Rickman et al., 
2011; Stewart et 
al., 2013) 
218 healthy non-obese 
humans (BMI: 22-28 kg/m2, 
CR: cont=2:1), including 67 
men (aged 21-50 yrs) and 153 
women (aged 21-47 yrs), 25% 
CR for 2 yrs. 
Highest yield possible of 
enrollment in the trial was 
achieved via the screening 
methods, which was more 
intense than disease-based 
clinical trials. So far, no reports 
are available on physiological and 
biochemical parameters etc.  
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In addition to the various beneficial effects, CR has a few adverse physical effects, 
such as growth retardation (for early onset of restriction), decreased reproductive 
functions, cold intolerance, and decreased bone density (humans) (Vitousek et al., 
2004).  Take reproductive function as an example, CR attenuates, delays, or abolishes 
fertility and fecundity in Drosophila, C. elegans, and female rats and mice (Spindler, 
2010).  Long-term CR suspends ovulation (Nelson et al., 1985) and affects sperm 
quality and counts (Brinkworth et al., 1992) in rats and mice.  CR that starts after 
weaning delays sexual maturation, however, refeeding CR female mice at late ages 
turns out to rescue the reproductive senescence observed in age-matched controls 
evidenced by the rate of follicular depletion and oestrous cycling (Nelson et al., 1985).  
Limited information is available in the literature about the reproductive function by 
long-term CR in humans (Vitousek et al., 2004).  
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Table 1.6.  The theories of life span extension by calorie restriction. 
Theories Evidence for Evidence against 
Develop-
mental 
delay 
CR slows development 
(McCay et al., 1935; McCay 
et al., 1975). 
Adults on a CR diet later in life also have 
longer life span (Weindruch and Walford, 
1982). 
Metabolic 
rate 
CR slows metabolic rate per 
unit of body mass (Krystal 
and Yu, 1994). 
After initial drop in the first 6 weeks, CR 
animals have equal or higher metabolic 
rates than AL (Masoro, 1982). 
Decrease 
in fat 
Secretary factors by fat are 
important to beneficial effects 
on neuroendocrine system 
and glucose homeostasis 
(Barzilai and Gupta, 1999). 
Little direct evidence to support that 
decreased fat is what extends life span in 
CR animals. 
Reduced 
ROS 
CR animals have less 
ROS-induced damages to 
macromolecules (Merry, 
2002). 
Antioxidants only slightly increase life 
span in flies and rodents. Longer life span 
in human SOD overexpressed flies is 
genotype- and sex-specific (Spencer et 
al., 2003). The SOD2-null mice do not 
show signs of premature aging (Van 
Remmen et al., 2003).  
Cell 
survival 
CR protects cells from 
stress-induced apoptosis 
(neurons, kidney, liver, and 
some immune cells) (Howitz 
and Sinclair, 2005). 
CR increases rates of apoptosis or genes 
that promote apoptosis, especially in 
rapidly dividing tissues, which is thought 
to be a major reason why CR suppresses 
cancer (Zhang and Herman, 2002). 
Decrease 
in 
glucose 
and 
insulin 
levels 
High glucose levels lead to 
accumulation of glycation 
end-products associated with 
aging. CR decreases blood 
glucose and insulin (Kalant et 
al., 1988) 
Whether lower glucose and insulin levels 
are the reason for the increase in life 
span by CR remains to be determined.  
Endocrin-
ology 
CR decreases insulin and 
IGF-1 levels (Harvey et al., 
2012). IGF-1 system seems 
to play an important role in 
the systemic response to CR. 
The life span of dwarf mice (deficient in 
various endocrine factors) can be further 
increased by CR (Bartke et al., 2001), 
indicating that CR might at least partially 
work via alternative mechanisms. 
Hormesis 
CR extends the life span of 
yeast via hormesis 
(Anderson et al., 2003). 
Supporting evidence in 
worms and flies. Long-lived 
animals have increased 
stress resistance. 
Hormesis is unproven in mammals. 
 
 
22 
 
1.6   Important mediators and signaling pathways during aging and calorie 
restriction 
Although studies on CR started nearly 70 years ago, the underlying mechanism of 
how CR delays the onset of aging and extends lifespan is still unknown (Anderson et al., 
2009).  Theories of life span extension by CR are proposed (Sinclair, 2005), most of 
which are controversial (Table 1.6).  There are several important nutrient-sensing 
proteins implicated in aging and CR, including protein deacetylase sirtuins (Bordone and 
Guarente, 2005), nutrient sensor mTOR (Estep et al., 2009), master regulator of energy 
metabolism PGC-1α (Corton and Brown-Borg, 2005), insulin/IGF-1 signaling (Bergamini 
et al., 2003), stress defensive and survival factors FoxOs (Kim et al., 2008a), energy 
sensor AMPK, as well as autophagy (Rubinsztein et al., 2011) etc.  These mediators 
and pathways may lead to life span extension through overlapping mechanisms. 
Sirtuins.  Among the mediators for CR, a family of NAD-dependent protein 
deacetylases termed sirtuins has received the most attention.  The connection between 
CR and sirtuins originates from the finding that the life span extension of yeast in a 
low-glucose medium appears to require Sir2 (silent mating type information regulation 2) 
(Lin et al., 2000).  The closest human ortholog to the yeast Sir2 gene is Sirt1, which 
deacetylates various transcription factors and coactivators, such as PGC-1 and FoxO 
(activation) as well as NFκB and p53 (inhibition) (Vaziri et al., 2001; Brunet et al., 2004; 
Motta et al., 2004; Yeung et al., 2004; Rodgers et al., 2005).  Sirt1, whose expression is 
induced by CR, may help mediate the beneficial effects of CR in mice as well (Haigis and 
Guarene, 2006).   The wine polyphenol resveratrol is a known Sirt1 activator, and small 
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molecules to activate Sirt1 are currently under clinical trials for aging-associated 
diseases, particularly type 2 diabetes.  
mTOR.  As a nutrient-responsive serine/threonine kinase, TOR integrates signals, 
such as nutrient and energy status, hormones, and growth factors, to regulate cell 
proliferation and survival, protein synthesis, autophagy etc.  Inhibition of TOR signaling 
extends life span of yeast, C. elegans, Drosophila, and mice (McCormick et al., 2011).  
CR-induced low glucose and low insulin that result from CR inhibit TOR activity. 
PGC1α.  PGC1α, a member of PGC1 family, is a master regulator of mitochondrial 
biogenesis and hepatic gluconeogenesis.  Similar to PGC1α, PGC1β also induces 
mitochondrial biogenesis and respiration.  However, PGC1β has no major effects on 
gluconeogenesis in liver, or adaptive thermogenesis in brown adipose tissue, which is 
opposite to PGC1α (Handschin and Spiegelman, 2006).  Sirt1 deacetylates and 
activates PGC1α.  Under low glucose conditions in cell culture, Sirt1 induces 
gluconeogenic genes and hepatic glucose output through PGC1α, but does not regulate 
the effects of PGC1α on genes on mitochondrial biogenesis (Rodgers et al., 2005).  
Long-term CR increases the expression of PGC1α in various tissues (including liver) of 
mice (Ranhotra, 2010).  CR increases PGC1α expression and mitochondrial respiration 
in skeletal muscle of mice (Hempenstall et al., 2011). 
Insulin/IGF-1 signaling.  Please see detailed discussion in previous section 
(section 1.2).  Decreased insulin/IGF-1signaling is associated with an extension of 
lifespan  in C. elegans, Drosophila, and mice (Anisimov, 2003).  A crucial event of the 
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effects of CR in rodents and monkeys is decreased insulin and IGF-1 and it is possible 
that the life span extension of CR is due to decreased IGF-1 (Anisimov, 2003).  
However, the potential role of IGF-1 signaling in human longevity is far from clear.  
Neither the Biosphere nor the CALERIE studies reported a decrease in serum IGF-1 in 
humans after sustained CR (Walford et al., 2002; Redman and Ravussin, 2009). 
FoxOs.  FoxO transcription factors control the response to different types of stress, 
promoting cell survival via activation of genes involved in DNA repair, detoxification 
machinery, cell cycle progression, apoptosis inhibition, and other functions (Puig and 
Tjian, 2006).  Key events downstream of the insulin/IGF-1 signaling include activation of 
IRS and inhibtion of Akt, thus inhibiting FoxOs.  CR down-regulates the insulin/IGF-1 
pathway and activates FOXO activity (Nakae et al., 2008).  C. elegans mutants have 
increased life span depending on the FoxO transcription factor Daf-16 (Dorman et al., 
1995).  Activation of FoxOs in Drosophila and C. elegans can increase longevity.  
However, there is a lack of solid evidence for a direct role of FoxOs in mediating 
longevity in mammals (Greer and Brunet, 2005). 
AMPK.  AMPK (AMP-activated protein kinase) plays crucial roles in cellular energy 
homeostasis by sensitively detecting the shift in the AMP/ATP ratio.  AMPK directly 
inhibits TOR signaling (Luo et al., 2005).  Enhanced AMPK signaling is capable of 
extending the life span of yeast, C. elegans, and Drosophila (Tschape et al., 2002; 
Apfeld et al., 2004; Harkness et al., 2004).  However, whether AMPK is involved in the 
life span extension of CR in these organisms is not clear.  In rodents, fasting increases 
AMPK activity in skeletal muscle (de Lange et al., 2006), however, CR appears to have 
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little or no effect on AMPK activity in skeletal muscle or liver (Gonzalez et al., 2004; To et 
al., 2007). 
Autophagy.  Autophagy, a degradation machinery of unnecessary or dysfunctional 
cellular components, plays crucial roles in protein homeostasis and organelle turnover. 
Increasing evidence suggest connection between aging and autophagy (Rubinsztein et 
al., 2011), especially macroautophagy, which is induced by nutrient deprivation 
(Mizushima and Klionsky, 2007).  Mutation of essential autophagy-related genes 
abolishes the life span extension in long-lived eat-2 mutants (a model of CR) of C. 
elegans (Jia and Levine, 2007) as well as Arabidopsis exposed to lower intensity of light 
(a model of CR in plants) (Minina et al., 2013).  In mammals, the rate of autophagy 
decreases with age in various tissues and autophagy is enhanced by CR (Cuervo et al., 
2005), but the role of autophagy in the life span extension of CR in mammals is not clear.  
Pharmacological intervention to elevate autophagy activity may provide therapeutic 
benefits to protein-aggregation related neurodegenerative disorders (Sarkar et al., 
2009). 
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1.7   Calorie restriction mimetics 
Increasing numbers of studies reveal that CR delays the onset of age-related 
diseases, improve stress resistance, and decelerate functional decline (Goodrick et al., 
1982; Barger et al., 2003).  Due to the difficulty to widely implement CR in humans, 
development of CR mimetics (CRMs) to mimic the beneficial effects of CR without 
reducing calorie intake has become an emerging field of research (Ingram et al., 2004).   
Screening compounds that mimic CR at the transcriptional level helps to identify 
candidate CRMs that extend longevity.  These screenings were primarily based on 
pathways involved in intermediary metabolism, stress response, and inflammation 
(Weindruch et al., 2001b).  Several CRMs have been identified by this 
expression-based screenings, such as metformin (Dhahbi et al., 2005) and resveratrol 
(Howitz et al., 2003; Pearson et al., 2008).  Metformin, a most widely prescribed drug to 
treat type 2 diabetes, is thought to work at least partially through activation of AMPK to 
regulate glucose uptake and metabolism (Boyle et al., 2010).  Resveratrol extends the 
life span of yeast, C. elegans, and Drosophila in a Sir2-dependent manner, by mimicking 
CR (Wood et al., 2004).  Although resveratrol is a CRM that can extend the life span in 
obese mice on a high-calorie diet (Baur et al., 2006) as well as an age-accelerated 
SAMP8 mice (Porquet et al., 2012), it is not effective in life span extension in wild-type 
mice fed a normal diet (Barger et al., 2008; Pearson et al., 2008).  Furthermore, 
2-deoxyglucose, which is a synthetic glucose analog that inhibits the glycolytic enzyme 
phosphohexose isomerase, inhibits tumor growth, decreases insulin and body 
temperature, and increases glucocorticoids, all of which mimic CR (Ingram et al., 2004).  
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However, 2-deoxyglucose has adverse chronic effects on cardiovascular function, which 
diminishes the enthusiasm for long-term administration (Ingram et al., 2004).  In 
summary, CRMs are mainly screened based on the similarities of the transcriptional 
profiles induced by compounds and CR, and long-term studies are needed to indentify 
whether these candidate CRMs can extend life span. 
Since 2003, NIA has started an Interventions Testing Program (ITP) to evaluate 
pharmacological and dietary chemicals that are potential therapeutic candidates to slow 
aging or prevent various aging-related diseases (Miller et al., 2007).  Up to five 
compounds were added to the study each year and tested at three independent sites 
(the Jackson Laboratory, University of Michigan, and University of Texas).  Whether 
these compounds can extend the life span and delay disease and dysfunction is tested 
in genetically heterogeneous mice of both genders.  A summary of some compounds in 
testing is shown in Table 1.7.  Rapamycin, which is an inhibitor of mTOR, extends life 
span in both male and female mice when given at either early or late-stage of life 
(Harrison et al., 2009; Miller et al., 2011).  Aspirin and nordihydroguaiaretic acid 
(NDGA), both of which have anti-inflammatory and antioxidant activities, can extend life 
span in male mice, but not in female mice (Strong et al., 2008).  Some polyphenolic 
phytochemicals, such as resveratrol, green tea extract, and curcumin, do not have 
statistical significant effects on life span in male or female mice (Strong et al., 2013).  
Interestingly, bile acids (BAs), as one of the few endogenous compounds tested, were 
added to the ITP in 2011, and the testing results of whether BAs can extend the life span 
of mice have not been published yet.
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Table 1.7.  Some compounds in testing for extending the longevity of mice. 
Compound 
Weight in 
the diet 
Treatment 
start age 
Test 
start 
(year) 
Extend 
life? 
(Yes/No) 
Publication 
Aspirin 20 ppm 4 months 2004 Y (M) (Strong et al., 2008) 
NDGA 2,500 ppm 9 months 2004 Y (M) (Strong et al., 2008) 
NDGA 
(Phase II) 
800 ppm; 
2,500 ppm; 
5,000 ppm 
6 months (M);
6 months (M);
6 months  
2010; 
2010; 
2010 
N/A N/A 
NFP 200 ppm 4 months 2004 N (M&F) (Strong et al., 2008) 
4-OH-PBN 315 ppm 4 months 2004 N (M&F) (Strong et al., 2008) 
Rapamycin 
14 ppm; 
14 ppm 
20 months;  
9 months 
2005; 
2006 
Y (M&F); 
Y (M&F) 
(Harrison et al., 2009)
(Miller et al., 2011) 
Rapamycin 
(Phase II) 
4.7 ppm; 
14 ppm; 
42 ppm 
9 months; 
9 months; 
9 months 
2009; 
2009; 
2009 
N/A N/A 
Metformin 1,000 ppm 9 months 2011 N/A N/A 
Metformin + 
Rapamycin 
1,000 ppm 
+ 14 ppm 
9 months 2011 N/A N/A 
Simvastatin 
12 ppm; 
120 ppm 
10 months; 
10 months 
2006; 
2006 
N (M&F) (Miller et al., 2011) 
Resveratrol 
300 ppm; 
1,200 ppm; 
300 ppm 
12 months; 
12 months; 
4 months 
2006; 
2006; 
2007 
N (M&F) 
(Miller et al., 2011) 
(Strong et al., 2013) 
Oxaloacetic 
acid 
2,200 ppm 4 months 2007 N (M&F) (Strong et al., 2013) 
Green tea 
extract 
2,000 ppm 4 months 2007 N (M&F) (Strong et al., 2013) 
Curcumin 2,000 ppm 4 months 2007 N (M&F) (Strong et al., 2013) 
Medium 
Chain 
Triglyceride 
Oil 
60,000 
ppm 
4 months 2007 N (M&F) (Strong et al., 2013) 
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Table 1.7.  Some compounds in testing for extending the longevity of mice 
(cont'd). 
 
Compound 
Weight in 
the diet 
Treatment 
start age 
Test 
start 
(year) 
Extend 
life? 
(Yes/No) 
Publication 
17α-Estradiol 
4.8 ppm; 
14.4 ppm 
10 months; 
10 months 
2009; 
2011 
N/A N/A 
Acarbose 
1,000 
ppm 
4 months 2009 N/A N/A 
Fish Oil 
15,000 
ppm; 
50,000 
ppm 
9 months; 
9 months 
2010; 
2010 
N/A N/A 
Bile Acids 
5,000 
ppm 
5 months 2011 N/A N/A 
 
 
Each compound was given in the diet in the unit of part per million (ppm) by weight.  
Tests were performed in both genders, unless specially indicated.   
NFP: nitroflurbiprofen; 4-PH-PBN: 4-OH-α-phenyl-N-tert-butyl nitrone; NDGA: 
nordihydroguaiaretic acid; M: Male; F: Female; N/A: not available (results not published). 
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1.8   Overview of xenobiotic processing genes in liver 
Liver has a high expression of xenobiotic processing genes (XPGs), including uptake 
transporters, phase−I enzymes, phase−II enzymes and efflux transporters.  Hepatic 
uptake transporters play important roles in uptake of xenobiotics in liver.  Uptake 
transporters are mainly members of the solute carrier family (Slc), including organic 
anion-transporting polypeptides (Oatps), organic cation transporter 1 (Oct1), organic 
anion transporter 2 (Oat2) and equilibrative nucleoside transporter 1 (Ent1).  Phase−I 
enzymes catalyze oxidation, reduction, and hydrolysis reactions, including many 
cytochrome P450s (Cyps), flavin-containing monooxygenases (Fmos), cytochrome P450 
reductase (Por), NAD(P)H:quinone oxidoreductase (Nqo), alcohol dehydrogenases 
(Adhs), aldehyde dehydrogenases (Aldhs), carboxylesterases (Cess) and paraoxonases 
(Pons) etc.  Many of the phase−I metabolites can be further conjugated with sulfate, 
glucuronic acid, glutathione, methyl and acetyl groups catalyzed by phase−II enzymes, 
namely the sulfotransferases (Sults), UDP-glucuronosyltransferases (Ugts), glutathione 
S-transferases (Gsts), catechol-O-methyl transferase (Comt), and N-acetyltransferases 
(Nats), respectively.  Phase−I reactions increase the hydrophilicity of drugs a little, 
whereas most phase−II reactions, except methylation and acetylation, increase their 
hydrophilicity a lot.  After being metabolized by phase−I/II enzymes, xenobiotics 
become more hydrophilic and ready to be exported either into bile by canalicular efflux 
transporters like multidrug resistance-associate protein 2 (Mrp2), breast cancer resistant 
protein (Bcrp), multidrug and toxin extrusion 1 (Mate1), multidrug resistance proteins 
(Mdrs) 1 and 2, ATP-binding cassette transporters Abcg5 and Abcg8, or into blood to be 
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eliminated through urine by basolateral efflux transporters like multidrug resistant 
proteins (Mrps) 3, 4 and 6 and ATP-binding cassette transporter member 1 (Abca1) 
(Klaassen and Lu, 2008).  In summary, products of XPGs play key roles in drug 
metabolism and detoxification in liver (a brief scheme shown in Fig. 1.1.). 
Many of the XPGs are regulated by transcription factors (Klaassen and Aleksunes, 
2010), such as the aryl hydrocarbon receptor (AhR), constitutive androstane receptor 
(CAR/NR1I3), pregnane X receptor (PXR/NR1I2), peroxisome proliferator-activated 
receptor alpha (PPARα/NR1C1), nuclear factor E2-related factor 2 (Nrf2), retinoid X 
receptor alpha (RXRα/NR2B1), and hepatocyte nuclear factors (HNF1α and HNF4α).  
Many of these transcription factors can be activated by xenobiotics to regulate the 
transcription of drug metabolizing enzymes and transporters (Klaassen and Slitt, 2005).
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Fig. 1.1. 
 
 
The role of liver in "xenobiotic processing".  Absorption, distribution, metabolism, 
and excretion (or ADME), taken together is called toxicokinetics, which affects the 
concentrations of xenobiotics in the body and the kinetics of xenobiotic exposure to 
tissues, and thus their pharmacological or toxicological activities.  Liver is the primary 
site of xenobiotic metabolism and detoxification, and the liver expresses a large number 
of xenobiotic processing genes.   Xenobiotics in blood can enter hepatocytes either 
through diffusion or active uptake.  Once inside hepatocytes, they can undergo phase-I 
metabolism, including oxidation, reduction, and hydrolysis, to become more polar 
metabolites.  They can also undergo phase-II metabolism, when they are conjugated 
with sulfates, glucuronic acid, glutathione, etc.  Phase-II conjugation usually increases 
the hydrophilicity of xenobiotics, and this favors their hepatic excretion.  Hepatic efflux 
transporters mediate the excretion of xenobiotics and/or their metabolites into bile or 
back to blood. 
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1.9  Introduction to bile acids and the enterohepatic circulation. 
Bile acids (BAs) are a major constituent of bile.  BAs are amphipathic products 
from cholesterol metabolism in liver.  Primary BAs are synthesized and conjugated in 
the liver are called primary BAs.  Secondary BAs are formed from primary BAs by 
de-conjugation, de-hydroxylation, oxidation, and epimerization catalyzed by bacterial 
enzymes mainly in the lumen of large intestine (LI) (Ridlon et al., 2006).  In mice, 
primary BAs include cholic acid (CA), chenodeoxycholic acid (CDCA), α-muricholic acid 
(αMCA), and βMCA.  These BAs are converted to secondary BAs in the intestine, 
namely CA to deoxycholic acid (DCA), CDCA to lithocholic acid (LCA) and 
ursodeoxycholic acid (UDCA), αMCA and βMCA to murideoxycholic acid (MDCA), 
ωMCA, and hyodeoxycholic acid (HDCA) (Martin et al., 2007; Hofmann, 2009; Zhang 
and Klaassen, 2010). 
BAs are efficiently recycled through the enterohepatic circulation (EHC) (Fig. 1.2).  
Primary BAs are synthesized and conjugated in liver, stored in the gallbladder (GB), and 
secreted into the intestinal lumen to facilitate the absorption of dietary fats, where the 
BAs are transformed into secondary BAs by intestinal bacteria.  BAs are mainly 
reabsorbed from the ileum, and into the portal circulation.  The liver extracts BAs from 
the portal blood, thus ending one cycle of the EHC.   
BA de novo synthesis involves 17 different enzymes, many of which are 
preferentially expressed in liver (Russell, 2003).  The classic synthetic pathway starts 
with Cyp7a1, which is the rate-limiting BA synthetic enzyme (Chiang, 1998) that 
catalyzes the 7α-hydroxylation of cholesterol.  Cyp7a1 is the rate-limiting BA synthetic 
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enzyme (Chiang, 1998).  The alternative pathway starts with 27-hydroxylation of 
cholesterol by mitochondrial Cyp27a1  (Cali and Russell, 1991), and involves 
7α-hydroxylation by Cyp7b1 (Li-Hawkins et al., 2000b) to produce CDCA.  Cyp8b1, a 
12α-hydroxylase, is required for 12α-hydroxylation and thus CA formation (Chiang, 
2003).  Cyp8b1 catalyzes CA synthesis, and thus controls the ratio of CA to CDCA 
(Chiang, 2003).  Once synthesized from cholesterol, BAs are further conjugated with 
taurine or glycine by bile acid-CoA ligase (BAL) and bile acid-CoA:amino acid 
N-acyltransferase (BAT) in liver.  Mouse BAT is a taurine-specific conjugating enzyme 
(Falany et al., 1997), thus tauro-BAs are major conjugated BAs in mice. 
The expression of key BA synthetic enzymes (e.g. Cyp7a1 and Cyp8b1) are 
well-known to be suppressed by BAs by a feedback inhibition mechanism.  There are 
two major mechanisms of this transcriptional regulation: 1) FXR activation by BAs in liver 
leads to the expression of the target gene, small heterodimer partner (SHP), which 
suppresses the transactivation of Cyp7a1 by liver receptor homolog-1 (LRH-1) (Goodwin 
et al., 2000).  2) FXR activation by BAs in intestine leads to the expression of the target 
gene, fibroblast growth factor 15 (Fgf15), an intestinal hormone that can mediate 
transcriptional regulation in liver through its interaction with membrane receptor Fgfr4 
(Inagaki et al., 2005).  The suppression of Cyp7a1 is mediated by intestinal FXR-Fgf15 
pathway, whereas the suppression of Cyp8b1 is more dependent on the FXR signaling 
in liver (Kim et al., 2007; Kong et al., 2012).   
The EHC of BAs is promoted by BA transporters.  In liver, there are BA uptake 
transporters, namely the Na+/taurocholate cotransporting polypeptide (Ntcp) for 
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conjugated BAs (Anwer, 2004) and the organic anion transporting polypeptide 1b2 
(Oatp1b2) for unconjugated BAs (Csanaky et al., 2011), and BA efflux transporter, 
namely the bile salt export pump (Bsep) (Wang et al., 2001).  In ileum, there are BA 
uptake transporter, namely the apical sodium-dependent bile acid transporter (Asbt) 
(Dawson et al., 2003), and BA efflux transporter, namely the organic solute transporter 
alpha and beta (Ostα and Ostβ) (Ballatori et al., 2008; Rao et al., 2008).   
 1.10  Bile acids as signaling molecules 
BAs have multifaceted physiological functions.  They solubilize cholesterol and 
other lipids in the bile to promote their elimination from the liver, and facilitate the 
absorption, transport, and distribution of dietary fats and lipid soluble vitamins (Hofmann 
and Hagey, 2008).  Two BA receptors have been identified, the farnesoid X receptor 
(FXR/Nr1h4) (Makishima et al., 1999; Parks et al., 1999; Wang et al., 1999), which is 
involved in glucose and lipid metabolism (Claudel et al., 2005), and the 
membrane-bound receptor (TGR5/GPBAR1) (Kawamata et al., 2003), which increases 
energy expenditure in brown adipose tissue and muscle (Watanabe et al., 2006).  In 
addition to the two well-known BA receptors, BAs have been shown to activate protein 
kinases A and C and mitogen-activated protein kinase pathways, as well as other 
nuclear receptors including PXR, CAR, vitamin D receptor (VDR/NR1I2), and liver X 
receptor (LXR/NR1H3) (Trauner et al., 2010).   
BAs regulate the homeostasis of glucose (Scholmerich et al., 1985; Staels and 
Kuipers, 2007), lipids (Sinal et al., 2000; Sirvent et al., 2004), and energy expenditure 
(Watanabe et al., 2006; Li et al., 2012), in addition to their own homeostasis (Song et al., 
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2011).  In response to nutrient intake, glucose and insulin signaling in liver triggers 
alterations in BA homeostasis (Li et al., 2012).  Furthermore, altered BAs and BA 
signaling are associated with metabolic syndromes, cardiovascular, heaptobiliary, and 
gastrointestinal diseases, etc (Gadaleta et al., 2010; Khurana et al., 2011; Li and Chiang, 
2012).  This enables BA-controlled signaling pathways to be promising novel drug 
targets to treat common metabolic diseases, such as obesity, type 2 diabetes, 
hyperlipidemia, and atherosclerosis (Houten et al., 2006). 
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Fig. 1.2. 
 
Scheme of the enterohepatic circulation of BAs in mice.  Primary BAs are 
synthesized and conjugated in hepatocytes, and secreted into intestine to facilitate fat 
digestion.  Cyp7a1 is the rate-limiting enzyme for BA biosynthesis.  Primary BAs are 
conjugated mainly with taurine in mice, by conjugating enzymes BAL and BAT.  BAs 
are excreted into the canalicular bile by Bsep.  In the intestinal lumen, BAs are 
transformed into secondary BAs by intestinal bacteria.  BAs are efficiently reabsorbed 
by Asbt into ileocytes and effluxed into the portal blood by Ostα/β.  Ntcp and Oatp1b2 
take up BAs into hepatocytes.  CA, CDCA, αMCA, and βMCA are the primary BAs in 
mice.  DCA is the secondary BA of CA, LCA and UDCA are secondary BAs of CDCA, 
and ωMCA, MDCA, and HDCA are secondary BAs of α,βMCA. 
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cholic acid CA 3α, 7α, 12α-trihydroxy-5β-cholan-24-oic acid
chenodeoxycholic acid CDCA 3α, 7α-dihydroxy-5β-cholan-24-oic acid
α-muricholic acid αMCA 3α, 6β, 7α-trihydroxy-5β-cholan-24-oic acid
β-muricholic acid βMCA 3α, 6β, 7β-trihydroxy-5β-cholan-24-oic acid
tauro-cholic acid T-CA 3α, 7α, 12α-trihydroxy-5β-cholan-24-oyltaurine
deoxycholic acid DCA 3α, 12α-dihydroxy-5β-cholan-24-oic acid
lithocholic acid LCA 3α-hydroxy-5β-cholan-24-oic acid
ursodeoxycholic acid UDCA 3α, 7β-dihydroxy-5β-cholan-24-oic acid
murideoxycholic acid MDCA 3α, 6β-dihydroxy-5β-cholan-24-oic acid
ω-muricholic acid ωMCA 3α, 6α, 7β-trihydroxy-5β-cholan-24-oic acid
hyodeoxycholic acid HDCA 3α, 6α-dihydroxy-5β-cholan-24-oic acid
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Chapter 2: STATEMENT OF PURPOSE  
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Aging is a complex physiological process characterized with progressive functional 
decline in various organs over time, which will eventually result in functional decline or 
death of the whole organism.  CR is the dietary intervention that has been reproducibly 
shown to increase both mean and maximum life span in a variety of species ranging from 
unicellular organism to mammals, and effective in decreasing the incidence of 
aging-related diseases in humans.  A modern theory suggests that aging results from 
declined detoxification of a broad spectrum of toxic metabolites generated by both 
xenobiotic and endobiotic metabolism.  Up-regulation of genes involved in phase-I and 
phase-II metabolism, all of which are involved in detoxification, is proposed to be one of 
the best longevity mechanisms (Gems and McElwee, 2005).  In addition, BAs, which 
are signaling molecules, are suggested to have anti-aging effects (Amador-Noguez et 
al., 2007; Gems, 2007; Goldberg et al., 2010a).  Therefore, investigating the regulation 
of xenobiotic and BA metabolism by CR is of importance.  The present dissertation is 
poised to fill this critical knowledge gap. 
The central hypothesis of this dissertation is that CR increases the abilities of 
metabolism and detoxification in liver and increases BAs, both of which could contribute 
to longevity.  The goal of this dissertation is to investigate first the effect of aging on 
XPG expression in liver and BA homeostasis, and secondly the regulation of XPG 
expression in liver and the enterohepatic circulation of BAs by CR. 
Specific aim 1 was designed to characterize the effect of aging on the expression of 
XPGs in liver.  Liver plays a major role in the metabolism and detoxification of 
xenobiotics (drugs and environmental chemicals) as well as endobiotics.  Limited 
 
 
40 
 
information is available on the age-dependent expression profiles of XPGs in liver during 
aging.  In order to reveal possible molecular mechanisms of altered xenobiotic 
disposition and toxicity in the elderly, multiplex suspension assays were performed to 
determine the age-dependent mRNA profiles of XPGs in livers of mice from 3 to 27 
months of age.  Totally 101 XPGs were quantified, including 7 uptake transporters, 41 
phase−I enzymes, 36 phase−II enzymes, 10 efflux transporters, and 7 transcription 
factors.  It is known in the literature that many XPGs have gender-divergent expression 
in liver, thus gender differences of XPG expression during aging were investigated in this 
aim as well.   
Specific aim 2 was designed to investigate the regulation of BA homeostasis during 
aging.  In addition to the traditional roles of BAs to facilitate cholesterol hepatic 
elimination of cholesterol and intestinal absorption of dietary fats and lipid-soluble 
vitamins, BAs have recently been recognized as signaling molecules regulating the 
homeostasis of glucose, lipids, and energy.  Altered glucose and lipid homeostasis 
occurs during aging.  However, information on BA levels during aging is rather limited 
and inconsistent.  Utilizing the ultra-performance liquid chromatography-tandem mass 
spectrometry (UPLC-MS/MS) technique, specific aim 2 determined BA profiles in serum 
and livers of mice from 3 to 27 months of age.  The expression of genes involved in the 
enterohepatic circulation of BAs was quantified to mechanistically explain the 
age-related changes of BA concentrations and composition.  Furthermore, both male 
and female mice were utilized to investigate whether there are any gender differences of 
BA homeostasis during aging.   
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Specific aim 3 was designed to determine the effect of CR on XPG expression in 
liver.  The detoxification theory indicates that aging results from a progressive decline in 
detoxification of a broad spectrum of toxic metabolites generated by both xenobiotic and 
endobiotic metabolism.  Longevity assurance mechanisms are proposed to primarily 
involve the removal of various toxic molecules that cause damage and cannot be 
repaired under normal conditions.  Accumulating evidence in C. elegans, Drosophila, 
and recently in long-lived mice, such as dwarf mice, Little mice, and rapamycin-treated 
mice, have shown that up-regulation of genes involved in phase-I and phase-II 
metabolism, all of which are involved in detoxification, is associated with longevity.  
However, data on regulation of XPGs in CR mice are very inconsistent, mainly due to 
variation of diets (purified diet/non-purified, calories, and nutrition composition), different 
feeding regimes (percent of restriction, feeding time, and duration of CR feeding), as well 
as the age and strain of mice.  Specific aim 3 utilized a "dose-response" model (0, 15, 
30, or 40% CR for one month), to investigate the regulation of XPG expression in liver by 
graded CR under the same study design. 
Specific aim 4 was designed to determine the effect of CR on the enterohepatic 
circulation of BAs.  In addition to the regulatory role of BAs in nutrient and energy 
homeostasis, a couple of reports have recently suggested that BAs are possibly 
anti-aging molecules.  In long-lived Little mice, elevated levels of BAs activate the 
expression of many XPGs possibly via BA nuclear receptor FXR, and increases 
resistance to xenobiotic stress, which possibly contributes to longevity.  A chemical 
screen identified lithocholic acid (a secondary BA) as an anti-aging compound that 
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extended the life span of yeast.  Moreover, 3-keto BA-like steroids, called dafachronic 
acids, have dual roles in modulating the life span of C. elegans.  Given the promising 
association of BAs and longevity, studying the regulation of BAs in the best-known 
anti-aging intervention CR is of great importance.  For the first time, BA metabolism was 
investigated in CR models.  To systematically determine the regulation of BA 
enterohepatic circulation by graded CR, individual BAs were quantified by UPLC-MS/MS 
in serum, liver, gallbladder, as well as small and large intestine of mice fed an ad libitum 
or CR (15, 30, or 40%) diet for one month.  Furthermore, the expression of genes 
involved in the enterohepatic circulation of BAs was quantified to mechanistically explain 
the CR-induced changes of BA concentrations and composition. 
In summary, utilizing a "dose-response" model of CR, analytical tools, and 
molecular techniques, the present dissertation has investigated the alterations of XPG 
expression in liver and BA homeostasis with aging, and more importantly the regulation 
of XPG expression in liver, and the enterohepatic circulation of BAs by the best known 
anti-aging intervention CR.  The data generated from these studies will provide further 
evidence to the detoxification theory of aging and further understand the possible role of 
BAs as longevity signaling molecules, and may provide useful information on drug 
elimination pathways that one should monitor in the elderly as well as people on diets. 
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Chapter 3: EXPERIMENTAL MATERIALS AND METHODS 
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3.1  Chemicals and Reagents.   
The sources of individual BA standards and internal standards are described 
previously by Zhang and Klaassen (Zhang and Klaassen, 2010).  Rabbit anti-rat Ntcp 
antibody (K4), which has cross-reactivity with mouse Ntcp, was a generous gift from 
Bruno Steiger (University Hospital, Zurich, Switzerland).  A polyclonal antibody to 
mouse Oatp1b2 was developed in our laboratory.  β-Actin antibody (ab8227) was 
purchased from Abcam, Inc. (Cambridge, MA).  Goat anti-rabbit IgG horseradish 
peroxidase-linked secondary antibody was purchased from Sigma-Aldrich (St. Louis, 
MO).  All other chemicals and reagents, unless indicated, were purchased from 
Sigma-Aldrich (St. Louis, MO). 
3. 2  Animals and Husbandry. 
All mice were housed in an AAALAC-accredited facility at the University of 
Kansas Medical Center, with a 14-h light/10-h dark-cycle, in a temperature-, and 
humidity-controlled environment and ad libitum access to water.  All animal experiments 
were approved by the Institutional Animal Care and Use Committee at the University of 
Kansas Medical Center. 
Aging study.  To investigate the effect of aging on XPG expression in liver and 
BA homeostasis, male (M) and female (F) C57BL/6 mice of various ages were 
purchased from the National Institute of Aging (Bethesda, MD) and acclimated for at 
least one month before tissue collections.  Mice were given ad libitum access to 
standard rodent chow (Harlan Teklad 8604; Harlan Teklad, Madison, WI), until they 
reached 3, 6, 9, 12, 15, 18, 21, 24, and 27 months of age. 
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CR study.  To investigate the regulation of XPG expression in liver and BA 
enterohepatic circulation by CR, male C57BL/6 mice (3-month old) were purchased from 
Charles River Laboratories (Wilmington, MA), fed with purified AIN-93M diet (TD94048, 
Harlan Teklad, Madison, WI) for one week, and then randomly divided into four 
experimental groups, namely ad libitum (AL), 15% CR, 30% CR, and 40% CR (n=5).  
All mice were housed individually, and the AL control mice were given ad libitum access 
to TD94048 diet throughout this study.  The diet consumption of the AL group was 
recorded daily, and subsequently 85%, 70%, and 60% of this amount were given to 15%, 
30%, and 40% CR groups, respectively, for one month.  Feed was given between 
17:00-18:00 daily.  CR mice finished their daily feed within 2 hours after feeding.  In 
order to prevent sudden weight loss, a gradual decrease in feed was provided to the 
mice one week before the start of CR feeding (Table 3.1).  In order to prevent 
malnutrition caused by insufficient intake of macronutrients or micronutrients, custom 
enriched diets TD110466, TD110467, and TD110468 were designed to feed 15%, 30%, 
and 40% CR groups, respectively (Table 3.2).  Body weights were recorded weekly. 
3.3  Glucose Tolerance Test (GTT).   
CR study.  GTT was performed in all four groups of mice on Day 21 of CR 
feeding.  The AL mice were fasted for 6 h starting from 8 AM, and the CR mice had 
finished their daily allots of feed the previous night.  A single dose of D-glucose (20% 
solution in water; 10 mL/kg) was injected i.p.  Blood was taken from tails of mice at 0, 
30, 60, 90, and 120 min thereafter, and glucose concentrations were determined using a 
ReliOn Ultima glucose monitor (Arkray USA, Inc., Minneapolis, MN). 
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Table 3.1.  Scheme of the CR study 
 
  Day -7 to Day -4 Day -3 to Day 0 Day 1 to Day 30 
AL  DI* (TD94048) DI (TD94048) DI (TD94048) 
15% CR 90%DI (TD94048) 90%DI (TD94048) 85%DI (TD110466) 
30% CR 85%DI (TD110466) 85%DI (TD110466) 70%DI (TD110467) 
40% CR 85%DI (TD110466) 70%DI (TD110467) 60%DI (TD110468) 
 
* DI: daily intake of food (g) of mice under AL feeding.  DI was recorded daily.
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Table 3.2.  Custom diet formula 
 
experiment group AL 15% CR 30% CR 40% CR 
Diet ID TD94048 TD110466 TD110467 TD110468 
Diet intake (g) 100% 85% 70% 60% 
Formula (g/kg) 
    Casein 140 164.7 200 233.3 
    L-cystine 1.8 2.1 2.6 3 
    Corn Starch 466 420 354 295 
    Maltodextrin 155 155 155 155 
    Sucrose 100 100 100 100 
    Soybean Oil 40 47.1 57.1 66.7 
    Cellulose 50 55 63 67.8 
    Mineral Mix (94049) 35 41.2 50 58.3 
    Vitamin Mix (94047) 10 11.8 14.3 16.7 
    Choline Bitartrate 2.5 2.9 3.6 4.2 
    TBHQ, antioxidant 0.008 0.009 0.011 0.013 
Calorie (kcal/g) 3.6 3.6 3.6 3.6 
 
All custom diets were designed based on purified AIN-93M diet.  
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3. 4  Sample Collection. 
All sample collections were between 9:00 and 12:00 in the morning, to minimize 
the variations due to the circadian rhythm of XPG expression (Zhang et al., 2009) and 
BA metabolism (Zhang et al., 2011a). 
Aging study.  At 3, 6, 9, 12, 15, 18, 21, 24, and 27 months of age, mice (n=5-7) 
were anesthetized with pentobarbital (50 mg/kg, i.p.), and serum was collected from the 
suborbital vein.  After cervical dislocation, liver and ileum (posterior one third of small 
intestine) were removed, snap-frozen in liquid nitrogen, and stored at -80°C.   
CR study.  Fasting plasma was collected on Day 24 of CR feeding.  The AL 
mice were fasted for 4 h starting from 8 AM, and the CR mice had finished their daily 
allots of feed the previous night.  All mice were anesthetized with pentobarbital (50 
mg/kg), and then about 100 μL of plasma was collected by retro-orbital bleeding using 
heparin-coated capillary tubes.  At the end of the one-month CR feeding, all mice were 
anesthetized with pentobarbital (50 mg/kg), and serum was collected by retro-orbital 
bleeding.  After cervical dislocation, liver and gallbladder (GB) were removed, 
snap-frozen in liquid nitrogen, and stored at -80°C.  The small (SI) and large intestine 
(LI) were flushed with 10 mL saline and the intestinal contents were collected separately 
on ice, and stored at -80°C.  The SI and LI tissue were divided into three (duodenum, 
jejunum, and ileum) and two (cecum and colon) sections respectively, and collected 
separately, and stored at -80°C. 
3.5  Total RNA Isolation.   
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Total RNA was isolated from liver tissue using RNA Bee reagent (Tel-Test Inc., 
Friendswood, TX) following the manufacturer's protocol.  The concentration of total 
RNA in each sample was quantified spectrophotometrically at 260 nm.  High quality of 
RNA was confirmed by visualizing two discrete rRNA bands in a RNA gel, with the 28S 
band doubling the intensity of the 18S band. 
3.6  Multiplex Suspension Assay.   
Aging study.  The mRNAs of XPGs in liver were quantified in Chapter 4 by 
Panomics 2.0 QuantiGene Plex technology (Panomics/Affymetrix Inc., Fremont, CA), 
following the manufacturer's protocol.  Individual gene information can be found on 
Panomics web site (http://www.panomics.com) with Panel numbers 21079, 21095, 
21152, 21153, 21174, 21175, 21176, and 21197.  Table 3.3 listed all XPGs that were 
quantified by multiplex suspension assay.  The mRNAs of BA-related genes were 
quantified in Chapter 5 by multiplex suspension assay (Panels 21095, 21151, and 
21152).  
CR study.  The mRNAs of XPGs in liver were quantified in Chapter 6 by 
multiplex suspension assay (Panels 21079, 21150, 21152, 21153, 21174, 21175, and 
21176).  The mRNAs of genes encoding BA synthetic enzymes (Cyp7a1, Cyp8b1, 
Cyp27a1, and Cyp7b1) and BA transporters in liver (Ntcp, Oatp1b2, and Bsep), as well 
as intestinal genes (Fgf15) were also quantified in Chapter 7 by multiplex suspension 
assay (Panel 21150).   
Fluorescence was analyzed using a Bio-Plex 200 system array reader with 
Luminex 100 X-MAP technology, and data were acquired using Bio-Plex data manager 
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software 5.0 (Bio-Rad, Hercules, CA).  The mRNAs of target genes were normalized to 
housekeeping gene glyceraldehyde 3-phophate dehydrogenase (Gapdh).   
3.7  Branched DNA Assay.   
The branched DNA (bDNA) assay (Quantigene High Volume bDNA Signal 
Amplification Kit; Panomics/Affymetrix Inc., Fremont, CA) was used to quantify the 
mRNA of catechol-O-methyltransferase (Comt) in Chapter 4, because this gene was not 
included in any pre-designed panels of the multiplex suspension assay.  The assay was 
performed as described previously (Cheng et al., 2005).  Probe sets (containing capture 
extenders, label extenders, and blockers) specific to Comt were designed using 
ProbeDesigner software (Bayer Corp., Emeryville, CA), shown in Table 3.4. 
3.8  Reverse Transcription and Real-time PCR Analysis.   
Total RNA was transcribed to single-stranded cDNA using a High Capacity cDNA 
Reverse Transcription Kit 1001073 (Applied Biosystems, Foster City, CA), and then the 
cDNA products were amplified by PCR, using Power SYBR Green PCR Master Mix in a 
7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA).  The 
sequences of all real-time PCR primers (Integrated DNA Technologies, Coralville, IA) 
are listed in Table 3.5. 
Aging study.  The mRNAs of Gapdh in livers of male and female mice at 3 and 
27 months of age were quantified in Chapter 4.  The mRNAs of BA conjugating 
enzymes (BAL and BAT) and BA transporters in ileum (Asbt, Ostα, and Ostβ) were 
quantified in quantified in Chapter 5, normalized to β-actin. 
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CR study.  The mRNAs of Comt and transcription factors were quantified in 
Chapter 6, and normalized to β-actin.  The real-time PCR primers for Comt were 
designed as universal primers to detect all of the three transcripts of Comt.  The 
mRNAs of genes encoding BA conjugating enzymes (BAL and BAT), BA transporters in 
ileum (Asbt, Ostα, and Ostβ), ileal BA binding protein (Ibabp), and proteins involved in 
Cyp7a1 regulation (FXR, SHP, Fgf15, and Fgfr4) were quantified in Chapter 7, and 
normalized to β-actin.   
.   
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Table 3.3.  Summary of XPGs quantified by multiplex suspension assay in mice 
liver. 
Uptake 
Transporters 
Oatp1a1, Oatp1a4, Oatp1b2, Oatp2b1, Oct1, Oat2, Ent1 
Phase-I Enzymes 
Cyp1a1, Cyp1a2, Cyp2b10, Cyp3a11, Cyp4a14, Por, Nqo1 
Fmo1, Fmo2, Fmo3, Fmo4, Fmo5, Fmo9, Fmo12, Fmo13 
Adh1, Adh4, Adh5, Adh6b, Adh7, Adhfe1 
Aldh1a1, Aldh1a7, Aldh1b1, Aldh2, Aldh3a2, Aldh4a1, 
Aldh6a1, Aldh7a1, Aldh8a1, Aldh9a1 
Ces1c, Ces1e, Ces1f, Ces1g, Ces2c, Ces3a, Aadac, Esd 
Pon1, Pon3 
Phase-II Enzymes 
Sult1a1, Sult1d1, Sult1e1, Sult2a1/2, Sult3a1, Sult5a1, 
Papss1, Papss2 
Ugt1a1, Ugt1a5, Ugt1a6a, Ugt1a9, Ugt2a3, Ugt2b1, Ugt2b34, 
Ugt2b35, Ugt2b36, Ugt3a1, Ugt3a2, Ugp2, Ugdh 
Gsta1, Gsta4, Gstm1, Gstm2, Gstm3, Gstm4, Gstm6, Gstp1, 
Gstp2, Gstt1, Gstt2, Mgst1, Mgst3 
Nat1, Nat2, Nat3 
Efflux Transporters 
Mrp2, Mrp3, Mrp4, Mrp6, Mate1, Mdr2, Bcrp, Abca1, Abcg5, 
Abcg8 
 
(Major XPGs were quantified in this dissertation.  The selection was based on our 
laboratory's experience and the known functions of XPGs on xenobiotic metabolism.) 
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Table 3.4.  Oligonucleotide probes for quantifying mouse Comt mRNA by the 
branched DNA assay. 
Comt (Accession No: NM_001111063) 
Target 
Region Function Sequence 
301-319 CE ggatgcgctgctcctttgtTTTTTctcttggaaagaaagt 
337-355 CE ggtctccaggctttgcgtgTTTTTctcttggaaagaaagt 
476-497 CE caataagctcctagctccagcaTTTTTctcttggaaagaaagt 
550-572 CE tcagggttaatctccatggtgagTTTTTctcttggaaagaaagt 
356-373 LE cctccaggacgctctgggTTTTTaggcataggacccgtgtct 
374-398 LE ttctctgagcagtaggtatcaatggTTTTTaggcataggacccgtgtct 
399-417 LE cacgttcatggcccactccTTTTTaggcataggacccgtgtct 
436-456 LE ccgaatcactgcatccatgatTTTTTaggcataggacccgtgtct 
457-475 LE ccagcgagggcctgtactcTTTTTaggcataggacccgtgtct 
498-515 LE cgcacggctgagtagccaTTTTTaggcataggacccgtgtct 
320-336 BL Ttgctgcacatggcgca 
418-435 BL Ttggccttttgcgtcacc 
516-531 BL Cagcaggcgggccatt 
532-549 BL Aagcctggctccaggtgg 
• CE, capture extender; LE, label extender; BL, blocker. 
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Table 3.5.  Sequences of Real-Time PCR primers 
Gene  Accession Number Sequences 
Comt * NM_001111062, Comt-F 5'-cacgaactcaaaccaaccaa-3' 
NM_007744, NM_001111063 Comt-R 5'-ctgttggctgctgtctcatt-3' 
AhR NM_ 013464 AhR-F 5'- accagaactgtgagggttgg-3' 
AhR-R 5'- ctcccatcgtatagggagca-3' 
CAR NM_ 009803 CAR-F 5'- ctcaaggaaagcagggtcag-3' 
CAR-R 5'- agttcctcggcccatattct-3' 
PXR AF031814 PXR-F 5'- cccatcaacgtagaggagga-3' 
PXR-R 5'-tctgaaaaaccccttgcatc-3' 
PPARα NM_ 011144 PPARα -F 5'-atgaagagggctgagcgtag-3' 
PPARα -F 5'-aaacgcaacgtagagtgctgt-3' 
Nrf2 BC026943 Nrf2-F  5'-cgagatatacgcaggagaggtaaga-3' 
Nrf2-R 5'-gctcgacaatgttctccagctt-3' 
BAL  NM_009512 BAL-F 5'-tgtgtgtgaaggaacctgga-3' 
BAL-R 5'-acccggacaactttgtgaag-3' 
BAT  NM_007519 BAT-F 5'-tagagcacaccacgttcctg-3' 
BAT-R 5'-gcacaggctcatcaacaaga-3' 
Asbt NM_011388 Asbt-F 5'-tggaatgcagaacactcagc-3' 
Asbt-R 5'-gcaaagacgagctggaaaac-3' 
Ostα  NM_145932 Ostα-F 5'-ttgtgatcaaccgcatttgt-3' 
Ostα-R 5'-ctcctcaagcctccagtgtc-3' 
Ostβ  NM_178933 Ostβ-F 5'-atcctggcaaacagaaatcg-3' 
Ostβ-F 5'-ggccaagtctggtttctctg-3' 
Ibabp  NM_008375 Ibabp-F 5'-caccattggcaaagaatgtg-3' 
Ibabp-R 5'-aacttgtcacccacgacctc-3' 
FXR  NM_009108 FXR-F 5'-tgggtaccagggagagactg-3' 
FXR-R 5'-gtgagcgcgttgtagtggta-3' 
SHP NM_011850 SHP-F 5'-ctcatggcctctaccctcaa-3' 
SHP-R 5'-ggtcacctcagcaaaagcat-3' 
Fgf15 NM_008003 Fgf15-F 5'-agaacagctccaggaccaga-3' 
Fgf15-R 5'-tccatgctgtcactctccag-3' 
Fgfr4  NM_008011 Fgfr4-F 5'-ctgccagaggaagacctcac-3' 
Fgfr4-R 5'-gtagtggccacggatgactt-3' 
β-actin  NM_007393 β-actin-F 5'-ggccaaccgtgaaaagatga-3' 
    β-actin-R 5'-cagcctggatggctacgtaca-3' 
Gapdh NM_008084 Gapdh-F 5'-aactttggcattgtggaagg-3' 
Gapdh-R 5'-ggatgcagggatgatgttct-3' 
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3.9  BA Extraction.   
Internal standards (40 µg/mL d4-G-CDCA and 20 µg/mL d4-CDCA in MeOH) were 
added to the samples, and BAs were extracted from serum and livers (Zhang and 
Klaassen, 2010), GBs (tissue with bile inside) (Zhang et al., 2011b), as well as SI and LI 
contents (Zhang et al., 2012b) using methods reported previously by our laboratory. 
3.10  BA Quantification by Ultra-performance Liquid Chromatography-Tandem 
Mass Spectrometry (UPLC-MS/MS).  
BAs were quantified by UPLC-MS/MS using methods reported previously by our 
laboratory (Zhang and Klaassen, 2010).  Major individual BAs quantified were TCA, 
TDCA, TCDCA, TLCA, TUDCA, TαMCA, TMDCA, TβMCA, TωMCA, THDCA, CA, DCA, 
CDCA, LCA, UDCA, αMCA, MDCA, βMCA, ωMCA, and HDCA.  The concentrations of 
individual BAs were summed to derive the concentrations of conjugated, unconjugated, 
and total BAs 
3.11  Plasma and Liver Lipid Parameters.   
CR study.  The triglycerides (TG; Pointe Scientific Inc, Canton, MI), total 
cholesterol (Wako Diagnostics, Richmond, VA), and nonesterified fatty acids (FAs; Wako 
Diagnostics, Richmond, VA) in fasting plasma collected on Day 24 of CR feeding were 
quantified using colorimetric assays according to the manufacturer's instructions.  Liver 
lipids were extracted as described previously (McGrath and Elliott, 1990), and the TG, 
total cholesterol, and FAs in liver were quantified with the same protocol as plasma 
lipids. 
3.12  Preparation of Crude Membrane Fractions.   
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Livers were homogenized in ST buffer (0.25 M sucrose, 10 mM Tris•HCl, pH 7.4) 
containing protease inhibitors and centrifuged at 100,000 g for 60 min at 4°C. The 
membrane pellet was rinsed and resuspended with ST buffer with protease inhibitor.  
Protein concentrations were determined using Pierce protein assay reagents accordingly 
to the manufacturer's instructions (Pierce Biotechnology, Rockford, IL). 
3.13  Western Blot Analysis.   
Western blots of Ntcp and Oatp1b2 were performed as previously described with 
minor modifications (Csanaky et al., 2009).  Primary antibodies were diluted in blocking 
buffer as follows: Ntcp (K4, 1:2000) and Oatp1b2 (1:1000).  Membranes were stripped 
and reprobed with β-actin antibody (ab8227, 1:10000) as the loading control.  
Intensities of protein bands were determined using the Image J software (National 
Institutes of Health). 
3.14  Statistical Analysis. 
Data are presented as mean ± SEM.   
Aging study.  In Chapters 4 and 5, asterisks (*)  represent gender differences 
between male and female mice, determined by Student’s t-test (p < 0.05).  Daggers (†) 
and double daggers (‡) represent age differences (p < 0.05) compared to 3 months of 
age in male and female mice, respectively, determined by one-way ANOVA, followed by 
Duncan's post-hoc test.  In Chapter 5, pound signs (#) indicate differences of BA 
proportions between 3 and 27 months. 
CR study.  In Chapters 6 and 7, data were analyzed by one-way ANOVA, 
followed by Duncan’s post-hoc test, differences being considered significant at p < 0.05 
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(*).  In Chapter 7, to compare the BA compositions between AL and 40% CR groups, 
data were analyzed by Student's t-test, differences being considered significant at p < 
0.05. 
3.15  Hierarchical Clustering Analysis. 
In Chapter 4, hierarchical clustering of XPGs that had mRNA changes with aging 
(p < 0.05, ANOVA) was performed using JMP 8.0 software (SAS Institute, Cary, NC).  
In Chapter 6, hierarchical clustering of XPGs that had mRNA changes by CR (p < 0.05, 
ANOVA) was also performed using JMP 8.0 software.  Relatively high mRNA is 
represented in red color, whereas relatively low mRNA is in blue.  The mRNA levels 
were normalized within each gene, so the relative color intensity is not comparable 
between genes. 
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Chapter 4: REGULATION OF XENOBIOTIC-PROCESSING GENE EXPRESSION IN 
LIVER OF MICE DURING AGING 
 
 
 
 
 
 
 
 
Adapted from Fu et al., 2012. Drug Metab Dispos, 40, 1216-1225, with permission from 
the publisher.  Copyright © 2012 by The American Society for Pharmacology and 
Experimental Therapeutics. 
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4.1  Abstract 
Aging is a physiological process characterized with progressive functional decline in 
various organs over time.  In order to reveal possible molecular mechanisms of altered 
xenobiotic disposition and toxicity in the elderly, age-dependent mRNA profiles of 101 
XPGs were characterized in livers of male and female mice from 3 to 27 months of age, 
including 7 uptake transporters, 41 phase−I enzymes, 36 phase−II enzymes, 10 efflux 
transporters, and 7 transcription factors.  Gender differences across the lifespan 
(significant at five ages or more) were observed for 52 XPGs, including 15 
male-predominant (e.g. Oatp1a1, Cyp3a11, Ugt1a6a, Comt, and Bcrp) and 37 
female-predominant genes (e.g. Oatp1a4, Cyp2b10, Sult1a1, Ugt1a1, and Mrp3).  
During aging , the mRNA levels of 44% of the 101 XPGs changed in male mice and 63% 
changed in female mice.  In male mice, mRNAs of 40 XPGs (e.g. Oatp1a1, Ces2c, 
Gstm4, Gstp1, and Ces1e) were lower in aged mice (over 21 months of age), whereas 
mRNAs of 4 XPGs (e.g. Oat2 and Gstm2) were higher in aged mice.  In female mice, 
mRNAs of 43 XPGs (e.g. Oatp1a1, Cyp1a2, Ces1f, Sult3a1, Gstt2, Comt, Ent1, Fmo3, 
and Mrp6) were lower in aged mice, whereas mRNAs of 21 XPGs (e.g. Oatp1a4, Nqo1, 
Adh7, Sult2a1/2, Gsta1, and Mrp4) were higher in aged mice.  In conclusion, 51% of the 
101 XPGs have gender differences in liver mRNA levels across the lifespan of mice, and 
the mRNAs of 40% of the XPGs are lower in aged male mice and 43% are lower in aged 
female mice.  
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4.2   Introduction 
Aging is characterized with declining physiological functions of various organs and 
increased incidence of multiple concomitant diseases such as diabetes, hypertension, 
and arthritis (Sandhiya and Adithan, 2008).  The older population, described as people 
over the age of 65, made up 12.8% of the U.S. population during the past decade.  This 
population is the recipient of approximately 33% of all prescription drugs and 40% of all 
nonprescription drugs.  The elderly have been reported to have changes in the 
absorption, distribution, metabolism, and excretion (ADME) of many drugs, such as 
non-steroid anti-inflammatory drugs, antihypertensive, anticonvulsant, and psychiatric 
drugs (Cusack, 2004).  In rodent studies, increased susceptibility to environmental 
chemicals has been observed during aging (Birnbaum, 1991). 
Gender differences in the baseline expression of many XPGs are regulated by sex 
hormones or sex-dependent growth hormone patterns (Waxman and O'Connor, 2006).  
Gender-divergent expression regulated by growth hormone secretion was reported for 
Cyps (Pampori and Shapiro, 1999), Sults (Liu and Klaassen, 1996; Alnouti and 
Klaassen, 2006), Ugts (Buckley and Klaassen, 2009), and Gsts (Srivastava and 
Waxman, 1993; Knight et al., 2007), as well as xenobiotic transporters (Tanaka et al., 
2005; Cheng et al., 2006; Maher et al., 2006).  Because of the altered sex hormones 
and growth hormone levels in old age (Rudman et al., 1990; Bjornerem et al., 2004), it is 
important to investigate the gender-differences of XPG expression during aging. 
Genome-wide studies of gene expression profiling have accelerated the research 
on transcriptional alterations by CR.  Most of the alterations in skeletal muscle of mice 
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during aging were completely or partially prevented by CR by a metabolic shift toward 
increased protein turnover and decreased macromolecular damage (Lee et al., 1999).  
The same group showed CR selectively attenuated age-associated induction of genes 
involved in inflammatory and stress responses in the brain (Lee et al., 2000).  CR was 
also shown to result in a 19% global inhibition of age-related changes in gene expression 
in mouse hearts (Lee et al., 2002). 
Previous studies concerning age-dependent expression of xenobiotic metabolism 
genes have been restricted to only a couple of age groups (Handler and Brian, 1997; 
Wauthier et al., 2004; Mori et al., 2007; Lee et al., 2008), and thus possible changes of 
XPG expression could have been missed.  Previous reports were primarily in rats, with 
limited data available for mice.  Mice are a common laboratory model due to the 
availability of well-characterized mouse genome and genetically engineered strains.  In 
addition, previous studies seldom report gender differences of XPG mRNA levels during 
aging.  Taken together, the present study was designed to investigate the 
comprehensive age-dependent mRNA profiles of XPGs in livers of both male and female 
C57BL/6 mice with aging. 
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4.3   Results 
In the present study, data at 3 and 27 months of age were compared most often, 
because they represent young adult and senescent ages respectively.  The mRNA 
levels of XPGs were normalized to Gapdh, which is the most commonly used 
house-keeping gene.  The mRNA of Gapdh was quantified by real-time PCR.  Gapdh 
mRNA remained relatively constant during aging and did not have gender differences 
(data not shown) (Fu et al., 2010b). 
4.3.1  Uptake Transporters during Aging.   
Among the uptake transporters that had decreased mRNAs with age, Oatp1a1 
mRNA decreased most markedly between 3 and 27 months of age (M: 55%; F: 100%), 
and Oct1 mRNA decreased slightly between 3 and 27 months (M: 28%; F: 24%) (Fig. 
4.1).  In contrast, Oatp1a4 mRNA increased 96% between 3 and 27 months in male 
mice, and 30% between 3 and 18 months in female mice.  Oatp2b1 mRNA at 9-27 
months was higher than 3 months in female mice, whereas in male mice the changes 
were not obvious.  Ent1 mRNA increased from 3 to 9 months and tended to decrease 
thereafter in female mice, whereas in male mice it remained constant.  The mRNA 
levels of Oatp1b2 and Oat2 remained relatively constant with aging.  The mRNA levels 
of most uptake transporters had significant gender differences across the lifespan, 
including male-predominant Oatp1a1 and female-predominant Oatp1a4, Oatp2b1, Oct1, 
and Ent1.  Oatp1a1 mRNA was more than 300% higher in male than female mice.  In 
contrast, Oatp1a4 mRNA was more than 300% higher in female than male mice.  The 
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mRNAs of Oatp2b1, Oct1, and Ent1 were all twice as high in female as those in male 
mice.   
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Fig. 4.1. 
 
 
The mRNA profiles of uptake transporters with aging in livers of male and female 
mice.  Asterisks (*) represent gender differences, determined by student t-test (p < 
0.05).  Daggers (†) and double daggers (‡) represent age differences (p < 0.05) 
compared to 3 months of age in male and female mice, respectively, determined by 
one-way ANOVA, followed by Duncan's post-hoc test.   
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4.3.2  Phase−I Xenobiotic Metabolizing Enzymes during Aging.   
With aging, the mRNAs of Cyp1a1 (M and F) and Cyp1a2 (M and F) decreased 
approximately 50% between 3 and 27 months of age (Fig. 4.2).  Cyp3a11 mRNA 
decreased about 50% between 3 and 27 months in female mice, whereas it remained 
relatively constant with age in male mice.  Interestingly, Nqo1 mRNA level remained 
relatively constant with age in male mice, but doubled between 3 and 27 months in 
female mice.  The mRNA levels of Cyp2b10, Cyp4a14, and Por remained relatively 
constant with aging in both genders.  Most Cyps had female-predominant mRNA 
patterns across the lifespan: the mRNAs of Cyp2b10 (10-fold) and Cyp4a14 (8-fold) 
were higher in female than male mice.  The mRNAs of Cyp1a1, Por, and Nqo1 were 
also higher in female mice.  Cyp3a11 was the only Cyp gene with a male-predominant 
mRNA pattern.   
The mRNA levels of Fmos did not change much with aging (Fig. 4.3).  The mRNAs 
of Fmo2, 3, and 4 had a moderate increase between 3 and 27 months in female mice.  
Fmo4 mRNA in male mice also increased moderately between 3 and 27 months of age.  
The mRNA levels of a number of Fmos had a female-predominant pattern across the 
lifespan.  Remarkably, Fmo3 mRNA was about 200-fold higher in female than male 
mice.  In addition, higher mRNAs in females were also observed for Fmo1, Fmo2, and 
Fmo4.  In contrast, Fmo5 mRNA level was male-predominant across the life span. 
Adh4 mRNA decreased about 50% between 3 and 27 months of age in female mice 
(Fig. 4.4).  Interestingly, Adh6b decreased 29% in male mice and increased 16% in 
female mice between 3 and 27 months.  The mRNA of Adh7 increased 93% in female 
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mice between 3 and 18 months.  The mRNA levels of Adh1, Adh5, and Adhfe1 did not 
change much with aging.  Most Adh mRNA levels did not show a consistent 
gender-divergent pattern across the lifespan.  Adh4 mRNA level was 
male-predominant, whereas Adh6b was female-predominant after one year old. 
Aldh1a1 mRNA at 6-27 months was 33% lower than 3 months in female mice (Fig. 
4.5).  The mRNA of Aldh1a7 increased between 3 and 15 months of age in male mice.  
The mRNAs of Aldh2 and Aldh9a1 increased between 3 and 12 months and decreased 
thereafter in both genders. The mRNA levels of the remaining Aldhs remained relatively 
constant with aging.  A number of the Aldh mRNA levels had a female-predominant 
pattern across the lifespan, including Aldh3a2, 4a1, and 6a1, which were 100% higher in 
female than male mice.  Interestingly, Aldh7a1 mRNA was higher in male than female 
mice only between 15 and 27 months.   
For many Cess, such as Ces1c, Ces1e, and Esd, the highest mRNAs were 
observed when the mice were about 12 months of age and decreased thereafter (Fig. 
4.6).  Decreased mRNAs were observed for Ces1f (F: 49%), Ces2c (M: 60%; F: 49%), 
and Ces3a (F: 75%) between 3 and 27 months of age.  Most of the Ces and Pon mRNA 
levels did not show gender-divergent patterns, except Ces2c and Ces3a, which had a 
male-predominant mRNA pattern, which was 200% higher in male than female mice.   
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Fig. 4.2. 
 
 
The mRNA profiles of major cytochrome P450s (P450s), P450 reductase (Por), and 
NAD(P)H:quinone oxidoreductase (Nqo1) with aging in livers of male and female 
mice.  Asterisks (*) represent gender differences, determined by student t-test (p < 
0.05).  Daggers (†) and double daggers (‡) represent age differences (p < 0.05) 
compared to 3 months of age in male and female mice, respectively, determined by 
one-way ANOVA, followed by Duncan's post-hoc test. 
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Fig. 4.3. 
 
 
The mRNA profiles of flavin-containing monooxygenases (Fmos) with aging in 
livers of male and female mice.  Asterisks (*) represent gender differences, 
determined by student t-test (p < 0.05).  Daggers (†) and double daggers (‡) represent 
age differences (p < 0.05) compared to 3 months of age in male and female mice, 
respectively, determined by one-way ANOVA, followed by Duncan's post-hoc test. 
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Fig. 4.4. 
 
 
 
The mRNA profiles of alcohol dehydrogenases (Adhs) with aging in livers of male 
and female mice.  Asterisks (*) represent gender differences, determined by student 
t-test (p < 0.05).  Daggers (†) and double daggers (‡) represent age differences (p < 
0.05) compared to 3 months of age in male and female mice, respectively, determined 
by one-way ANOVA, followed by Duncan's post-hoc test. 
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Fig. 4.5. 
 
 
The mRNA profiles of aldehyde dehydrogenases (Aldhs) with aging in livers of 
male and female mice.  Asterisks (*) represent gender differences, determined by 
student t-test (p < 0.05).  Daggers (†) and double daggers (‡) represent age differences 
(p < 0.05) compared to 3 months of age in male and female mice, respectively, 
determined by one-way ANOVA, followed by Duncan's post-hoc test. 
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Fig. 4.6. 
 
 
 
The mRNA profiles of carboxylesterases (Cess) and paraoxonases (Pons) with 
aging in livers of male and female mice.  Asterisks (*) represent gender differences, 
determined by student t-test (p < 0.05).  Daggers (†) and double daggers (‡) represent 
age differences (p < 0.05) compared to 3 months of age in male and female mice, 
respectively, determined by one-way ANOVA, followed by Duncan's post-hoc test. 
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4.3.3  Phase−II Xenobiotic Metabolizing Enzymes during Aging.   
Sults catalyze the conjugation of xenobiotics with sulfate groups, and the 
3'-phosphoadenosine 5'-phosphosulfate synthetase (Papss) catalyzes the synthesis of 
the sulfate donor for all Sults.  In contrast to the changes of mRNA levels of most XPGs 
during aging, the mRNAs of a number Sults increased with age in mice (Fig. 4.7).  
Increased mRNAs with age were observed for Sult1a1 (M: 123%; F: 40%), Sult1e1 (M: 
9.8-fold; F: 315-fold), Sult2a1/2 (F: 732%), and Papss1 (M: 211%, F: 209%).  In 
contrast, Sult3a1 mRNA decreased 76% in the aged female mice, and Sult5a1 
decreased about 50% between 3 and 27 months of age in both genders.  The mRNAs 
of Sult1d1 and Papss2 peaked at 18 months of age in female mice.  The mRNA levels 
of the majority of Sults had marked female-predominant patterns across the lifespan, 
namely Sult1a1, 1d1, 1e1, 2a1/2, 3a1, and 5a1.  In addition, Papss2 mRNA level had a 
female-predominant pattern.   
Ugts catalyze the conjugation reaction with glucuronic acids, and UDP-glucose 
pyrophosphorylase 2 (Ugp2) catalyzes the synthesis of UDP-glucose from 
glucose-1-phosphate, which is an important precursor for the glucuronidation 
co-substrate UDP-glucuronic acid.  The mRNAs of Ugt2b1 (M: 36%; F: 60%) and 
Ugt2b35 (M: 30%) decreased between 3 and 27 months of age (Fig. 4.8).  Ugt2b36 
mRNA also decreased in aging male and female mice.  Ugt1a6a mRNA reached peaks 
at 12 months of age in both genders.  The mRNAs of Ugt3a1 and Ugt3a2 reached 
peaks at 12 months in male mice. Ugp2 mRNA decreased between mid-age and old-age 
in both genders.  The mRNA levels of Ugt1a1, 1a5, 1a9, 2a3, and 2b34 did not change 
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much with aging.  The mRNA levels of some Ugts had female-predominant patterns 
across the lifespan, namely Ugt1a1, Ugt1a5, Ugt1a9, and Ugt2b34.  In contrast, 
Ugt1a6a, 2b1, and 2b35 had male-predominant pattern.   
Gsta1 mRNA increased (M: 183%; F: 124%) between 3 and 27 months of age in 
both genders (Fig. 4.9).  Gstm3 mRNA increased 112% between 3 and 27 months in 
female mice.  A 35-50% decrease in mRNAs between 3 and 27 months was observed 
for Gstm4 (M), Gstm6 (F), Gstp1 (M), and Gstt2 (M and F).  The mRNA of Gstp2 
increased 95% between 3 and 27 months in male mice, whereas it decreased 43% in 
female mice.  Mgst3 mRNA increased slightly between 6 and 18 months in both 
genders.  Some of the Gst mRNAs had female-predominant patterns across the 
lifespan (namely Gstm2, Gstt1, and Mgst3), whereas some had male-predominant 
patterns (namely Gstm6, Gstp1, and Gstp2).  Gstp1 and Gstp2 mRNAs were about 
300% higher in male than female mice, whereas Gstt1 and Mgst3 mRNAs were 200% 
higher in female than male mice.   
Nat1 mRNA increased (M: 60%; F: 35%) between 3 and 27 months of age, whereas 
Nat2 mRNA level did not change much with aging (Fig. 4.10).  Comt mRNA decreased 
markedly (93%) between 3 and 27 months of age in female mice, whereas it remained 
relatively constant in male mice.  The mRNAs of Nats did not have marked 
gender-divergent patterns across the lifespan.  Comt mRNA level had a 
male-predominant pattern in aging mice.   
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Fig. 4.7. 
 
 
 
The mRNA profiles of sulfotransferases (Sults) and 3'-phosphoadenosine 
5'-phosphosulfate synthetase (Papss) enzymes with aging in livers of male and 
female mice.  Asterisks (*) represent gender differences, determined by student t-test 
(p < 0.05).  Daggers (†) and double daggers (‡) represent age differences (p < 0.05) 
compared to 3 months of age in male and female mice, respectively, determined by 
one-way ANOVA, followed by Duncan's post-hoc test. 
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Fig. 4.8. 
 
 
 
The mRNA profiles of UDP-glucuronosyltransferase (Ugts) and UDP-glucose 
pyrophosphorylase (Ugp2) with aging in livers of male and female mice.  Asterisks 
(*) represent gender differences, determined by student t-test (p < 0.05).  Daggers (†) 
and double daggers (‡) represent age differences (p < 0.05) compared to 3 months of 
age in male and female mice, respectively, determined by one-way ANOVA, followed by 
Duncan's post-hoc test. 
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Fig. 4.9. 
 
The mRNA profiles of glutathione S-transferases (Gsts) with aging in livers of 
male and female mice.  Asterisks (*) represent gender differences, determined by 
student t-test (p < 0.05).  Daggers (†) and double daggers (‡) represent age differences 
(p < 0.05) compared to 3 months of age in male and female mice, respectively, 
determined by one-way ANOVA, followed by Duncan's post-hoc test. 
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Fig. 4.10. 
 
The mRNA profiles of N-acetyltransferases (Nats) and catechol-O-methyl 
transferase (Comt) with aging in livers of male and female mice.  Asterisks (*) 
represent gender differences, determined by student t-test (p < 0.05).  Daggers (†) and 
double daggers (‡) represent age differences (p < 0.05) compared to 3 months of age in 
male and female mice, respectively, determined by one-way ANOVA, followed by 
Duncan's post-hoc test. 
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4.3.4  Efflux Transporters during Aging.   
Mrp4 mRNA increased 363% between 3 and 27 months of age in female mice, 
whereas it remained relatively constant in male mice (Fig. 4.11).  A significant decrease 
of mRNA between 3 and 27 months was observed in male mice for Mrp3 (26%) and Bcrp 
(27%).  Mrp2, Mrp3, Mrp6, Abca1, and Abcg8 mRNAs peaked at 12 months of age in 
female mice.  The mRNA levels of some efflux transporters had female-predominant 
mRNA patterns, such as Mrp3, Mrp4, Mate1, and Mdr2.  In contrast, Bcrp had a 
male-predominant mRNA pattern.   
4.3.5  Transcription Factors during Aging.   
With aging, the mRNA levels of all the transcription factors remained relatively 
constant (Fig. 4.12).  The mRNAs of AhR and HNF1α were slightly higher at 24 and 27 
months of age than at 3 months in male mice.  The mRNA levels of AhR and CAR were 
female-predominant across the life span.  The mRNA levels of remaining transcription 
factors did not have gender differences.   
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Fig. 4.11. 
 
 
The mRNA profiles of efflux transporters with aging in livers of male and female 
mice.  Asterisks (*) represent gender differences, determined by student t-test (p < 
0.05).  Daggers (†) and double daggers (‡) represent age differences (p < 0.05) 
compared to 3 months of age in male and female mice, respectively, determined by 
one-way ANOVA, followed by Duncan's post-hoc test. 
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Fig. 4.12. 
 
The mRNA profiles of major transcription factors with aging in livers of male and 
female mice.  Asterisks (*) represent gender differences, determined by student t-test 
(p < 0.05).  Daggers (†) and double daggers (‡) represent age differences (p < 0.05) 
compared to 3 months of age in male and female mice, respectively, determined by 
one-way ANOVA, followed by Duncan's post-hoc test. 
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4.3.6  Hierarchical Cluster Analysis of Age-dependent mRNA Profiles of 
Xenobiotic Processing Genes.    
The mRNA levels of 44% of the 101 XPGs changed with aging in male mice and 
63% changed in female mice.  The mRNA profiles of these XPGs with age (Fig. 4.13) 
were analyzed by hierarchical cluster analysis, with red color representing relatively high 
and blue for relatively low mRNAs. The age-dependent changes of mRNA levels of these 
XPGs could be classified into three clusters for both genders (Table 4.1), namely 
early-age pattern (highest level observed at 3-9 months of age), mid-age pattern (highest 
level observed at 12-18 months of age), and old-age pattern (highest level observed at 
21-27 months of age).  In male mice, mRNAs of 40 XPGs (e.g. Oatp1a1, Ces2c, 
Gstm4, Gstp1, and Ces1e) were lower in aged mice (over 21 months of age), whereas 
mRNAs of 4 XPGs (e.g. Oat2 and Gstm2) were higher in aged mice.  In female mice, 
mRNAs of 43 XPGs (e.g. Oatp1a1, Cyp1a2, Ces1f, Sult3a1, Gstt2, Comt, Ent1, Fmo3, 
and Mrp6) were lower in aged mice, whereas mRNAs of 21 XPGs (e.g. Oatp1a4, Nqo1, 
Adh7, Sult2a1/2, Gsta1, and Mrp4) were higher in aged mice.  In conclusion, the 
mRNAs of 40% of the XPGs were lower in aged male mice and 43% were lower in aged 
female mice. 
  
 
 
82 
 
Fig. 4.13. 
 
Hierarchical cluster analysis of the mRNA profiles of XPGs during aging in livers 
of male and female mice.  Clustering analysis results are shown in the dendrogram, 
with y-axis representing the XPGs that change with aging and x-axis representing the 
nine age groups of mice (from 3 to 27 months).  The red color represents relatively high 
mRNAs and blue represents relatively low mRNAs.  The spectrum of each gene is 
standardized and specific to the scale of its own mRNA.  Therefore, it is not valid to 
compare the mRNA levels among different genes according to the color. 
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Table 4.1.  Summary of three patterns of age-dependent mRNA changes of XPGs 
in livers of male and female mice. 
 
Patterns Male Female
early-age 15/101* 20/101 
mid-age 25/101 23/101 
old-age 4/101 21/101 
 
XPGs that don't change with aging:  male: 57/101; female: 37/101. 
* means the ratio of the number of XPGs in each pattern of age-dependent changes of 
mRNA to the total number of XPGs.  
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4.5   Discussion 
The present study characterizes comprehensive mRNA profiles of XPGs with aging 
in livers of mice.  Nine groups of mice from 3 to 27 months of age are examined, which 
gives much more details of age-dependent changes than previous reports (Peng et al., 
2005; Mori et al., 2007; Lee et al., 2008).  Using both male and female mice, the  
present study uniquely reveals gender-divergent mRNA profiles of XPGs across the life 
span. 
Many uptake transporters are altered during aging.  Oatps are sodium-independent 
uptake transporters whose substrates are diverse, mainly amphipathic organic 
compounds, including bile acids, hormones and their conjugates, toxins, and various 
drugs (Hagenbuch and Gui, 2008).  The mRNA of liver-enriched Oatp1a1 decreases 
more than 50% in aged males, and surprisingly decreases almost 100% in aged females 
(Fig. 4.1).  The mRNA of liver-specific Oatp1b2 decreases from 12 to 27 months of age 
in females.  The mRNA of organic cation uptake transporter Oct1 decreases during 
aging in both genders.  Taken together, liver appears to remove xenobiotics from the 
blood more slowly in the elderly. 
The phase-I enzymes that are altered most during aging are Cyp and Ces families.  
Cyps are heme-containing enzymes, which catalyze monooxygenase reactions.  The 
Cyp1, Cyp2, and Cyp3 families are the Cyps primarily involved in the metabolism of 
drugs, xenobiotics, and steroids (Monostory and Dvorak, 2011).  Most of the Cyps 
quantified in the present study have an age-dependent decrease in mRNAs, such as 
Cyp1a1 (F) and Cyp1a2 (M and F), as well as Cyp3a11 (F) to a lesser degree (Fig. 4. 
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2.).  This suggests a possible mechanism for decreased metabolism of some 
xenobiotics in the elderly.  Cess catalyze the hydrolysis of many clinically useful drugs 
with ester moieties, resulting in mainly inactivation of drugs (such as heroin, cocaine, and 
flumazenil) as well as the activation of prodrugs (such as anticancer drugs CPT-11 and 
capecitabine) (Redinbo and Potter, 2005).  The nomenclature of mouse Cess in the 
present study was reported previously (Holmes et al., 2010).  The decreased mRNAs of 
Cess1f, 2c, and 3a during aging in females (Fig. 4.6) indicates it may take longer for the 
anticancer prodrugs to take effect in the elderly, and the ester drugs may have longer 
half-life in the elderly.  For other phase-I enzymes, such as Fmos (Fig. 4.3), Adhs (Fig. 
4.4), Aldhs (Fig. 4.5), and Pons (Fig. 4.6), aging has little effect on their mRNA levels. 
Aging has profound effects on altering the mRNA levels of phase-II enzymes.  All 
of the Sults quantified in the present study remain female-predominant during aging.  
The mRNAs of Sult1a1 and Papss1 increase during aging in both genders.  Sult1e1 
mRNA increases 9.8-fold in males and 315-fold in females between 3 and 27 months of 
age (Fig. 4.7).  Sult1e1 sulfonates a variety of estrogens (Falany et al., 1995), and is 
the predominant determinant of the ratio of the active unconjugated estrogen to the 
inactive estrogen sulfate.  In addition to the aging-induced decline of ovarian function 
and female sex hormone secretion, the increased Sult1e1 and possibly increased 
inactivation of estrogens might also contribute to decreased biologically active estrogens 
in aged females.  The mRNA level of Sult2a1/2 is abundant in females, but extremely 
low in males at young adulthood (3-month old), which is consistent with our previous 
publication (Alnouti and Klaassen, 2006).  The DHEA-sulfotransferase Sult2A is known 
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as a rat senescence marker protein, the expression of which is increased in aged male 
rats (Echchgadda et al., 2004).  The present study shows that Sult2a1/2 mRNA 
increases 732% in aged female, but remains at extremely low levels in males during 
aging (Fig. 4.7).  This discrepancy may result from species differences.  Additional 
work is necessary to definitely determine the mechanisms underlying the age- and 
sex-dependent regulation of Sult2a1/2 in mice.  In contrast to the elevated mRNAs of 
Sult1a1, 1e1, and 2a1/2, Sult3a1 mRNA decreases 76% in the aged female mice.  
Sult3a1 is the only Sult isozyme that catalyzes N-sulfonation, rather than O-sulfonation 
of amines such as phenyltetrahydropyridine, aniline, 4-chloroaniline, 2-naphthylamine, 
and desipramine (Yoshinari et al., 1998).  4-Chloroaniline is carcinogenic in male rats 
and mice (Chhabra et al., 1991), mainly because of the toxic intermediate 
N-phenylhydroxylamine.  The C-hydroxylated product of 4-chloroaniline is sulfated and 
ready for excretion.  The decreased mRNA of Sult3a1 after 12 months of age in male 
mice (Fig. 4.7) suggests that the detoxification of 4-chloroaniline might decline with age, 
which could favor cancer development induced by 4-chloroaniline. 
The mRNAs of most Ugts remain relatively constant with aging (Fig. 4.8).  
However, Ugt2b1 mRNA decreases between 3 and 27 months of age in both genders.  
A previous study (Buckley and Klaassen, 2009) reported that the regulation of Ugt2b1 
expression in mouse liver was attributed to male-pattern growth hormone secretion.  
This may explain the dramatic decrease of Ugt2b1 expression for male mice with age, 
and less dramatic for females. 
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Gsts catalyze the biotransformation and disposition of a wide range of chemical 
carcinogens, therapeutic drugs, the products of oxidative stress, and steroid hormones 
such as ∆5-androstenedione (Johansson and Mannervik, 2001).  Gstp1 mRNA 
decreases with age (Fig. 4.9).  Gstp2 mRNA increases with age, but is at a much lower 
level than Gstp1.  Gstp catalyzes the glutathione conjugation of cisplatin as a 
detoxification pathway (Townsend et al., 2009).  The decrease in Gstp1 mRNA with 
aging in the present study provides a possible mechanism of changes in cisplatin toxicity 
during aging. 
The Comt catalyzes the methylation of catecholamine neurotransmitters, L-DOPA, 
catecholestrogens (2- and 4-hydroxylated estrogen), as well as drugs, such as carbidopa 
and dobutamine.  The highest Comt activity has been found in liver and kidney.  Comt 
activity is also detected in several glands, muscle, adipose, blood cells and other tissues. 
One important function of Comt is to detoxify catecholestrogens, which appears to be 
important in initiating some estrogen-dependent cancers, possibly by generating reactive 
oxygen species and subsequent DNA damage (Weisz et al., 1998).  The decreased 
Comt with aging in females (Fig. 4.10) suggest the detoxification of catecholestrogens in 
livers might decrease in aged females. 
Most efflux transporters are altered during aging.  The mRNAs of Mrp3 and Bcrp 
decrease during aging in both genders (Fig. 4.11).  Mrp3 is important in transporting 
bilirubin glucuronides and bile acids from liver into blood, whereas Bcrp is important in 
liver for transporting sulfate and glucuronide conjugates of xenobiotics into bile.  The 
decreased expression of Mrp3 and Bcrp with age suggests that glucuronide conjugates 
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of xenobiotics as well as bilirubin might accumulate in hepatocytes with age.  
Interestingly, Mrp4 mRNA increases between 3 and 27 months of age in female mice 
(Fig. 4.11).  A previous study shows higher mRNA of Mrp4 in female kidneys is due to 
repression by both 5alpha-dihydroxytesteosterone and male-pattern growth hormone 
secretion in males (Maher et al., 2006).  Hypothesizing that similar mechanisms of 
hormonal regulation of female-predominant expression of Mrp4 exist in liver, the 
elevation in Mrp4 mRNA during aging possibly results from the decline of sex hormones 
and growth hormones with senescence. 
The mRNAs of key transcription factors quantified in the study remained relatively 
constant during aging (Fig. 4.12).  No apparent correlation between the mRNA profiles 
of XPG and transcription factors were observed across aging process (Fig. 4.13).   
All of the data collected in the present study regarding the expression of XPGs are 
at the mRNA level.  One needs to be cautious when interpreting the data, because 
mRNA levels don’t always correlate with protein levels and protein activities.  According 
to previous reports that the decreased protein contents (Peng et al., 2005; Mori et al., 
2007) as well as enzyme activities (Warrington et al., 2004) of many phase-I and 
phase-II enzymes are regulated at the transcriptional level, the results from this study will 
provide a good indication for most enzymes and transporters.  For transporters, it is 
especially difficult to quantify protein and activity of transporters, due to the lack of 
specific antibodies as well as specific substrates for activity assays. 
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In summary, the current study investigates the effect of aging on the mRNA levels of 
101 xenobiotic processing genes (XPGs) in livers of male and female mice.  Gender 
differences across the lifespan (significant at five ages or more) are observed for 52 
XPGs, including 15 male-predominant (e.g. Oatp1a1, Cyp3a11, Ugt1a6a, Comt, and 
Bcrp) and 37 female-predominant genes (e.g. Oatp1a4, Cyp2b10, Sult1a1, Ugt1a1, and 
Mrp3).  The mRNA levels of 44% of the XPGs change with aging in male mice and 63% 
change in female mice.  In male mice, mRNAs of 40 XPGs (e.g. Oatp1a1, Ces2c, 
Gstm4, Gstp1, and Ces1e) are lower in aged mice (over 21 months of age), whereas 
mRNAs of 4 XPGs (e.g. Oat2 and Gstm2) are higher in aged mice.  In female mice, 
mRNAs of 43 XPGs (e.g. Oatp1a1, Cyp1a2, Ces1f, Sult3a1, Gstt2, Comt, Ent1, Fmo3, 
and Mrp6) are lower in aged mice, whereas mRNAs of 21 XPGs (e.g. Oatp1a4, Nqo1, 
Adh7, Sult2a1/2, Gsta1, and Mrp4) are higher in aged mice.  In conclusion, 51% of the 
101 XPGs have gender differences in liver mRNA levels across the lifespan of mice, and 
the mRNAs of 40% of the XPGs are lower in aged male mice and 43% are lower in aged 
female mice.  Considering the role of XPGs in detoxification and elimination of drugs 
and environmental chemicals, the present results may improve the interpretation of 
long-term toxicity studies in old animals, and aid in determining the effective and safe 
dose for the elderly.  
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Chapter 5: REGULATION OF BILE ACID HOMEOSTASIS DURING AGING OF MICE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This study was published as Fu et al., 2012. PLoS One, 7, e32551.  
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5.1  Abstract 
Aging is a physiological process with a progressive decline of adaptation and 
functional capacity of the body.  BAs have been recognized as signaling molecules 
regulating the homeostasis of glucose, lipid, and energy.  The current study 
characterizes the age-related changes of individual BA concentrations by 
ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) in 
serum and liver of male and female C57BL/6 mice from 3 to 27 months of age.  Total 
BA concentrations in serum increased 340% from 3 to 27 months in female mice, 
whereas they remained relatively constant with age in male mice.  During aging, male 
and female mice shared the following changes: (1) BA concentrations in liver remained 
relatively constant; (2) the proportions of beta-muricholic acid (βMCA) increased and 
deoxycholic acid (DCA) decreased between 3 and 27 months in serum and liver; and (3) 
total BAs in serum and liver became more hydrophilic between 3 and 27 months.  In 
female mice, (1) the mRNAs of hepatic BA uptake transporters, the Na+/taurocholate 
cotransporting polypeptide (Ntcp) and the organic anion transporting polypeptide 1b2 
(Oatp1b2), decreased after 12 months, and similar trends were observed for their 
proteins; (2) the mRNA of the rate-limiting enzyme for BA synthesis, cholesterol 
7α-hydroxylase (Cyp7a1), increased from 3 to 9 months and remained high thereafter.  
However, in male mice, Ntcp, Oatp1b2, and Cyp7a1 mRNA levels remained relatively 
constant with age.  In summary, the current study shows gender-divergent profiles of 
BA concentrations and composition in serum and liver of mice during aging, which is 
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likely due to the gender-divergent expression of BA transporters Ntcp and Oatp1b2 as 
well as the synthetic enzyme Cyp7a1. 
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5.2  Introduction 
Elderly people have an increased incidence of various age-related diseases, 
including liver and gastrointestinal diseases.  The prevalence of chronic liver disease 
increases in the elderly, such as alcoholic liver disease, non-alcoholic fatty liver disease, 
viral hepatitis C, as well as hepatocellular carcinoma (Frith et al., 2009).  In addition, the 
risk of stomach cancer increases with age, and more than 90% of colon cancers were 
found in people over 50-years of age. 
In the enterohepatic system, BAs play multifaceted physiological functions.  Apart 
from their well-known roles for dietary lipid absorption and cholesterol homeostasis, BAs 
are increasingly appreciated as complex metabolic signaling molecules (Li and Chiang, 
2012), regulating glucose, lipid, and energy metabolism.  In humans, up to 95% of the 
BAs are efficiently recycled daily through the "enterohepatic circulation" (EHC), and only 
5% are newly synthesized.   
BAs can regulate their own homeostasis (Zhang and Klaassen, 2010; Song et al., 
2011). BAs activate their nuclear receptor FXR in liver, which transactivates small 
heterodimer partner (SHP).  SHP subsequently forms inactive heterodimer with liver 
related homologue-1 (LRH-1) (Goodwin et al., 2000), resulting in decreased transcription 
of Cyp7a1.  In addition, BAs also activate FXR in the intestine, which induces fibroblast 
growth factor 15 (Fgf15), an intestinal hormone that travels through the circulation to the 
liver and down-regulates Cyp7a1 transcription (Inagaki et al., 2005; Kim et al., 2007). 
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Limited information is available on the effect of aging on BA homeostasis (Uchida et 
al., 1978; Bertolotti et al., 1993; Salemans et al., 1993a).  Bertolotti et al. studied the 
effect of aging on cholesterol 7 alpha-hydroxylation, which is the rate-limiting step of bile 
acid synthesis.  Among the 28 patients of 34-83 year old of both sexes, they found a 
reduced rate of conversion of cholesterol to BAs during aging, particularly in females, 
evidenced by a tritium release assay (Bertolotti et al., 1993).  It was also reported in the 
same year that postprandial serum levels of conjugated cholic, chenodeoxycholic, and 
deoxycholic acid were increased more in the younger subjects, whereas postprandial 
serum levels of unconjugated BAs didn’t differ between younger and elderly age groups.  
This indicates that conjugated BAs are reabsorbed less effectively in the elderly, which 
may lead to increased risk of colorectal cancer (Salemans et al., 1993a).   
In a more recent study, Amador-Noguez et al. reported increased expression of 
xenobiotic metabolizing genes in livers of long-lived lit/lit mice, and concluded that FXR 
is the only nuclear receptor responsible for the up-regulation of gene expression among 
the three potential regulators studied.  Because FXR is known to be activated by BAs 
and it increases the mRNAs of BA metabolizing enzymes, they administered cholic acid 
to wild-type mice and were able to reproduce the changes in drug metabolizing gene 
expression seen in lit/lit mice (Amador-Noguez et al., 2007).  Therefore, a hypothetical 
model of aging-regulatory systems in lit/lit mice characterized by decreased IGF-1 and 
increased BAs by blocking growth hormone signaling that retard aging was proposed 
(Gems, 2007).  This paper is novel because it indicates the possible role of BAs as 
contributors to longevity.  A hormesis effect was proposed as a possible explanation to 
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the pro-longevity effect of low levels of BAs which are toxic at high levels (Song et al., 
2011).  A similar concept was proved in C. elegans that transient heat stress could 
increase their lifespan (Cypser et al., 2006).  In addition, chemical genetic screen 
identified lithocholic acid as an anti-aging compound in yeast in a TOR-independent 
manner (Goldberg et al., 2010).  Moreover, 3-keto BA-like steroids, called dafachronic 
acids, increase the life span of C. elegans, through DAF-12 (a homolog of FXR) (Held et 
al, 2006; Gerisch et al., 2007).  Although the whole field of BA homeostasis during 
aging still needs a lot of research, the idea of BAs contributing to the longevity is very 
intriguing (Ferbeyre, 2010b; Roux and Chartrand, 2010). 
The current study aims to describe the effect of aging on BA composition and 
concentration, and determine the molecular mechanism with respect to the expression of 
genes involved in BA homeostasis in mice.  To address these questions, both male and 
female mice at nine ages, from 3- to 27-months old, were used for serum and tissue 
collection for BA, mRNA, and protein quantification.  Substantial information on the 
changes of BA concentrations and composition in male and female mice during aging 
was obtained, as well as possible regulatory mechanisms for these changes. 
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5.3  Results 
5.3.1  Total BA Concentrations in Serum during Aging.   
Total BA concentrations in serum remained relatively constant in male mice, 
whereas in female mice, they increased 340% from 3 to 27 months of age, due to an 
increase in both conjugated (280%) and unconjugated (400%) BAs (Fig. 5.1).  Female 
mice had higher total BA concentrations than male mice from 9 (190%) to 27 (370%) 
months. 
5.3.2  Conjugated BAs in Serum during Aging.   
In male mice, the concentrations of most conjugated BAs (T-CA, T-αMCA, 
T-βMCA, T-UDCA, and T-HDCA) remained relatively constant during aging (Fig. 5.2A).  
In female mice, the concentrations of three BAs increased between 3 and 27 months, 
namely T-βMCA (610%), T-UDCA (470%), and T-ωMCA (260%).  However, the 
concentrations of T-CA, T-αMCA, T-DCA, T-MDCA, and T-HDCA remained relatively 
constant with age. 
The composition of conjugated BAs in serum changed during aging (Fig. 5.2B).  In 
male mice, the proportions of T-βMCA (11.8%→19.1%) and T-MDCA (3.1%→8.7%) 
increased, whereas T-DCA (12.4%→5.2%) and T-HDCA (2.4%→1.6%) decreased 
between 3 and 27 months of age.  In female mice, the proportions of T-βMCA 
(13.0%→25.9%) and T-UDCA (1.8%→2.8%) increased, whereas T-MDCA 
(2.5%→1.2%) and T-DCA (8.1%→4.3%) decreased between 3 and 27 months. 
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Fig. 5.1. 
 
 
Total BA concentrations in serum during aging of male and female mice.  Data are 
presented as means ± SEM of 5-7 mice.  Daggers (†) represent statistically significant 
difference from the value at 3 months of age during aging of male mice.  Double 
daggers (‡) represent statistically significant difference from the value at 3 months of age 
during aging of female mice.  Age-dependent differences were considered at p < 0.05 
by one-way ANOVA, followed by Duncan’s post-hoc test.  Asterisks (*) represent 
statistically significant difference between male and female mice at respective ages 
during aging (p < 0.05), by Student's t-test. 
 
  
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
Male
Female
Total BAs
0.0
0.5
1.0
1.5
2.0
2.5
3.0 Conjugated BAs
3 6 9 12 15 18 21 24 27
0.0
0.5
1.0
1.5
2.0
2.5 Unconjugated BAs
Age (months)
S
er
u
m
 B
il
e
 A
ci
d
 C
o
n
ce
n
tr
at
io
n
 (
n
m
o
l/
m
l)
†
‡* ‡*
* * * *
‡
* *
*
‡*
‡*
(n
m
o
l/m
L
)
 
 
98 
 
Fig. 5.2. 
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Continued to the following page. 
 
Fig. 5.2.  (continued) 
 
Concentrations of conjugated BAs in serum during aging of male and female 
mice.  (A) Concentrations of individual conjugated BAs in serum during aging and (B) 
proportions of them in all conjugated BAs in serum at 3 and 27 months of age in male 
and female mice.  Data are presented as means ± SEM of 5-7 mice.  Daggers (†) 
represent statistically significant difference from the value at 3 months of age during 
aging of male mice.  Double daggers (‡) represent significant difference from the value 
at 3 months of age during aging of female mice.  Age-dependent differences were 
considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  
Asterisks (*) represent statistically significant difference between male and female mice 
at respective ages during aging (p < 0.05), by Student's t-test.  In panel B, pound signs 
(#) represent differences of BA proportions between 3 and 27 months. 
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5.3.3  Unconjugated BAs in Serum during Aging.   
In male mice, the concentration of UDCA increased 800% from 3 to 27 months of 
age (Fig. 5.3A).  CA increased (12.1-fold) from 3 to 21 months and decreased 
thereafter.  Similarly, βMCA increased 24.6-fold from 3 to 15 months and decreased 
thereafter, and HDCA increased 480% from 3 to 27 months and decreased thereafter.  
CDCA and DCA remained relatively constant with age.  In female mice, gradual 
age-dependent increase in concentrations of βMCA (530%) and DCA (210%) was 
observed between 3 and 27 months.  CDCA was higher at 15 (370%) and 27 (360%) 
months than at 3 months of age. UDCA was 430% higher at 24 than 3 months.  CA and 
HDCA remained relatively constant with age. 
The composition of unconjugated BAs in serum also changed during aging (Fig. 
5.3B).  In male mice, the proportions of βMCA (14.2%→36.7%), UDCA (4.1%→9.5%), 
and HDCA (8.1%→11.3%) increased, whereas CDCA (5.6%→3.2%) and DCA 
(48.9%→24.4%) decreased between 3 and 27 months of age.  In female mice, the 
proportion of βMCA (23.6%→38.1%) increased, whereas DCA (36.6%→23.0%) and 
HDCA (3.3%→1.5%) decreased between 3 and 27 months. 
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Fig. 5.3. 
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Continued to the following page. 
Fig. 5.3.  (continued) 
 
Concentrations of unconjugated BAs in serum during aging of male and female 
mice.  (A) Concentrations of individual unconjugated BAs in serum during aging and (B) 
proportions of them in all unconjugated BAs in serum at 3 and 27 months of age in male 
and female mice.  Data are presented as means ± SEM of 5-7 mice.  Daggers (†) 
represent statistically significant difference from the value at 3 months of age during 
aging of male mice.  Double daggers (‡) represent significant difference from the value 
at 3 months of age during aging of female mice.  Age-dependent differences were 
considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  
Asterisks (*) represent statistically significant difference between male and female mice 
at respective ages during aging (p < 0.05), by Student's t-test.  In panel B, pound signs 
(#) represent differences of BA proportions between 3 and 27 months. 
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5.3.4  Total BA Concentrations in Liver during Aging.   
The concentrations of total, conjugated, and unconjugated BAs in liver remained 
relatively constant with age, except a small increase (170%) of total BAs at 15 months of 
age in female mice, and a small increase (390%) of unconjugated BAs at 15 months in 
male mice (Fig. 5.4). 
5.3.5  Conjugated BAs in Liver during Aging.   
In male mice, the concentration of T-α+βMCA gradually increased (350%), whereas 
T-DCA gradually decreased (65.8%) between 3 and 27 months of age (Fig. 5.5A).  
T-CA, T-CDCA, T-LCA, T-UDCA, T-MDCA, T-ωMCA, and T-HDCA remained relatively 
constant with age.  In female mice, the concentrations of T-CDCA, T-α+βMCA, 
T-UDCA, and T-MDCA doubled between 3 and 15 months, and decreased thereafter.  
Similarly, T-LCA doubled between 3 and 9 months and decreased thereafter.  T-CA, 
T-DCA, T-ωMCA, and T-HDCA remained relatively constant with age. 
The composition of conjugated BAs in liver changed during aging (Fig. 5.5B).  In 
male mice, the proportion of T-α+βMCA (20.2%→42.1%) increased, whereas T-DCA 
(11.0%→2.2%), T-LCA (0.5%→0.1%), and T-ωMCA (16.6%→9.5%) decreased 
between 3 and 27 months of age.  In female mice, the proportion of T-α+βMCA 
(29.6%→35.7%) increased, whereas T-DCA (6.2%→3.7%), T-LCA (0.3%→0.1%), 
T-MDCA (1.4%→0.9%), and T-HDCA (1.7%→0.9%) decreased between 3 and 27 
months. 
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Fig. 5.4. 
 
 
 
Total BA concentrations in liver during aging of male and female mice.  Data are 
presented as means ± SEM of 5-7 mice.  Daggers (†) represent statistically significant 
difference from the value at 3 months of age during aging of male mice.  Double 
daggers (‡) represent significant difference from the value at 3 months of age during 
aging of female mice.  Age-dependent differences were considered at p < 0.05 by 
one-way ANOVA, followed by Duncan’s post-hoc test.  Asterisks (*) represent 
statistically significant difference between male and female mice at respective ages 
during aging (p < 0.05), by Student's t-test. 
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Fig. 5.5. 
 
 
Continued to the following page. 
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Fig. 5.5.  (continued) 
 
Concentrations of conjugated BAs in liver during aging of male and female mice.  
(A) Concentrations of individual conjugated BAs in liver during aging and (B) proportions 
of them in all conjugated BAs in liver at 3 and 27 months of age in male and female mice.  
Data are presented as means ± SEM of 5-7 mice.  Daggers (†) represent statistically 
significant difference from the value at 3 months of age during aging of male mice.  
Double daggers (‡) represent significant difference from the value at 3 months of age 
during aging of female mice.  Age-dependent differences were considered at p < 0.05 
by one-way ANOVA, followed by Duncan’s post-hoc test.  Asterisks (*) represent 
statistically significant difference between male and female mice at respective ages 
during aging (p < 0.05), by Student's t-test.  In panel B, pound signs (#) represent 
differences of BA proportions between 3 and 27 months. 
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5.3.6  Unconjugated BAs in Liver during Aging.   
In male mice, The concentration of βMCA increased (530%) from 3 to 15 months 
and decreased 50.8% thereafter (Fig. 5.6A).  In female mice, CA was 390% higher at 
18 than 3 months, and ωMCA increased (170%) between 3 and 15 months and 
decreased 52.1% thereafter.  CDCA, αMCA, DCA, LCA, UDCA, and HDCA remained 
relatively constant with age in both genders.   
The composition of unconjugated BAs in liver changed during aging (Fig. 5.6B).  In 
male mice, the proportion of βMCA (38.9%→66.4%) increased, whereas CA 
(11.2%→7.8%), DCA (2.5%→0.6%), LCA (0.2%→0.1%), UDCA (1.3%→0.9%), MDCA 
(2.2%→1.4%), ωMCA (32.3%→14.8%), and HDCA (2.7%→1.6%) decreased between 3 
and 27 months.  In female mice, αMCA (6.4%→4.3%), DCA (1.9%→1.2%), LCA 
(0.2%→0.05%), MDCA (1.9%→0.7%), and HDCA (1.5%→0.6%) decreased between 3 
and 27 months. 
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Fig. 5.6. 
 
Continued to the following page. 
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Fig. 5.6.  (continued) 
 
Concentrations of unconjugated BAs in liver during aging of male and female 
mice.  (A) Concentrations of individual unconjugated BAs in liver during aging and (B) 
proportions of them in all unconjugated BAs in liver at 3 and 27 months of age in male 
and female mice.  Data are presented as means ± SEM of 5-7 mice.  Daggers (†) 
represent statistically significant difference from the value at 3 months of age during 
aging of male mice.  Double daggers (‡) represent significant difference from the value 
at 3 months of age during aging of female mice.  Age-dependent differences were 
considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  
Asterisks (*) represent statistically significant difference between male and female mice 
at respective ages during aging (p < 0.05), by Student's t-test.  In panel B, pound signs 
(#) represent differences of BA proportions between 3 and 27 months. 
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5.3.7  The mRNA and Proteins of BA Hepatic Transporters during Aging.   
The mRNA levels of BA uptake transporter Ntcp and efflux transporter Bsep 
remained relatively constant with age (Fig. 5.7A).  Whereas they shared an 
age-dependent expression pattern in female mice, which was first an increase from 3 to 
9 months (Ntcp: 140%; Bsep: 170%) and then a decrease from 9 to 27 months (Ntcp: 
30.8%; Bsep: 42.8%).  The mRNA level of uptake transporter Oatp1b2 for 
unconjugated BAs remained constant with age in male mice, whereas in female mice, it 
increased 150% from 3 to 12 months and decreased 43% thereafter.  The mRNA of 
male-predominantly expressed uptake transporter Oatp1a1 in male mice decreased 
gradually (54.9%) between 3 and 27 months.  Interestingly, Oatp1a1 mRNA in female 
mice decreased markedly (89.4%) from 3 to 6 months and remained extremely low 
thereafter.   
As shown in Fig. 5.7B, decreased proteins in female livers were observed by 
western blots at 27 months for Ntcp (59%) and Oatp1b2 (53.4%), confirming the 
decreased expression of these two uptake transporters at a later stage of life in female 
mice. 
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Fig. 5.7. 
 
The mRNA and proteins of BA transporters in livers during aging of male and 
female mice.  A. The mRNAs of Ntcp, Bsep, Otap1a1, and Oatp1b2 during aging in 
male and female livers.  Data are presented as means ± SEM of 5-7 mice, by 
normalization to Gapdh.  B. Protein abundance of Ntcp and Oatp1b2 in several 
representative ages in female livers.  Western blots for Ntcp (~50 kDa) and Oatp1b2 
(~75 kDa) were performed using liver membrane protein fractions (40 µg protein/lane) 
from livers of female mice at 3, 9, 12, and 27 months of age.  β-Actin (~45 kDa) was 
used as loading control for each transporter.  Bars represent the relative protein 
expression ± SEM of 3 mice.  Daggers (†) represent statistically significant difference 
from the value at 3 months of age during aging of male mice.  Double daggers (‡) 
represent significant difference from the value at 3 months of age during aging of female 
mice.  Age-dependent differences were considered at p < 0.05 by one-way ANOVA, 
followed by Duncan’s post-hoc test.  Asterisks (*) represent statistically significant 
difference between male and female mice at respective ages during aging (p < 0.05), by 
Student's t-test. 
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5.3.8  The mRNA changes of BA Synthetic Enzymes in Liver during Aging.   
The mRNA of the rate-limiting enzyme Cyp7a1 for BA synthesis increased 290% 
from 3 to 18 months in male mice and tended to decrease thereafter, whereas in female 
mice, it increased 300% from 3 to 15 months and remained high thereafter (Fig. 5.8).  
Cyp8b1 mRNA decreased 46.5% between 3 and 27 months in male mice, whereas in 
female mice, it decreased 46.6% between 3 and 24 months, and then increased 
thereafter.  Cyp27a1 mRNA level remained relatively constant with age in male mice, 
whereas in female mice, it increased 120% from 3 to 9 months and then decreased 
39.0% thereafter.  Cyp7b1 mRNA decreased 43.8% between 3 and 21 months and 
tended to increase thereafter in male mice, whereas it remained low and constant with 
age in female mice. 
5.3.9  The mRNA changes of Regulators of Cyp7a1 Transcription during Aging.   
In liver, the mRNA level of FXR remained relatively constant with age in both 
genders (Fig. 5.9).  SHP mRNA level was relatively constant with age in male mice, 
whereas in female mice, it markedly decreased (74.1%) from 12 to 15 months and 
remained low thereafter.  Fgfr4 mRNA increased (57.1%) from 3 to 9 months and 
remained high thereafter in female mice, whereas it remained low and constant with age 
in male mice.  In ileum, Fgf15 mRNA gradually increased 670% between 3 and 27 
months in male mice, whereas in female mice, it increased 430% between 3 and 12 
months and decreased 73.3% thereafter.  
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Fig. 5.8. 
 
 
The mRNA changes of BA synthetic enzymes in livers during aging of male and 
female mice.  Data are presented as means ± SEM of 5-7 mice, by normalization to 
Gapdh.  Daggers (†) represent statistically significant difference from the value at 3 
months of age during aging of male mice.  Double daggers (‡) represent significant 
difference from the value at 3 months of age during aging of female mice.  
Age-dependent differences were considered at p < 0.05 by one-way ANOVA, followed 
by Duncan’s post-hoc test.  Asterisks (*) represent statistically significant difference 
between male and female mice at respective ages during aging (p < 0.05), by Student's 
t-test. 
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Fig. 5.9. 
 
 
 
The mRNA changes of regulators of Cyp7a1 transcription during aging of male 
and female mice.  Figure shows mRNA data for FXR, SHP, and Fgfr4 in liver (L) and 
Fgf15 in ileum (I).  Data are presented as means ± SEM of 5-7 mice, by normalization to 
Gapdh.  Daggers (†) represent statistically significant difference from the value at 3 
months of age during aging of male mice.  Double daggers (‡) represent significant 
difference from the value at 3 months of age during aging of female mice.  
Age-dependent differences were considered at p < 0.05 by one-way ANOVA, followed 
by Duncan’s post-hoc test.  Asterisks (*) represent statistically significant difference 
between male and female mice at respective ages during aging (p < 0.05), by Student's 
t-test. 
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5.4  Discussion 
The present study demonstrates a female-specific increase of total BA 
concentrations in serum during aging of mice.  Both conjugated and unconjugated BAs 
in serum increase with age in female mice, whereas they remain relatively constant with 
age in male mice (Fig. 5.1).  It has been reported that there were no age-related 
changes between young (8 weeks) and middle-aged (12 months) male rats in biliary BA 
secretion, distribution of BAs in the bile and intestine, nor the turnover frequency of BAs 
(Uchida et al., 1990), and in addition, the biliary BA secretion in aged (106 weeks) male 
rats was similar to younger rats (Uchida et al., 1978).  The finding of the present study 
that concentrations of total BAs in both serum and liver are similar in young and aged 
male mice is consistent with the previous reports in aged male rats.  In humans, fasting 
concentrations of conjugated and unconjugated serum BAs were similar between 12 
younger (mean age 37 years, range 22-59 years; seven female, five male) and 12 elder 
(mean age 67 years, range 60-82 years; seven female, five male) subjects (Salemans et 
al., 1993b).  This finding in humans is different from the present results in mice, possibly 
because 1) there are species differences in BA composition and BA conjugation 
between humans and mice, 2) the small number of subjects compromises the conclusion 
from the human study, and 3) possible changes of BAs in female subjects may be 
missed because male and female subjects were not analyzed separately in the human 
study. 
Total BAs in serum and liver become more hydrophilic during aging in both male 
and female mice.  Heuman (Heuman, 1989) and Wang et al. (Wang et al., 2003) have 
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reported the order of hydrophobicity indices of individual BAs as follows: T-ωMCA (~-0.9) 
< T-αMCA (-0.84) < T-βMCA (-0.78) < T-MDCA (~-0.6) < T-UDCA (-0.47) < T-HDCA 
(-0.35) < T-CA (0.00) < T-CDCA (+0.46) <T-DCA (+0.59) < T-LCA (+1.00), ωMCA 
(~-0.77) < αMCA (~-0.7) < βMCA (~-0.65) < MDCA (~-0.47) < UDCA (-0.31) < HDCA 
(~-0.22) < CA (+0.13) < CDCA (+0.59) < DCA (+0.72) < LCA (+1.13).  The 
hydrophobicity index (HI) of individual BAs and their proportions in biological samples 
are used to predict the HI of total BAs at physiological pH.  Total BAs become more 
hydrophilic during aging, because the HI of total BAs decreases between 3 and 27 
months in serum (M: -0.096 → -0.24; F: -0.095 → -0.20) and liver (M: -0.27 → -0.42; F: 
-0.32 → -0.38).  The decrease is largely due to the increased proportion of hydrophilic 
βMCA and decreased proportion of hydrophobic DCA (Fig. 5.2B, Fig. 5.3B, Fig. 5.5B, 
and Fig. 5.6B). 
The changes of individual BAs during aging in the present study provide important 
evidence that BAs may function as markers for longevity.  A very intriguing finding in the 
long-lived lit/lit  mice is that they had increased concentrations of several BAs in the 
serum, and feeding CA to wild-type mice reproduced the expression profiles of 
xenobiotic metabolism genes observed in the long-lived mice, which might increase 
resistance to stress and alleviate age-related tissue damage (Amador-Noguez et al., 
2007).  Females had a longer life expectancy than males in many species, including 
humans (Vina et al., 2005).  Female Wistar rats lived on average 14% longer than 
males, and female BALB/cJ mice lived much longer than males.  The median life span 
of female mice in a heterogeneous background was shown to be longer than males at 
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three research sites (Harrison et al., 2009).  C57BL/6J mice are long-lived mice 
compared to other inbred strains, and females tended to live longer than males, but this 
was not statistically significant, possibly due to the small number of animals (Goodrick, 
1975).  In the present study, serum concentrations of T-CA, T-αMCA, T-βMCA, T-DCA, 
and T-UDCA are higher in female C57BL/6 mice, and increase during aging in female 
mice (Fig. 5.2A).  The long-lived lit/lit mice were shown to have increased βMCA, 
CDCA, LCA, DCA, CA, and UDCA in serum (Amador-Noguez et al., 2007).  Therefore, 
increased serum concentrations of some individual BAs, such as CA, βMCA, DCA, and 
UDCA might correlate with the tendency of increased longevity in female C57BL/6 mice.  
UDCA is used clinically to treat gallstones.  In cancer cells, UDCA induced senescence 
through increased histone hypoacetylation and inhibiting telomerase activity (Akare et 
al., 2006).  In the present study, T-UDCA in serum increases 470% between 3 and 27 
months of age in female mice (Fig. 5.2A).  UDCA in serum increases 800% between 3 
and 27 months in male mice, and increases 430% between 3 and 24 months in female 
mice (Fig. 5.3A).  The increased serum concentrations of UDCA during aging indicate 
that UDCA in serum may be an important marker of longevity. 
Interesting, findings from the present study also show gender-divergent changes of 
expression of BA hepatic uptake and efflux transporters during aging of mice.  In female 
mice, BA uptake transporters Ntcp and Oatp1b2 have decreased expression from about 
12 to 27 months (Fig. 5.7A and B), and the BA efflux transporter Bsep has decreased 
expression from 9 to 27 months of age (Fig. 5.7A).  In contrast, in male mice, the 
expression of Ntcp, Oatp1b2, and Bsep remains constant during aging.  
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Female-predominant Ntcp expression in young adult mice is due to the inhibitory effect 
of male-pattern growth hormone secretion (Cheng et al., 2007).  The lower 
sodium-dependent uptake of taurocholate in hepatocytes from female rats was partially 
due to female-specific lower expression of Ntcp (Simon et al., 1999).  The 
gender-divergent expression changes of Ntcp and Oatp1b2 during aging in the present 
study might be regulated by gender differences in growth hormone secretion patterns, or 
changes of female sex hormones with the cease of rodent estrous cycles.  In contrast 
with the changes of BA uptake transporters, the mRNA levels of BA-conjugating 
enzymes (BAL and BAT) and ileal BA transporters (Asbt and Ostα/β) remain relatively 
constant with age in both genders (data not shown).  Decreased expression of uptake 
transporters Ntcp and Oatp1b2 likely contributes to the accumulation of BAs in serum 
with aging in female mice.  
In addition to the decreased expression of BA uptake transporters, increased 
Cyp7a1 expression probably contributes to the increased concentrations of total BAs in 
serum during aging in female mice.  The present study shows Cyp7a1 mRNA increases 
from 3 to 9 months of age, and remains at a high level thereafter in female mice, 
whereas in male mice, it remains constant during aging (Fig. 5.8).  However, the 
present data are opposite to previous reports in human livers showing decreased 
cholesterol 7α-hydroxylation in the elderly (Einarsson et al., 1985; Bertolotti et al., 1993) 
and an inverse correlation between age and CYP7A1 mRNAs (Bertolotti et al., 2007) in 
both male and female subjects.  There are probably species differences in BA changes 
during aging between human and mice, and the reliability of the findings in the human 
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study is compromised by the low correlation coefficient (about -0.6) and the small 
number of subjects. 
The present study characterizes the mRNA changes of several regulators for 
Cyp7a1 transcription during aging.  SHP mRNA level remains at low levels from 15 to 
27 months compared to that at 3 months in female mice (Fig. 5.9), and is inversely 
correlated with Cyp7a1 mRNA during aging in female mice (Fig. 5.8).  This can be 
explained by the down-regulation of Cyp7a1 transcription by the FXR-SHP pathway.  
The Fgf15-Fgfr4 signaling is also important for down-regulating Cyp7a1 transcription.    
However, the mRNAs of neither Fgf15 nor Fgfr4 correlate with the elevated Cyp7a1 
mRNA (Fig. 5.9).  Therefore, in the present models, we conclude that Cyp7a1 
transcription appears to be regulated by SHP inhibition during aging. 
The current study provides a comprehensive description of the age-related changes 
of BA composition and concentration in serum and liver of male and female C57BL/6 
mice from 3 to 27 months of age.  The major findings are that (1) total BA 
concentrations in serum increase during aging in female mice, whereas they remain 
relatively constant in male mice; (2) livers maintain constant concentrations of BAs 
during aging in both genders; (3) total BAs in serum and liver become more hydrophilic 
during aging in both genders, largely due to the increased proportion of βMCA and 
decreased proportion of DCA between 3 and 27 months; (4) mRNAs of Ntcp and 
Oatp1b2 decrease from 9 to 27 months in female mice, whereas they remain relatively 
constant in male mice; (5) Cyp7a1 mRNA increases from 3 to 9 months and remains at 
high levels thereafter in female mice, which inversely correlates with SHP mRNA during 
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aging.  In male mice, however, Cyp7a1 mRNA level remains constant with age.  
Therefore, the female-specific increased total BAs in serum during aging appear to result 
from a female-specific BA-related gene expression pattern, which is the decreased BA 
uptake transporters, Ntcp and Oatp1b2, and the increased rate-limiting enzyme for BA 
synthesis Cyp7a1. 
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Chapter 6: CALORIE RESTRICTION FEMINIZES THE HEPATIC EXPRESSION OF 
XENOBIOTIC-METABOLIZING ENZYMES AND TRANSPORTERS IN MICE 
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6.1  Abstract 
CR is one of the most effective anti-aging interventions in various species 
including mammals.  The detoxification theory suggests that aging results from a 
decline in detoxification capabilities and thus accumulation of damaged macromolecules.  
Therefore, we hypothesize that hepatic drug metabolism and detoxification are likely 
altered by CR.  Male C57BL/6 mice were fed ad libitum, or CR (15, 30, or 40%) diets for 
one month.  Messenger RNA levels of 98 XPGs were quantified in liver, including 7 
uptake transporters, 39 phase-I enzymes, 37 phase-II enzymes, 10 efflux transporters, 
and 5 transcription factors.  In general, 15% CR did not alter the mRNA levels of most 
XPGs, whereas 30 and 40% CR altered over half of the XPGs (32 increased and 29 
decreased).  CR up-regulated some phase-I enzymes (fold increase), such as Cyp4a14 
(12), Por (2.3), Nqo1 (1.4), Fmo2 (5.4), and Fmo3 (346), and numerous phase-II 
enzymes, such as Sult1a1 (1.2), Sult1d1 (2.0), Sult1e1 (33), Sult3a1 (2.2), Gsta4 (1.3), 
Gstm2 (1.3), Gstm3 (1.7), and Mgst3 (2.2).  CR increased Oatp1a4 mRNA (11), and 
decreased transporters Oatp1a1 (97%), Mrp3 (42%), and Bcrp (68%).  CR feminized 
the mRNA profiles of 32 XPGs in livers of male mice.  The gender-divergent expression 
of some XPGs is regulated by male-pattern growth hormone, which is decreased by CR.  
In conclusion, CR alters the mRNA levels of over half of the 98 XPGs quantified in livers 
of male mice, and over half of these alterations appear to be attributable to feminization 
of the liver. 
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6.2  Introduction 
CR, defined as reduced calorie intake of a nutritious diet without causing 
malnutrition, is one of the most effective anti-aging interventions in various species 
including mammals.  Since 1935, when the first study was done in rats (McCay et al., 
1935), CR has been known to increase both the mean and maximum lifespan in various 
species, ranging from yeast, fish, invertebrate animals to hamsters, mice, and dogs.  
Moreover, CR decreases the incidence of age-related diseases, such as cardiovascular 
abnormalities and insulin sensitivity in nonhuman primates (Colman et al., 2009) and in 
humans (Fontana et al., 2004; Redman et al., 2007).   
Genome-wide microarray analyses reveal that CR reverses a large proportion of 
gene expression changes that occur with aging in several tissues, including heart, liver, 
skeletal muscle, brain, and colon (Han et al., 2000; Lee et al., 2002; Selman et al., 2006).  
Although several key players (such as insulin/IGF-1, Sirtuins, FoxO, PGC-1α, and 
autophagy) have been suggested to be important in mediating changes for healthy aging 
by CR (Martin et al., 2006; Vaquero and Reinberg, 2009; Petrovski and Das, 2010), the 
mechanism of how CR exerts its anti-aging effects still remain elusive. 
The recent detoxification theory of aging suggests that a decline of detoxification 
capabilities and thus accumulation of damage to macromolecules by reactive 
intermediates lead to aging (Gems and McElwee, 2005).  In alignment with this 
hypothesis, decreased expression of many genes in xenobiotic metabolism pathways 
has been reported in livers of aged mice (Cao et al., 2001; Lee et al., 2011; Fu et al., 
2012b).  Furthermore, microarray studies suggest that xenobiotic metabolism pathways 
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are one of the gene categories that are altered by CR (Cao et al., 2001; Tsuchiya et al., 
2004).  Therefore, it was predicted that CR delays aging, at least partially, by 
up-regulating xenobiotic metabolism and thus increasing xenobiotic resistance (Iqbal et 
al., 2009).  
Our recent study has systematically demonstrated gender differences of XPG 
expression in livers of mice (Fu et al., 2012b).  Gender-divergent gene expression in 
rodent liver is determined in large part by growth hormone secretory pattern, which is 
continuous in females and pulsatile in males (Waxman and O'Connor, 2006).  Our 
laboratory has shown that male-pattern growth hormone is an important contributor to 
the gender-divergent expression of many XPGs, such as Oatps, Sults, Ugts, and Mrps 
(Cheng et al., 2006; Maher et al., 2006; Buckley and Klaassen, 2009; Alnouti and 
Klaassen, 2011).   
Previous studies on the effect of CR on liver function utilized rats (Apte et al., 2002), 
long-lived mice models (Tsuchiya et al., 2004), different CR feeding regimens (Selman et 
al., 2006; Rocha et al., 2007), only provided a global picture by genome-wide microarray 
(Han et al., 2000; Cao et al., 2001), or focused on some pathway, such as glucose 
metabolism (Dhahbi et al., 1999; Luo et al., 2008) or anti-oxidant system (De Cabo et al., 
2004).  The present study was designed to determine the effects of CR on liver 
xenobiotic processing systems, with respect to the mRNA profiles of major XPGs.  The 
C57BL/6 mouse model, which is used extensively in biomedical research, was chosen 
for the present study.  Utilizing a graded CR model (0, 15, 30, or 40%) where the same 
housing conditions, same quality of diets, same feeding regimen are guaranteed, reliable 
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comparison of the effects of graded CR on XPGs is obtained for the first time in the 
present study, to provide with certainty which xenobiotic metabolizing enzymes and 
transporters have altered hepatic expression during CR. 
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6.3  Results 
6.3.1  Validation of Graded CR Model. 
Previous studies on CR often use one degree of CR (from 15% to 60% CR) and 
various feeding regimens and diet formulas (Scholmerich et al., 1985; Faulks et al., 
2006; Yoshida et al., 2006; Rocha et al., 2007; Boily et al., 2008; Kim et al., 2008b; 
Niemann et al., 2008; Yamamoto et al., 2009).  Therefore, in order to determine which 
degree of CR altered XPG expression, a graded CR model was utilized in the present 
dissertation.  Duration of one-month of CR was selected because the literature 
indicates that short-term CR can mimic the majority of gene expression profiles resulting 
from long-term CR (Cao et al., 2001), and short-term CR (21-day) is sufficient to protect 
against hepatotoxicity of thioacetamide (Apte et al., 2003).   
Effect of Graded CR on Body Weight.  As expected, the body weights of CR 
mice were lower than AL mice, and they reached a "steady state" by the end of the 
one-month CR feeding (Fig. 6.1).  It is very interesting to note that the final body 
weights of 15%, 30%, and 40% CR mice were 15%, 28%, and 38% lower than AL mice, 
respectively. 
Effect of Graded CR on Hepatic Expression of Typical CR-responsive Target 
Genes.  Sirtuin 1 (Sirt1) and PGC1α are two known CR-responsive target genes.  As 
expected, the mRNAs of Sirt1 (274%) and PGC1a (157%) in liver were up-regulated by 
CR (Fig. 6.2). 
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Fig. 6.1. 
 
 
The body weight changes by graded CR.  Body weight was recorded weekly during 
this study (Day 0 represents the start for one-month CR).  The curves show body weight 
changes in four groups of mice, namely AL, 15%, 30%, and 40% CR.  Data are 
presented as means ± SEM of 5 mice. 
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Fig. 6.2. 
 
 
 
The mRNA changes of CR-responsive target genes in livers by graded CR.  Data 
are presented as means ± SEM of 5 mice.  Asterisks (*) represent statistically 
significant differences were considered at p < 0.05 by one-way ANOVA, followed by 
Duncan’s post-hoc test.  The triangle marks represents increased calorie restriction 
(CR). 
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6.3.2  The Effect of Graded CR on Hepatic Expression of Uptake Transporters.   
Organic anion-transporting polypeptides (Oatps) are sodium-independent uptake 
transporters for a wide range of substrates, mainly amphipathic organic compounds, 
including bile salts, hormones and their conjugates, toxins, and various drugs 
(Hagenbuch and Gui, 2008).  The mRNA of Oatp1a1 was markedly decreased by 30% 
CR (54.7%) and 40% CR (97.2%) (Fig. 6.3).  In contrast, Oatp1a4 mRNA was 
increased markedly by 30% CR (462%) and 40% CR (11.3-fold).  The mRNA level of 
Oatp1b2 was not altered by CR, as well as Oatp2b1 (data not shown).  Organic anion 
transporter 2 (Oat2) mediates the uptake of various organic anions, such as 
5-fluorouracil and paclitaxel (Klaassen and Lu, 2008).  Oat2 mRNA was decreased by 
30% CR (54.3%) and 40% CR (77.0%).  Organic cation transporter 1 (Oct1) plays an 
important role in the uptake of cationic drugs, such as acetylcholine, acyclovir, 
cimetidine, and tetraethylammonium (Klaassen and Aleksunes, 2010).  Oct1 mRNA 
was gradually decreased by 30% CR (23.9%) and 40% CR (34.4%).  Equilibrative 
nucleoside transporters (Ents) are sodium-independent, bidirectional facilitated carriers 
of endogenous nucleosides as well as cancer and antiviral nucleoside analogs 
(Klaassen and Aleksunes, 2010).  Ent1 mRNA was increased by 30% CR (53.4%) and 
40% CR (77.8%).  In general, CR altered the hepatic expression of 5 of the 7 uptake 
transporters quantified, increasing two (Oatp1a4 and Ent1) and decreasing three 
(Oatp1a1, Oat2, and Oct1).  
6.3.3  The Effect of Graded CR on Hepatic Expression of Phase-I Enzymes.   
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Cytochrome P450s (P450s) are heme-containing monooxygenases.  P450s 
involved in xenobiotic metabolism primarily belong to Cyp1, Cyp2, and Cyp3 families.  
Substrates for the Cyp4 family are mainly fatty acids and eicosanoids, but also include 
some xenobiotics (Renaud et al., 2011).  The mRNA of Cyp1a1 was increased 191% by 
30% CR (Fig. 6.4).  Cyp1a2 mRNA was increased 55.3% by 15% CR, but decreased 
38.1% by 40% CR.  Cyp2b10 and Cyp3a11 mRNA levels were not altered by CR.  
Cyp4a14 mRNA was increased markedly by 30% CR (534%) and 40% CR (12.1-fold).  
The mRNA of cytochrome P450 reductase (Por), the electron donor to P450s, was 
increased by 30% CR (84.1%) and 40% CR (233%).  NAD(P)H:quinone oxidoreductase 
1 (Nqo1) reduces quinones to hydroquinones, and thus prevents the one electron 
reduction of quinones that results in free radical production.  Nqo1 mRNA was 
increased 135% by 40% CR.  In general, CR altered the hepatic expression of 5 of the 7 
P450 related enzymes quantified, increasing Cyp1a1, Cyp4a14, Por, and Nqo1.  
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Fig. 6.3. 
 
 
The mRNA changes of uptake transporters in livers by graded CR.  Data are 
presented as means ± SEM of 5 mice.  Asterisks (*) represent statistically significant 
differences were considered at p < 0.05 by one-way ANOVA, followed by Duncan’s 
post-hoc test.  The triangle marks represents increased calorie restriction (CR). 
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Fig. 6.4. 
 
 
The mRNA changes of P450s, Por, and Nqo1 in livers by graded CR.  Data are 
presented as means ± SEM of 5 mice.  Asterisks (*) represent statistically significant 
differences were considered at p < 0.05 by one-way ANOVA, followed by Duncan’s 
post-hoc test.  The triangle marks represents increased calorie restriction (CR). 
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Flavin-containing monooxygenases (Fmos) catalyze the oxidation of endobiotics, as 
well as a wide range of xenobiotics, including tertiary and secondary alkyl- and 
arylamines, many hydrazines, thiocarbamides, thioamides, sulfides, disulfides, thiols, 
and other soft nucleophiles (Hines et al., 1994).  Fmo1 mRNA was decreased 33.2% by 
15% CR, but increased 58.5% by 40% CR (Fig. 6.5).  Fmo2 mRNA was increased by 
30% CR (206%) and 40% CR (535%).  Fmo3 mRNA was increased 346-fold by 40% 
CR.  Fmo4 mRNA was increased 150% by 40% CR.  Fmo5 mRNA was decreased by 
15% CR (43.3%), 30% CR (38.5%), and 40% CR (26.8%).  Fmo9 mRNA was 
decreased by 15% CR (79.9%), 30% CR (94.9%), and 40% CR (64.3%).  Fmo13 
mRNA level was not altered by CR.  In general, CR altered the hepatic expression of 6 
of the 7 Fmos quantified, increasing 4 (Fmo1, 2, 3, 4) and decreasing 2 (Fmo5 and 
Fmo9). 
Alcohol dehydrogenases (Adhs) and aldehyde dehydrogenases (Aldhs) are pivotal 
enzymes in metabolizing both endogenous and exogenous alcohols and aldehydes 
(Cheung et al., 2003).  The mRNA of Adh1 was increased slightly by 30% CR (31.6%) 
and 40% CR (33.2%) (Fig. 6.6).  Adh4 mRNA was decreased 36.3% by 40% CR.  The 
mRNA levels of Adh5 and Adh6a were not altered by CR.  Adh7 mRNA was decreased 
27.9% by 15% CR.  Adhfe1 mRNA was decreased 25.9% by 40% CR.  As for the 
aldehyde dehydrogenase family, Aldh3a2 mRNA was decreased by 15% CR (36.4%), 
30% CR (33.4%), and 40% CR (33.1%) (Fig. 6.7).  Aldh8a1 mRNA was increased by 
30% CR (79.9%) and 40% CR (85.7%).  The mRNA levels of Aldh1a1, 1a7, 1b1, 2, 
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4a1, 6a1, 7a1, and 9a1 were not altered by CR.  In general, CR had minor effects on 
the hepatic expression of Adhs and Aldhs. 
Carboxylesterases (Cess) are important for the hydrolysis of drugs, as well as 
detoxification of organophosphate and pyrethroid insecticides.  Ces1e mRNA was 
decreased 37.1% by 40% CR (Fig. 6.8).  Ces1f mRNA was decreased 46.5% by 40% 
CR.  Ces2c mRNA was decreased markedly by 15% CR (54.3%), 30% CR (83.0%), 
and 40% CR (91.5%).  Ces3a mRNA was decreased by 30% CR (42.3%) and 40% CR 
(75.5%).  The mRNA levels of Ces1c, Ces1g, and Esd were not altered by CR.  
Paraoxonases (Pons) that catalyze the hydrolysis of organophosphates are also 
antioxidant enzymes that scavenge oxidized phospholipids (Marsillach et al., 2008).  
Pon1 mRNA was increased by 30% CR (62.3%) and 40% CR (64.5%).  Pon3 mRNA 
level was not altered by CR.  In general, CR altered the hepatic expression of 5 of the 9 
Cess and Pons quantified, increasing 1 (Pon1) and decreasing 4 (Ces1e, 1f, 2c, and 
Ces3a). 
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Fig. 6.5. 
 
 
The mRNA changes of Fmos in livers by graded CR.  Data are presented as means 
± SEM of 5 mice.  Asterisks (*) represent statistically significant differences were 
considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  The 
triangle marks represents increased calorie restriction (CR). 
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Fig. 6.6. 
 
 
The mRNA changes of Adhs in livers by graded CR.  Data are presented as means 
± SEM of 5 mice.  Asterisks (*) represent statistically significant differences were 
considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  The 
triangle marks represents increased calorie restriction (CR). 
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Fig. 6.7. 
 
 
The mRNA changes of Aldhs in livers by graded CR.  Data are presented as means 
± SEM of 5 mice.  Asterisks (*) represent statistically significant differences were 
considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  The 
triangle marks represents increased calorie restriction (CR). 
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Fig. 6.8. 
 
 
The mRNA changes of Cess and Pons in livers by graded CR.  Data are presented 
as means ± SEM of 5 mice.  Asterisks (*) represent statistically significant differences 
were considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  
The triangle marks represents increased calorie restriction (CR). 
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6.3.4  The Effect of Graded CR on Hepatic Expression of Phase-II Enzymes.   
Phase−II reactions catalyze conjugation reactions of xenobiotics, most of which 
enhance the hydrophilicity of xenobiotics, thus favoring their excretion into bile or blood.  
Sulfotransferases (Sults) catalyze the conjugation of xenobiotics with sulfate.  Sult1a1 
mRNA was increased by 30% CR (84.6%) and 40% CR (123%) (Fig. 6.9).  Sult1d1 
mRNA was increased by 30% CR (126%) and 40% CR (204%).  Sult1e1 mRNA was 
increased 33.2-fold by 40% CR.  Sult2a1/2 mRNA level was not altered by CR.  
Sult3a1 mRNA was increased 224% by 40% CR.  Sult5a1 mRNA was decreased 
57.3% by 40% CR.  The sulfate donor for all Sult enzymes is synthesized by two 
3'-phosphoadenosine-5'-phosphosulfate synthase (Papss) enzymes.  Papss1 mRNA 
level was not altered by CR.  Papss2 mRNA was increased by 30% CR (58.3%) and 
40% CR (104%).  In general, CR altered the hepatic expression of 6 of the 8 Sults 
quantified, increasing 5 (Sult1a1, 1d1, 1e1, 3a1, and Papss2) and decreasing 1 
(Sult5a1). 
UDP-glucuronosyltransferases (Ugts) catalyze the conjugation reaction with 
glucuronic acid.  The mRNA of Ugt1a1 was increased by 30% CR (36.1%) and 40% CR 
(73.0%) (Fig. 6.10).  Ugt1a5 mRNA was increased by 30% CR (80.2%) and 40% CR 
(76.5%).  Ugt1a6a mRNA was decreased by 15% CR (30.3%), 30% CR (23.3%), and 
40% CR (30.3%).  Ugt2b1 mRNA was decreased by 30% CR (51.0%) and 40% CR 
(68.5%).  Ugt2b36 mRNA was decreased by 15% CR (25.6%), 30% CR (21.2%), and 
40% CR (23.8%).  Ugt3a1 mRNA was decreased 43.8% by 40% CR.  Ugt3a2 was 
decreased 28.6% by 40% CR.  The mRNA levels of Ugt1a9, Ugt2a3, Ugt2b34, and 
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Ugt2b35 were not altered by CR.  The co-substrate for glucuronidation, UDP-glucuronic 
acid, is synthesized by two sequential enzymes, namely UDP-glucose 
pyrophosphorylase 2 (Ugp2) and UDP-glucose 6-dehydrogenase (Ugdh).  Ugp2 mRNA 
level was not altered by CR (data not shown).  Ugdh mRNA was decreased by 15% CR 
(39.6%), 30% CR (38.7%), and 40% CR (50.1%).  In general, CR altered the hepatic 
expression of 8 of the 13 Ugts quantified, increasing 2 (Ugts1a1, 1a5) and decreasing 6 
(Ugt1a6a, 2b1, 2b36, 3a1, 3a2, and Ugdh).  
Glutathione-S-transferases (Gsts) catalyze the conjugation of chemicals with 
glutathione.  The mRNA of Gsta1 was increased 92.2% by 40% CR (Fig. 6.11).  Gsta4 
mRNA was increased by 30% CR (50.9%) and 40% CR (132%).  Gstm1 mRNA was 
increased by 30% CR (37.3%) and 40% CR (38.1%).  Gstm2 mRNA was increased by 
15% CR (49.5%), 30% CR (139%), and 40% CR (131%).  Gstm3 mRNA was increased 
by 30% CR (120%) and 40% CR (174%).  Gstm4 mRNA was increased by 30% CR 
(59.4%) and 40% CR (37.7%).  Gstm6 mRNA was increased by 15% CR (48.8%), 30% 
CR (58.8%), and 40% CR (25.6%).  Gstp1 mRNA was decreased markedly by 30% CR 
(60.1%) and 40% CR (80.8%).  Gstp2 mRNA was decreased by 30% CR (37.1%) and 
40% CR (50.7%).  Gstt1 mRNA was increased slightly by 30% CR (35.6%) and 40% 
CR (25.7%).  Gstt2 mRNA was increased by 30% CR (60.5%) and 40% CR (90.6%).  
The mRNA of microsomal Gst Mgst1 was decreased by 15% CR (14.5%), 30% CR 
(25.9%), and 40% CR (41.2%).  Mgst3 mRNA was increased by 15% CR (35.3%), 30% 
CR (151%), and 40% CR (225%).  In general, CR altered the hepatic expression of all 
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13 Gsts quantified, increasing 10 (Gsta1, a4, m1, m2, m3, m4, m6, t1, t2, and Mgst3) 
and decreasing 3 (Gstp1, p2, and Mgst1). 
N-acetyltransferases (Nats) and catechol-O-methyltransferase (Comt) catalyze 
conjugation reactions with acetyl and methyl groups, respectively.  In contrast to the 
other conjugation pathways, these two pathways decrease the hydrophobicity of the 
substrates.  The mRNA levels of Nat1 and Nat2 were not altered by CR (Fig. 6.12).  
The mRNA of Comt was decreased by 30% CR (52.2%) and 40% CR (64.6%).  In 
general, CR decreased the hepatic expression of Comt but did not alter the expression 
of Nats. 
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Fig. 6.9. 
 
 
The mRNA changes of Sults and Papss in livers by graded CR.  Data are presented 
as means ± SEM of 5 mice.  Asterisks (*) represent statistically significant differences 
were considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  
The triangle marks represents increased calorie restriction (CR). 
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Fig. 6.10. 
 
 
 
The mRNA changes of Ugts and Ugdh in livers by graded CR.  Data are presented 
as means ± SEM of 5 mice.  Asterisks (*) represent statistically significant differences 
were considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  
The triangle marks represents increased calorie restriction (CR). 
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Fig. 6.11. 
 
 
The mRNA changes of Gsts in livers by graded CR.  Data are presented as means ± 
SEM of 5 mice.  Asterisks (*) represent statistically significant differences were 
considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  The 
triangle marks represents increased calorie restriction (CR). 
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Fig. 6.12. 
 
 
The mRNA changes of Nats and Comt in livers by graded CR.  Data are presented 
as means ± SEM of 5 mice.  Asterisks (*) represent statistically significant differences 
were considered at p < 0.05 by one-way ANOVA, followed by Duncan’s post-hoc test.  
The triangle marks represents increased calorie restriction (CR). 
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6.3.5  The Effect of Graded CR on Hepatic Expression of Efflux Transporters.   
Efflux transporters play a key role in the elimination of xenobiotics.  Multidrug 
resistance-associated protein 3 (Mrp3) is important in retro-transporting bilirubin 
glucuronides and bile acids back into blood, whereas breast cancer resistant protein 
(Bcrp) is important for transporting sulfate and glucuronide conjugates into bile.  The 
mRNA of Mrp3 was decreased by 15% CR (38.3%), 30% CR (49.7%), and 40% CR 
(41.8%) (Fig. 6.13).  Mrp6 mRNA was decreased 28.5% by 40% CR.  Multidrug 
resistance protein 2 (Mdr2) mRNA was decreased by 30% CR (30.8%) and 40% CR 
(36.0%).  Bcrp mRNA was decreased gradually by 15% CR (22.4%), 30% CR (53.3%), 
and 40% CR (67.8%).  Abca1 mRNA was decreased 27.7% by 40% CR.  The mRNA 
levels of Mrp2, Mrp4, Mate1, Abcg5, and Abcg8 were not altered by CR.  In general, CR 
altered the hepatic expression of 5 of the 10 efflux transporters quantified, decreasing 
Mrp3, 6, Mdr2, Bcrp, and Abca1. 
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Fig. 6.13. 
 
 
The mRNA changes of efflux transporters in livers by graded CR.  Data are 
presented as means ± SEM of 5 mice.  Asterisks (*) represent statistically significant 
differences were considered at p < 0.05 by one-way ANOVA, followed by Duncan’s 
post-hoc test.  The triangle marks represents increased calorie restriction (CR). 
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6.3.6  The Effect of Graded CR on Hepatic Expression of Transcription Factors.   
The expression of many XPGs are regulated by transcription factors, such as the 
aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), pregnane X 
receptor (PXR), peroxisome proliferator-activated receptor alpha (PPARα), and nuclear 
factor E2-related factor 2 (Nrf2) (Klaassen and Slitt, 2005).  These transcription factors 
are responsive to xenobiotics and their activation leads to increased or decreased 
expression of various XPGs (Klaassen and Aleksunes, 2010).  In order to determine the 
regulation of XPGs in this graded CR model, mRNAs of major transcription factors were 
quantified in livers.  The mRNA of AhR tended to be increased by 30% and 40% CR, 
but was not statistically significant (Fig. 6.14).  The mRNA of CAR was increased by 
30% CR (41.2%) and 40% CR (116%).  The mRNA of Nrf2 was increased by 30% CR 
(23.2%) and 40% CR (28.1%).  The mRNA levels of PXR and PPARα were not altered 
by CR.  In general, among the transcription factors quantified, CAR and Nrf2 were the 
only two whose hepatic expression was increased by CR. 
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Fig. 6.14. 
 
 
The mRNA changes of several transcription factors in livers by graded CR.  Data 
are presented as means ± SEM of 5 mice.  Asterisks (*) represent statistically 
significant differences were considered at p < 0.05 by one-way ANOVA, followed by 
Duncan’s post-hoc test.  The triangle marks represents increased calorie restriction 
(CR). 
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6.4  Discussion 
The present study demonstrates that 15% CR is not sufficient to alter the mRNA 
levels of most XPGs, whereas 30 and 40% CR alter over half of the XPGs (61 of 98), 
with 32 being increased and 29 decreased (Fig. 6.15).  XPGs that are markedly altered 
by CR belong to the Oatp, Fmo, Sult, and Gst families.    
In general, uptake transporters Oatp1a1 and Oatp1a4 demonstrate overlapping 
substrate specificity in vitro, such as sulphobromopthalein, sulfated steroids, β-lactam 
antibiotics, and fexofenadine.  However, Oatp1a4 has unique substrates such as 
digoxin (Klaassen and Aleksunes, 2010).  Interestingly, these two Oatps are oppositely 
regulated by CR (Fig. 6.3).  Further studies are needed to conclude the effects of CR 
on the transport of various Oatp substrates.   
Several P450s are up-regulated by CR.  Noticeably, Cyp4a14 mRNA is increased 
12 fold in the present study (Fig. 6.4), which is greater than the increase (2-fold) in 
long-lived C3B10RF1 mice with long-term CR (Cao et al., 2001), but smaller than the 
increase (50-fold) in 129/SV mice after 24 h starvation (Bauer et al., 2004).  Various 
mice strains and dietary regimens probably contribute to these discrepancies.  The 
up-regulation of Cyp4a14, an omega hydroxylase of arachidonic acids (Okita and Okita, 
2001), reflects the increased requirement for fatty acid oxidation in liver to generate 
energy. 
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Fig. 6.15. 
 
Continued to the following page. 
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Fig. 6.15.  (continued) 
Hierarchical clustering of the mRNA profiles of XPGs in livers by graded CR.  
Clustering analysis results are shown in the dendrogram, with y-axis representing the 
XPGs that change with graded CR (p < 0.05, one-way ANOVA) and x-axis representing 
the graded CR (0, 15, 30, and 40%).  In the heatmap, the red color represents relatively 
high mRNAs and blue represents relatively low mRNAs.  The spectrum of each gene is 
standardized and specific to the scale of its own mRNA. Therefore, it’s not valid to 
compare the mRNA levels among different genes according to the color. 
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In addition to P450s, Fmos are another phase-I enzyme family whose expression is 
altered markedly by CR.  Fmos typically make xenobiotic substrates more polar, less 
pharmacologically active, and more easily excreted (Cashman, 2000).  Human FMO3 
contributes to the metabolic clearance of a variety of drugs, such as cimetidine, nicotine, 
and tamoxifen, as well as the diet-derived substrate trimethylamine (Cashman, 2000).  
The current finding that CR markedly up-regulates Fmo3 (346-fold; Fig. 6.5) may 
suggest a marked increase in oxidative metabolism and clearance of its substrates. 
CR up-regulates numerous phase-II enzymes, including many Sults, some Ugts, 
and most Gsts.  Phase-II conjugation by these three enzyme families increases the 
hydrophilicity of xenobiotics and promotes eventual excretion of their polar metabolites, 
thus playing crucial roles in detoxification.  Sult1e1 sulfonates a variety of estrogens, 
and is the predominant determinant of the ratio of free estrogens to inactive sulfate 
conjugates.  The inhibition of CR on mammary tumorigenesis is thought to be mediated 
in part by suppression of estrogen levels (Sylvester et al., 1982).  This correlates with 
the marked elevation of Sult1e1 (33.2-fold) by CR (Fig. 6.9, and thus possibly increased 
estrogen sulfation.  Modest up-regulation of Sult1a1 and Sult1d1 by CR (Fig. 6.9) 
suggests a possible increase in sulfation and clearance of phenolic substrates (such as 
acetaminophen and troglitazone) (Runge-Morris et al., 2013).  Sult3a1 is the only Sult 
that catalyzes N-sulfonation, rather than O-sulfonation of amines, such as the 
neurotoxicant phenyltetrahydropyridine and the rodent carcinogen 4-chloroaniline 
(Yoshinari et al., 1998).  The modest increase of Sult3a1 by CR (Fig. 6.9) suggests 
possible elevation of metabolism and detoxification of these toxic substrates.   
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In comparison to Sults, Ugts are altered by CR to a lesser degree.  
Glucuronosyltransferases in liver are important for deactivating the biological activities of 
thyroid hormones (Barter and Klaassen, 1994), which are the master regulator of basal 
metabolic rate.  CR-induced increase of Ugt1a1 (Fig. 6.10), a glucuronosyltransferase 
for the conjugation of thyroid hormones (Findlay et al., 2000), correlates with a previous 
report that CR decreases thyroid hormones (Fontana et al., 2006).  Increased Ugt1a1 
and Ugt1a5 by CR in the present study are consistent with a previous finding that 
mutants of C. elegens with spontaneous CR have increased expression of Ugts, to 
potentially dispose of toxic endobiotic and xenobiotic compounds to ensure longevity 
(McElwee et al., 2004).  Therefore, elevated detoxification might be an evolutionarily 
conserved anti-aging pathway.  In contrast to modest increases in Ugt1a1 and Ugt1a5, 
CR down-regulates several Ugts, including Ugt1a6a, 2b1, 2b36, 3a1, 3a2, and Ugdh 
(Fig. 6.10).  Further studies are needed to investigate the significance of the 
down-regulation of these Ugts by CR. 
Up-regulation of Gsts appears to be a common pathway associated with longevity.  
Gsts conjugate a wide range of electrophilic compounds, promote their excretion, and 
thus detoxify electrophiles by preventing the damage to macromolecules.  Therefore, 
Gsts have been proposed as a candidate to assure longevity in multiple species 
(McElwee et al., 2007).  A comparison of the mRNA profiles of XPGs in livers of genetic 
long-lived models, namely Little mice and Ames dwarf mice (Amador-Noguez et al., 
2004), as well as dietary long-lived model CR mice (data from the present study), shows 
that common changes include increased Oatp1a4, Cyp4a14, Fmo3, Sult1a1, Papss2, 
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Gsta4, m3, t1, and Mgst3, and decreased Oatp1a1, Ces3a, Gstp2, and Comt.  
Noticeably, many of these XPGs belong to the Gst family.  Gsta4 plays crucial roles in 
detoxifying 4-hydroxy-2-nonenal, which is a major lipid peroxidation product known to 
cause oxidative stress and to accumulate during aging (Sohal and Weindruch, 1996).  
The increased expression of Gsta4 (about 2-fold) by CR (Fig. 6.11) may provide a 
potential anti-aging mechanism of CR, which is supported by the evidence that 
overexpression of mouse Gsta4 in C. elegans increases stress resistance and life span 
(Ayyadevara et al., 2005).  Among the various Gsts, the Pi class has attracted attention 
because high levels of Gsts have been linked with cancer incidence (Tew and 
Townsend, 2011).  In contrast to the general up-regulation of Gsts, Gstp1 and Gstp2 
are down-regulated by CR (Fig. 6.11), which correlates with lower cancer incidence in 
CR rodents and monkeys (Longo and Fontana, 2010). 
Transcription factors may not play leading roles in the regulation of CR-induced 
changes of XPGs.  AhR, PXR, and CAR do not appear to be activated by CR, because 
the expression of their prototypical target genes (Cyp1a2, Cyp3a11, and Cyp2b10, 
respectively) (Klaassen and Aleksunes, 2010) are not induced (Fig. 6.4).  Although 
CAR has been suggested to mediate the up-regulation of some phase-II enzymes by 
fasting (Maglich et al., 2004), our study and a previous report (Cao et al., 2001) exclude 
the possibility of CAR activation by CR in liver, due to the lack of increases in mRNAs of 
CAR target genes Cyp2b10 and Sult2a1.  PPARα, a regulator for fatty acid oxidation, 
may be activated by CR in liver, because of the increase in its prototypical target gene 
Cyp4a14 (Fig. 6.4), however, the role of PPARα in the regulation of drug metabolism is 
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minor.  Nrf2, a master regulator for antioxidant defense and electrophile detoxification, 
might be activated by CR in liver.  Because some Nrf2 target genes (such as Nqo1 and 
many Gsts) (Klaassen and Aleksunes, 2010; Wu et al., 2012) are up-regulated by CR 
(Fig. 6.4 and Fig. 6.11), in addition to the increase of Nrf2 mRNA (Fig. 6.14).  However, 
another Nrf2 target gene Mrp3 is down-regulated by CR (Fig. 6.13).  In summary, the 
CR-induced changes of XPGs do not appear to be regulated by a single transcription 
factor.  
Previous studies have shown that CR can feminize gene expression profiles in male 
mice (Estep et al., 2009) and long-lived mice have lost the sex dimorphism of gene 
expression (Amador-Noguez et al., 2005).  Comparing with our previous report on 
gender differences of XPG expression in livers of mice (Fu et al., 2012a), the present 
study indicates that CR feminizes the mRNA profiles of 32 XPGs, which is over half of 
the XPGs that are altered by CR.  For example, male mice have higher expression of 
Oatp1a1 in liver (Cheng et al., 2005), and Oatp1a1 mRNA is decreased markedly by 
40% CR (97.2%) (Fig. 6.3).  In contrast, male mice have lower expression of Oatp1a4 
in liver (Cheng et al., 2005), and Oatp1a4 mRNA is markedly increased by 40% CR 
(11.3-fold) (Fig. 6.3).  Both CR-induced decrease in male-predominant Oatp1a1 and 
increase in female-predominant Oatp1a4 are attributable to feminization effects by CR in 
male mice.  Feminization is also observed for male-predominantly expressed Ces2c, 
3a, Ugt1a6a, 2b1, Gstp1, p2, and Bcrp, as well as female-predominantly expressed 
Ent1, Cyp1a1, 4a14, Por, Nqo1, Fmo1-4, Aldh8a1, Pon1, Sult1a1, 1d1, 3a1, Papss2, 
Ugt1a1, 1a5, Gsta4, m2, t1, Mgst3, CAR, and Nrf2 (Table 6.1).  However, the 
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remainder of the XPGs that are altered by CR either do not have gender-divergent 
expression (19 XPGs) or their changes by CR fail to be explained by feminization (10 
XPGs).   
Pulsatile growth hormone secretory pattern in males mediates gender differences of 
many XPGs.  CR was reported to decrease plasma growth hormone levels in males 
(Chacon et al., 2005).  Therefore, the feminization effects of many XPGs by CR in 
males are likely attributable to the CR-induced decrease in growth hormone levels.  In 
general, humans have much smaller gender differences in XPG expression than rodents 
(Waxman and O'Connor, 2006).  Thus, one needs to be cautious when extrapolating 
the significance of feminization of XPG expression in liver by CR from mice to humans. 
In conclusion, the present study used a graded CR model and compared the mRNA 
profile changes of 98 XPGs in livers of male mice by CR.  The major findings are 1) CR 
(30 and 40%) altered over half of the XPGs; 2) CR up-regulated 17 phase-II drug 
metabolizing enzymes;  and 3) over half of the XPGs that are altered by CR appear to 
be due to feminization of the liver by CR.  Results from the present study on the 
alteration of XPGs by CR sheds light on the potential mechanisms of the anti-aging 
effects of CR, and may indicate which XPG pathways are altered, thus the dosing, 
pharmacokinetics, and toxicity of drugs might be altered in people on diets. 
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Table 6.1.  CR (30 and 40%) feminizes the mRNA profiles of over half of the XPGs 
that are altered in livers of male mice. 
  
mRNA 
changes 
by CR 
List of XPGs (Category: Name) 
♂ or ♀ 
predominant 
expression 
"Feminization 
effects" 
↓ 
Uptake transporter: Oatp1a1 
♂ 
Phase-I enzymes: Ces2c, Ces3a 
Phase-II enzymes: Ugt1a6a, Ugt2b1, 
Gstp1, Gstp2 
Efflux transporter: Bcrp 
↑ 
Uptake transporter: Oatp1a4, Ent1 
♀ 
Phase-I enzymes: Cyp1a1, Cyp4a14, 
Por1, Nqo1, Fmo1, Fmo2, Fmo3, 
Fmo4, Aldh8a1, Pon1 
Phase-II enzymes: Sult1a1, Sult1d1, 
Sult3a1, Papss2, Ugt1a1, Ugt1a5, 
Gsta4, Gstm2, Gstt1, Mgst3 
Transcription factors: CAR, Nrf2 
 
♂: male 
♀: female  
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Chapter 7: REGULATION OF BILE ACID ENTEROHEPATIC CIRCULATION BY 
GRADED CALORIE RESTRICTION IN MICE 
 
 
  
 
 
160 
 
7.1  Abstract 
Recent reports have suggested a connection between longevity and BAs, which are 
metabolites of cholesterol.  However, how BA metabolism is regulated by a well-known 
anti-aging intervention CR is not known.  Therefore, the present study quantified 20 
individual BAs in various compartments of the enterohepatic circulation by UPLC-MS/MS 
in a "dose-response" model of CR (0, 15, 30, or 40% CR for one month, C57BL/6 male 
mice).  CR (40%) increased the BA pool size (162%) and total BA concentrations in 
serum, gallbladder, and small intestinal contents.  Graded CR "dose-dependently" 
increased the concentrations of tauro-cholic acid (TCA) and many secondary BAs in 
serum, such as TDCA, DCA, lithocholic acid, ω-muricholic acid (ωMCA), and 
hyodeoxycholic acid.  Notably, 40% CR increased tauro-deoxycholic acid (TDCA) 
concentrations over 10 fold (serum, liver, and gallbladder).  CR (40%) increased the 
proportion of 12-hydroxylated BAs (CA and DCA), which correlated with the improved 
glucose tolerance and lipid parameters.  The increase in BAs correlated with increased 
expression of BA-synthetic (Cyp7a1) and conjugating enzymes (BAL), and the ileal 
BA-binding protein by 40% CR.  These results demonstrate that CR increases BAs 
possibly through orchestrated increases in BA synthesis by the classical pathway, as 
well as BA conjugation in liver and intracellular transport in ileum. 
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7.2  Introduction 
CR is the most effective intervention to increase longevity in mammals.  CR 
increases the lifespan of various species ranging from yeast, fish, invertebrate animals to 
hamsters, mice, rats, and dogs (Masoro, 2005).  Moreover, CR decreases the 
incidence of aging-related diseases in nonhuman primates (Colman et al., 2009) and 
human beings (Fontana et al., 2004; Johannsen et al., 2007).  However, the exact 
mechanism underlying the anti-aging effects of CR remains elusive. 
BAs are important endogenous molecules in the enterohepatic system.  
Synthesized from cholesterol in the liver, BAs regulate cholesterol homeostasis, and 
facilitate intestinal absorption of dietary lipids (Hofmann and Hagey, 2008).  Recently, 
BAs have been shown to be signaling molecules, regulating the homeostasis of BAs 
(Song et al., 2011), lipids (Sinal et al., 2000; Sirvent et al., 2004), glucose (Scholmerich 
et al., 1985; Staels and Kuipers, 2007), and energy (Watanabe et al., 2006; Li et al., 
2012).  FXR is closely involved in the metabolism of lipids (Sinal et al., 2000; Sirvent et 
al., 2004) and glucose (Scholmerich et al., 1985; Staels and Kuipers, 2007).  On its 
activation by BAs, FXR regulates bile acid synthesis, conjugation, and transport, as well 
as glucose and lipid metabolism (Claudel et al., 2005).  In addition, BAs are ligands for 
the G-protein-coupled receptor TGR5 (Maruyama et al., 2002), through which BAs can 
increase energy expenditure in brown adipose tissue and muscle (Watanabe et al., 
2006).  
Connection between longevity and bile acids (BAs) has been indicated by some 
recent reports.  In long-lived lit/lit mice, higher levels of BAs activated xenobiotic 
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metabolizing gene expression possibly via FXR (Amador-Noguez et al., 2007), and the 
authors suggested that this increased resistance to xenobiotic stress possibly 
contributes to the longevity. This finding indicates that BAs may be a longevity signal in 
long-lived lit/lit mice (Gems, 2007).  In addition, a chemical screen identified LCA as an 
anti-aging molecule that extended the life span of yeast (Goldberg et al., 2010b).  
Moreover, 3-keto BA-like steroids, called dafachronic acids, increase the life span of C. 
elegans, through DAF-12 (a homolog of FXR) (Held et al, 2006; Gerisch et al., 2007). 
Our laboratory also recently reported that female mice have higher BA concentrations in 
serum than males during aging (Fu et al., 2012b), which correlates with the tendency 
that female mice live longer.  These studies suggest a link between BAs and longevity. 
Because CR is the most effective anti-aging intervention in mammals, we 
hypothesized that BA concentrations would be higher in CR mice.  Therefore, the 
present study was designed to determine the effect of CR on BA homeostasis by varying 
the extent of CR (0, 15, 30, or 40%), and BA quantification in various compartments of 
the EHC by ultra-performance liquid chromatography-tandem mass spectrometry 
(UPLC-MS/MS). Furthermore, the mRNAs of BA-related genes were quantified to reveal 
possible mechanisms for BA alterations by CR.  
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7.3  Results 
7.3.1  Body Weight, Glucose, and Lipid Parameters in CR Mice.   
In order to validate the graded CR model, body weight was recorded weekly.  As 
expected, the body weights of CR mice were lower than AL mice, and they reached a 
"steady state" by the end of the study (Fig. 7.1A).  Interestingly, the final body weights 
of 15%, 30%, and 40% CR mice were all much lower than AL mice, which was 15%, 
28%, and 38%, respectively.  The health condition of CR mice were monitored 
throughout the study, and no malnutrition was apparent.  As shown in Fig. 7.1B, CR 
mice had better insulin sensitivity, evidenced by lower AUCs in glucose tolerance test 
(GTT).  In addition, 30 and 40% CR mice had lower blood glucose than AL mice before 
glucose challenge as well, but they were not hypoglycemic.  Lipid parameters in serum 
and liver of AL and CR mice were examined.  TG levels in plasma were decreased by 
40% CR, and interestingly, the levels in liver were decreased by CR proportionally.  
Moreover, cholesterol and FA levels were decreased by CR in plasma and liver (Fig. 
7.1C).  
7.3.2  Effect of Graded CR on Total BAs in Various Compartments of the 
Enterohepatic Circulation.   
Serum, liver, gallbladder (GB), small intestine (SI), and large intestine (LI) are the 
major compartments of the enterohepatic circulation (EHC) of BAs.  BA pool size is 
estimated by adding the BA amounts in liver, GB, and intestine.  Forty percent CR 
increased BA pool size (162%), due to the increased BA amounts in GB (133%) and SI 
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(174%) (Fig. 7.2, top-left panel).  However, CR did not alter BA amounts in liver and 
LI. 
In serum (Fig. 7.2, top-right panel), 40% CR increased total BA concentrations 
(231%).  Specifically, 40% CR increased the concentrations of both conjugated (335%) 
and unconjugated BAs (178%). In addition, 40% CR increased similarly the 
concentrations of primary (224%) and secondary BAs (233%).  In liver (Fig. 7.2), CR 
did not alter the amounts of conjugated, unconjugated, primary, or secondary BAs.  In 
GB (Fig. 7.2), 40% CR increased the amounts of conjugated (132%), primary (162%), 
and secondary BAs (77%), however, CR did not alter the amounts of unconjugated BAs.  
In the SI contents (Fig. 7.2), 40% CR increased the amounts of conjugated (179%), 
primary (219%), and secondary BAs (94%), however, CR did not alter the amounts of 
unconjugated BAs.  In the LI contents (Fig. 7.2), CR did not alter the amounts of 
conjugated, unconjugated, primary, or secondary BAs.   
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Fig. 7.1. 
 
Body weight, glucose, and lipid parameters in CR mice.  (A) Body weight changes 
of mice by graded CR (AL, 15%, 30%, or 40% CR) throughout the study.  Day 0 
represents the start for one-month CR.  The body weights of CR mice started to be 
lower than AL mice after 1 week of CR feeding.  (B) Glucose tolerance test (GTT).  
After 6 h of fasting, the basal blood glucose (time 0) was taken.  Then a bolus of 20% 
D-glucose was given (i.p.) and serial glucose levels were taken at indicated time points 
thereafter.  The blood glucose levels of CR mice were lower than AL mice after glucose 
challenge.  In addition, 30 and 40% CR mice had lower blood glucose than AL mice 
before glucose challenge as well.  (C) Triglycerides (TG), cholesterol, and fatty acids 
(FAs) in plasma and liver.  Data are presented as means ± SEM of 5 mice.  * p < 0.05, 
by one-way ANOVA, followed by Duncan’s post-hoc test (not shown in A and B panels). 
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Fig. 7.2. 
 
 
 
Effect of graded CR on total BAs in various compartments of the enterohepatic 
circulation.  (Top left) Total BA amounts in liver, gallbladder (GB), contents of small 
intestine (SI) and large intestine (LI), as well as total BA pool size.  (Top right) 
Concentrations of total, taurine-conjugated (T-BAs), unconjugated (U-BAs), primary, and 
secondary BAs in serum.  (Bottom) Amounts of total, conjugated, unconjugated, 
primary, and secondary BAs in liver, GB, SI, and LI.  Data are presented as means ± 
SEM of 5 mice.  * p < 0.05, by one-way ANOVA, followed by Duncan’s post-hoc test.  
 
  
Liver GB SI LI Total
T
o
ta
l 
B
A
s 
(
m
o
le
)
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
16.0
AL 
15% CR 
30% CR 
40% CR 
0.0
0.1
0.2
0.3
0.4
0.0
0.4
0.8
1.2
1.6
0.0
0.1
0.2
0.3
0.4
0.5
0.6
AL 
15% CR 
30% CR 
40% CR 
Liver
B
A
s 
(
m
o
le
)
0.000
0.005
0.010
0.015
0.020
0.025
0.0
1.0
2.0
3.0
4.0
AL 
15% CR 
30% CR 
40% CR 
Serum
B
A
s 
(n
m
o
l/m
l)
*
*
* *
*
* *
*
*
*
*
*
0.0
0.2
0.4
0.6
0.8
1.0
1.2
GB
B
A
s 
(
m
o
le
)
0.000
0.001
0.002
0.003
0.004
0.005
* *
*
*
B
A
s 
(
m
o
le
)
0.0
0.4
0.8
1.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
LI contents
To
tal
 BA
s
T-B
As
U-B
As
Pri
ma
ry
Se
co
nd
ary
0.0
2.0
4.0
6.0
8.0
10.0
12.0
SI contents
*
0.0
0.2
0.4
0.6
0.8
1.0
*
*
*B
A
s 
(
m
o
le
)
To
tal
 BA
s
T-B
As
U-B
As
Pri
ma
ry
Se
co
nd
ary
(n
m
o
l/
m
L
)
 
 
167 
 
7.3.3  Concentrations of Individual BAs in Various Compartments of CR Mice. 
Concentrations of Individual BAs in Serum of CR Mice.  Four BA pathways are 
classified to aid in reading Fig. 7.3, each of which involves the primary BA and its 
secondary BAs, as well as their taurine conjugates.  For example, the CA pathway 
involves TCA, TDCA, CA, and DCA.  In serum, 40% CR markedly increased the 
concentrations of TCA (872%), TDCA (11.2-fold), and DCA (10.6-fold) (Fig. 7.3).  CA 
was increased by 30% (262%), but not by 40% CR.  For the CDCA pathway, CR did not 
alter the concentrations of TCDCA, TLCA, TUDCA, or CDCA in serum, but LCA was 
increased by both 30% (262%) and 40% CR (408%), whereas, UDCA was increased by 
30% (205%), but not 40% CR.  For the αMCA pathway, 30% CR increased 
concentrations of TαMCA (558%) and αMCA (489%), whereas 40% CR did not alter 
either.  The secondary BAs MDCA and TMDCA were not altered by CR.  For the 
βMCA pathway, CR did not alter the concentrations of BA taurine conjugates (TβMCA, 
TωMCA, or THDCA) or βMCA.  The concentration of ωMCA was increased by both 
30% (95.6%) and 40% CR (135%), as was HDCA (128% and 169%). 
Amounts of Individual BAs in Livers and Gallbladders of CR Mice.  In livers 
(Fig. 7.3), for the CA pathway, 30 and 40% CR tended to double the amount of TCA in 
livers (not statistically different).  TDCA amount was increased by both 30% (222%) and 
40% CR (484%).  CR did not alter CA amount.  For the CDCA pathway, 40% CR 
decreased the amounts of TCDCA (45.9%), TUDCA (57.2%), but increased CDCA 
(146%).  CR did not alter the amounts of TLCA or UDCA in liver.  For the αMCA 
pathway, CR did not alter the amounts of BAs (TαMCA, TMDCA, αMCA, or MDCA) in 
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liver.  For the βMCA pathway, 40% CR decreased the amounts of βMCA (86.6%) and 
HDCA (70.0%), but CR did not alter the amounts of TβMCA, TωMCA, THDCA, or 
ωMCA. 
In gallbladders (GBs) (Fig. 7.3), for the CA pathway, 40% CR increased the 
amounts of TCA (355%), TDCA (10.4-fold), and DCA (10.4-fold), and 15% CR increased 
CA amount (190%).  CR did not alter the amounts of BAs in the CDCA, αMCA, or 
βMCA pathways, except a modest increase in αMCA by 15% CR (180%). 
Amounts of Individual BAs in Intestinal Contents of CR Mice.  In the contents 
of the small intestines (SI) (Fig. 7.3), for the CA pathway, 40% CR increased the 
amounts of TCA (506%) and TDCA (18.0-fold), 30% CR increased CA amount (746%), 
whereas CR did not alter DCA amount.  CR did not alter the amounts of BAs in the 
CDCA, αMCA, and βMCA pathways, except modest increases in αMCA (137%) and 
βMCA (210%) by 30% CR. 
In the contents of the large intestines (LI) (Fig. 7.3), for the CA pathway, 40% CR 
increased the amounts of TCA (694%), TDCA (639%), and DCA (253%), but CR did not 
alter CA amount.  CR did not alter the amounts of BAs in the CDCA pathway, except 
the increases in TCDCA (694%) and LCA (145%) by 15% CR.  CR did not alter the 
amounts of BAs in the αMCA or βMCA pathways, except decreases in MDCA (64.2%) 
and βMCA (73.6%) by 30% CR. 
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Fig. 7.3. 
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Continued to the following page. 
Fig. 7.3.  (continued) 
 
Individual BAs in various compartments of the enterohepatic circulation in CR 
mice.  Four pathways are classified, and each (CA pathway for instance) involves 
primary BAs (CA), and secondary BAs (DCA), and their taurine conjugates (TCA and 
TDCA).  CA, cholic acid; DCA, deoxycholic acid; CDCA: chenodeoxycholic acid; LCA, 
lithocholic acid; UDCA, ursodeoxycholic acid; MCA, muricholic acid; MDCA, 
murideoxycholic acid; HDCA, hyodeoxycholic acid.  Data are presented as means ± 
SEM of 5 mice.  * p < 0.05, by one-way ANOVA, followed by Duncan’s post-hoc test. 
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7.3.4  Altered Enterohepatic BA Composition by 40% CR.  
BA compositions in AL and 40% CR groups were analyzed by calculating the 
proportion of each BA and its taurine conjugates in total BA concentrations.  In general, 
40% CR increased the proportions of BAs in the CA pathway, but decreased the 
proportions of BAs in the CDCA, αMCA, and βMCA pathways (Fig. 7.4).  Specifically, 
40% CR doubled CA proportions in serum (8.4% to 17.2%), liver (20.5% to 41.1%), GB 
(26.4% to 53.5%), and SI (26.8% to 58.5%), and tended to increase CA proportion in LI 
(1.6% to 5.9%; not statistically different).  Similarly, 40% CR increased DCA proportions 
in serum (9.3% to 29.3%), liver (2.7% to 12.1%), GB (2.5% to 7.8%), SI (1.1% to 7.9%), 
and LI (3.5% to 13.7%).  In contrast, 40% CR decreased βMCA proportions in serum 
(10.9% to 2.9%), liver (26.5% to 13.2%), GB (20.7% to 11.0%), and SI (22.4% to 9.2%).  
In addition, 40% CR decreased ωMCA proportions in serum (44.1% to 31.9%), liver 
(22.3% to 14.9%), GB (20.5% to 11.5%), SI (22.6% to 10.0%), and LI (74.8% to 61.4%). 
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Fig. 7.4. 
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Continued to the following page. 
Fig. 7.4.  (continued) 
 
Altered enterohepatic BA composition by 40% CR.  For instance, the green portion 
of the pie chart represents the proportion of CA and TCA in total BA concentrations.  
Data are presented as means of 5 mice.  * p < 0.05, by one-way ANOVA, followed by 
Duncan’s post-hoc test.   
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7.3.5  Expression of BA-Synthetic and Conjugating Enzymes in CR Mice.    
The expression of BA synthetic and conjugating enzymes were quantified in the 
present study (Fig. 7.5).  In the classic pathway, 40% CR increased the mRNA of 
rate-limiting BA-synthetic enzyme Cyp7a1 (228%), but decreased the mRNA of Cyp8b1 
(53.8%).  In the alternative pathway, CR did not alter Cyp27a1 mRNA level.  However, 
Cyp7b1 was decreased by 40% CR (76.2%), and Cyp39a1 was increased by 40% CR 
(440%).  For BA conjugating enzymes, 40% CR increased BAL mRNA (123%), but CR 
had little or no effect on BAT mRNA level. 
7.3.6  Expression of Cyp7a1 Transcription Regulatory Factors in Liver and Ileum 
of CR Mice.   
The mRNAs of several key Cyp7a1 transcription regulatory factors were quantified 
(Fig. 7.6).  Forty percent CR increased the mRNAs of FXR in liver (87.5%) and SHP in 
ileum (120%).  In addition, 40% CR tended to increase the mRNA of Fgf15 in ileum, but 
was not statistically increased.  CR did not alter the mRNA levels of other Cyp7a1 
transcription regulatory factors, such as SHP and Fgfr4 in liver, and FXR in ileum. 
7.3.7  Expression of BA Transporters in the Enterohepatic Circulation in CR Mice.    
The expression of BA transporters in liver and ileum was quantified in the present 
study (Fig. 7.7).  Forty percent CR increased the mRNAs of Ntcp (35%) in liver and 
Ibabp (206%) in ileum.  However, CR did not alter the mRNA levels of other BA 
transporters, including Oatp1b2 and Bsep in liver, and Asbt, Ostα, and Ostβ in ileum. 
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Fig. 7.5. 
 
 
 
Expression of BA-synthetic and conjugating enzymes in CR mice.  Cyp7a1 and 
Cyp8b1 are enzymes in the classic pathway for BA synthesis.  Cyp7a1 is the 
rate-limiting enzyme for BA biosynthesis.  Cyp27a1, Cyp7b1, and Cyp39a1 are 
enzymes in the alternative pathway for BA synthesis.  BAL and BAT are BA conjugating 
enzymes.  Data are presented as means ± SEM of 5 mice.  The mRNA levels of each 
genes in AL mice were controls, set as 1.  * p < 0.05, by one-way ANOVA, followed by 
Duncan’s post-hoc test. 
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Fig. 7.6. 
 
 
 
Expression of Cyp7a1 transcription regulatory factors in liver and ileum of CR 
mice.  The transcription of Cyp7a1 is regulated by BA-induced feedback inhibition.  
One proposed mechanism involves BA receptor FXR and its target gene nuclear 
receptor SHP in liver.  The other mechanism involves "enterohepatic communication", 
where BAs activate FXR in the intestine, inducing an intestinal hormone Fgf15, which 
travels through the circulation to the liver and through Fgfr4 down-regulates Cyp7a1 
transcription.  Data are presented as means ± SEM of 5 mice.  The mRNA levels of 
each genes in AL mice were controls, set as 1.  *  p < 0.05, by one-way ANOVA, 
followed by Duncan’s post-hoc test. 
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Fig. 7.7. 
 
 
Expression of BA transporters in the enterohepatic circulation in CR mice.  In 
liver, BA uptake transporters Ntcp extracts conjugated BAs and Oatp1b2 extracts 
unconjugated BAs into hepatocytes, and the BA efflux transporter Bsep pumps out BAs 
into canalicular bile.  In ileum, the BA uptake transporter Asbt mediates the 
reabsorption of BAs from the intestinal lumen into ileocytes, the BA binding protein Ibabp 
mediates the intracellular transfer of BAs from apical to basolateral side of ileocyte 
membrane, and the BA efflux transporter Ostα/β pumps BAs out into portal blood. Data 
are presented as means ± SEM of 5 mice.  The mRNA levels of each genes in AL group 
were controls, set as 1.  * p < 0.05, by one-way ANOVA, followed by Duncan’s post-hoc 
test. 
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7.4  Discussion 
BAs are proposed to be potential mediators of longevity (Amador-Noguez et al., 
2007; Gems, 2007; Goldberg et al., 2010a).  The main hypothesis is that BAs could 
up-regulate xenobiotic metabolism and thus decrease molecular damage by toxic 
lipophilic by-products, which is a major contributor to aging (Gems and McElwee, 2005).  
The present study for the first time investigated the regulation of BA homeostasis by CR, 
the best known dietary intervention to ensure longevity, and comprehensively 
characterizes the BA profiles by CR in various compartments of the enterohepatic 
circulation.  Using a graded CR model, the present study demonstrates coordinated 
increases in BA pool size as well as BA concentrations/amounts by 40% CR in various 
compartments of the body, which correlates with the up-regulation of BA-synthetic and 
conjugating enzymes and ileal BA binding protein.   
Interestingly, graded CR increases several individual BAs in a "calorie-dependent" 
manner (Fig. 7.3).  It appears that CA and its secondary BA (DCA) have the highest 
inverse correlation to calorie intake.  In general, the secondary BAs (such as DCA, 
LCA, ωMCA, and HDCA) increase more than primary BAs after CR.  The present 
finding that some BAs such as CA, DCA, and LCA are increased by CR is consistent 
with previous reports that indicate that BAs might be longevity signals (Gems, 2007).  
The long-lived lit/lit mice have increased concentrations of several BAs in serum, such as 
LCA, DCA, CDCA, CA, etc.  Moreover, feeding CA to wild-type mice reproduced the 
expression profiles of xenobiotic metabolism genes observed in the long-lived mice 
(Amador-Noguez et al., 2007).  Increased resistance to stress and thus decreased 
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age-related damage to macromolecules such as DNA, lipids, and proteins have been 
proposed as a possible anti-aging mechanism (Gems and McElwee, 2005).  In addition, 
LCA can increase the life span of yeast in a chemical screen assay (Goldberg et al., 
2010b).  These studies provide some indication that BAs might be "the fountain of 
youth" (Ferbeyre, 2010a).  Therefore, the present study provides further support for this 
theory by demonstrating that CR, the most effective dietary intervention to retard aging, 
increases BA concentrations/amounts in several compartments of the EHC.  
The CR-induced increase in BAs would not be expected to cause hepatotoxicity.  
For example, in the bile duct ligation-induced cholestatic liver injury model, total BA 
concentrations increased 1,400-fold in serum at 6 h after surgery (Zhang et al., 2012a).  
In comparison, the increase in total BA concentrations in serum by CR (2.3-fold) in the 
present study is hundreds of magnitudes lower (Fig. 7.2).  Feeding DCA to mice (0.1% 
in diet for 7 days) leads to a 19-fold increase in DCA concentration in serum, and the 
serum alanine aminotransferase activity is about 50 IU/L (Song et al., 2011), indicating 
little or no hepatotoxicity.  Smaller increases in BA concentrations/amounts are 
identified in the present study, with the highest increase in TDCA, which is increased 
about 11-fold in serum, 5-fold in liver, 10-fold in GB, 18-fold in SI, and 6-fold in LI.  Thus, 
the CR-induced BA increases do not appear to have reached the concentration to cause 
toxicity. 
Furthermore, CR increases 12-hydroxylated BAs in various compartments of the 
EHC. CR alters BA composition (Fig. 7.4), namely increasing the proportions of CA and 
DCA, and decreasing the proportions of α-, β-, and ωMCAs.  Both CA and its secondary 
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BA, DCA, have 12-hydroxyl groups, whereas the MCAs do not.  In addition to the 
increased proportions, the concentrations/amounts of CA and DCA are increased in 
most compartments as well (Fig. 7.3).  Our finding on the correlation of increased 
proportions of 12-hydroxylated BAs and improved insulin sensitivity and decreased lipid 
parameters (Fig. 7.1B and C) in CR mice is consistent with the previous report that 
impaired generation of 12-hydroxylated BAs was associated with dyslipidemia and 
insulin resistance (Haeusler et al., 2012).  Therefore, our study provides further 
evidence for the role of BA composition or the presence of certain class of BAs in the 
regulation of glucose and lipid metabolism. 
The increases in BAs by CR correlate with the alterations of genes related to BA 
homeostasis.  Cyp7a1 plays the leading role in determining BA synthesis and BA pool 
size (Li et al., 2011).  In the present study, 40% CR increases Cyp7a1 expression (Fig. 
7.5), which correlates with the increase of BA pool size (Fig. 7.2).  This suggests that 
the increases in BA pool size by CR are likely due to increased expression of Cyp7a1.  
Opposite to the increase in CA, the expression of Cyp8b1, the enzyme that forms CA, is 
down-regulated by 40% CR (Fig. 7.5).  Some BA synthetic enzymes have 
gender-divergent expression in liver.  Both Cyp8b1 and Cyp7b1 are expressed higher 
in male than female mice (Fu et al., 2012b), which is opposite to Cyp39a1 (female > 
male) (Li-Hawkins et al., 2000a).  Interestingly, the expression of Cyp8b1 and Cyp7b1 
were decreased by CR, whereas Cyp39a1 was increased (Fig. 7.5).  This appears to 
be attributable to feminization of the liver by CR.  Previous reports have shown that CR 
can feminize genome-wide gene expression in male mice (Estep et al., 2009) and 
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long-lived mice have lost the sex dimorphism of gene expression (Amador-Noguez et al., 
2005).  Therefore, the current finding of CR-induced feminization of some BA synthetic 
enzymes suggests that the connection between feminization and longevity is an 
interesting area of research.   
Expression of the rate-limiting BA synthetic enzyme Cyp7a1 is regulated by 
BA-feedback inhibition through two mechanisms involving the liver FXR-SHP pathway 
and the intestinal FXR-Fgf15 pathway.  Recent data suggest that FXR-SHP plays a 
minor role in suppressing Cyp7a1, but is more important in Cyp8b1 suppression, 
whereas Fgf15 is important for both Cyp7a1 and 8b1 regulation (Kim et al., 2007; Kong 
et al., 2012).  The expression of the FXR target gene SHP in liver is not altered by CR 
(Fig. 7.6), indicating that FXR activation by BAs in liver remains constant during CR.  
This correlates with the observation that CR does not alter the amounts of total BAs in 
liver (Fig. 7.2).  In contrast, the expression of SHP in ileum is increased by CR, and 
another FXR target, Fgf15, also tends to be increased (Fig. 7.6), indicating that FXR 
activation in ileum is likely increased by CR, which may be due to increased the amounts 
of total BAs in SI (Fig. 7.2).  In summary, CR appears to increase FXR activation by 
BAs in intestine, and thus mediate feedback inhibition of Cyp8b1.  However, little or no 
feedback inhibition of Cyp7a1 is observed, possibly because of intrinsic induction of 
Cyp7a1 expression by CR.  
It is likely that CR increases BA conjugation in livers.  The mRNA of the BA 
conjugating enzyme BAL is increased by 30% CR (101%) and 40% CR (123%) (Fig. 
7.5).  This correlates with the increases in the proportions of taurine-conjugated BAs in 
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serum (34% to 45%), liver (93% to 98%), and SI contents (97% to 99%) (Fig. 7.4).  In 
addition, the proportions of conjugated and unconjugated forms of some individual BAs 
are altered differently by CR.  For example, the concentration of CA is not altered by 
40% CR, whereas TCA increases by 40% CR in serum (872%), livers (369%), GBs 
(432%), SI (506%) and LI contents (694%) (Fig. 7.3).  These differences are likely 
caused by an increase in the BA conjugating enzyme BAL by CR, and therefore, 
possibly increased taurine-conjugation of BAs. 
Interestingly, 40% CR increases the expression of ileal BA binding protein Ibabp, 
which is thought to mediate intracellular BA transfer in ileocytes (Grober et al., 1999).  
This suggests that CR could possibly increase the efficiency of BA recycling from the 
intestine back to liver.  In general, CR does not alter the expression of BA transporters 
in liver and ileum (Fig. 7.7).   
In conclusion, the present study demonstrates that CR increases BAs, possibly 
through orchestrated increases in BA synthesis and conjugation in liver and intracellular 
transport in ileum.  This study provides new evidence to support the connections 
between BAs and longevity by using this CR model.  Due to the difficulty to study 
endpoints of aging process in mammals, determining good biomarkers for aging and 
thus to evaluate anti-aging interventions is of great importance.  Compared to the 
previous limited knowledge about the connection between BAs and longevity, the 
present study provides comprehensive information about the BAs that are increased by 
CR, which lays a foundation for future studies on BAs as potential biomarkers for 
longevity, and possibly the development of BA-like compounds as anti-aging drugs.
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Chapter 8: CONCLUSIONS AND DISCUSSION 
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Fig. 8.1. 
 
 
 
The regulation of BA and xenobiotic metabolism by CR.  CR increases BA pool 
size, which is likely due to increased BA synthesis (Cyp7a1) and conjugation (BAL) as 
well as intestinal BA reabsorption (Ibabp).  Amounts of total BAs are increased by CR in 
gallbladder and small intestine, but remain relatively constant in liver.  Total BA 
concentrations in liver tend to double by CR, which may contribute to the CR-induced 
upregulation of phase-II xenobiotic metabolizing enzymes.  
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The present dissertation has characterized alterations of the expression of XPGs in 
liver and BA homeostasis by aging and the anti-aging intervention CR.  This 
dissertation identified gender divergent age-dependent changes of the expression of 
XPGs and female-specific elevation of total BA concentrations in serum during aging, 
and demonstrated that CR can feminize the expression profile of many XPGs and 
increase BAs in male mice (Fig. 8.1). 
Chapter 4 comprehensively characterized the mRNA profiles of XPGs with important 
functions in metabolism and disposition in liver during aging.  Nine groups of mice from 
3 to 27 months of age were investigated, which provides much more detailed information 
of age-dependent changes than previous reports (Peng et al., 2005; Mori et al., 2007; 
Lee et al., 2008).  About 40% of the XPGs (such as Oatp1a1, Cyp1a2, Ces1f, 2c, 
Sult5a1, Gstt2, Mrp3, and Bcrp) have lower expression in liver in old mice, which 
appears to correlate with decreased hepatic drug metabolism and disposition in the 
elderly (Bressler and Bahl, 2003; Schmucker, 2005).  Using both male and female mice, 
the present study reveals novel gender-divergent mRNA profiles of XPGs across the 
lifespan.  More XPGs with elevated expression with aging are observed in female (21 
XPGs) than male (4 XPGs) mice.  For instance, the increased expression of Nqo1, 
Sult1e1, 2a1/2, and Mrp4 are only observed in female mice.  According to the 
detoxification theory of aging, up-regulation of XPGs renders broad spectrum 
detoxification and is proposed to be one of the best longevity assurance mechanisms.  
Females have a longer life expectancy than males in humans (Vina et al., 2005) and 
rodents (Goodrick, 1975; Harrison et al., 2009).  Thus, the observations in Chapter 4 
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about the gender differences of XPG expression during aging appear to correlate with 
the phenomenon that females tend to live longer than males. 
Chapter 5 demonstrates gender-divergent alterations of BA homeostasis during 
aging.  Total BAs in liver are not altered during aging.  Total BA concentrations in 
serum increase 340% from 3 to 27 months in female mice, but remain unchanged with 
age in male mice.  Very recent reports suggest a connection between BAs and long life 
span (Gems, 2007).  The observation in Chapter 5 of higher BA concentrations in 
serum in aged female mice than aged male mice correlates with the longer life span in 
females.  Furthermore, the differences in BA concentration in serum between genders 
appear to be due to synergistic effects of female-specific increased expression of BA 
uptake transporters Ntcp and Oatp1b2 in liver as well as the rate-limiting enzyme for BA 
synthesis Cyp7a1. 
After the effect of aging on XPG expression and BA metabolism had been 
determined, Chapter 6 investigated the regulation of XPG expression in liver by CR, the 
best anti-aging intervention in mammals.  Previous reports on the regulation of XPGs in 
CR mice were very inconsistent, mainly due to the large variation of diets, feeding 
regimens, as well as age and strain of the mice.  Therefore, the "dose-response" model 
of CR in Chapter 6 enables a reliable comparison under the same experimental 
conditions to identify how graded CR regulates the expression of XPGs in liver.  Data 
show that CR up-regulates a large number of XPGs, such as uptake transporter 
Oatp1a4, phase-I enzymes Cyp4a14, Por, Nqo1, Fmo2, 3, and phase-II enzymes 
Sult1a1, 1d1, 1e1, 3a1, Gsta4, m32. m3, and Mgst3.  These changes are consistent 
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with previous observations of the association of up-regulation of XPGs and increased life 
span in C. elegans (McElwee et al., 2004), Drosophila (Iqbal et al., 2009), as well as 
several long-lived mice (dwarf mice, Little mice, and rapamycin-treated mice) 
(Amador-Noguez et al., 2007; Steinbaugh et al., 2012).  The present finding provides a 
critical piece of evidence in support of the detoxification theory of aging, which suggests 
increased detoxification of a broad spectrum of toxic metabolites is beneficial for 
longevity.  
In addition to the up-regulation of many XPGs, another important finding in Chapter 6 
is that CR appears to feminize the expression of over half of the XPGs that are altered.  
Previous studies have shown that CR feminizes gene expression profiles in livers of 
male mice (Estep et al., 2009) and mutation of GH/IGF-1 axis produced an almost 
complete loss of the sex-specific gene expression in livers of long-lived dwarf mice 
(Amador-Noguez et al., 2005).  These conclusions were generated from genome-wide 
microarray studies, providing the global changes.  Being unique in focusing on the 
xenobiotic metabolism pathway, Chapter 6 suggests that many gender-divergently 
expressed XPGs are feminized by CR, and the changes appear to be "dose-dependent" 
on the degree of CR.  Taking the longer life expectancy in females than males into 
consideration, the CR-induced feminization effects on the expression of some XPGs in 
liver may be consistent with the beneficial effects of CR on longevity.  Furthermore, 
decreased GH levels (Chacon et al., 2005) and IGF-1 signaling in CR mice (Barzilai and 
Bartke, 2009) may be the mechanism for the feminization of XPGs by CR, which is 
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similar to the finding in long-lived dwarf mice with deficient GH/IGF-1 signaling 
(Amador-Noguez et al., 2005).   
However, exceptions exist because some XPGs that are altered by CR either do not 
have gender-divergent expression (such as Oat2, Ces1e, Ugt3a1, and Mrp3) or their 
changes by CR fail to be explained by feminization effects (such as Oct1, Ces1f, 
Sult5a1, and Mdr2).  Some XPGs with gender-divergent expression are not changed by 
CR, such as Cyp2b10, Ugt1a9, and Mate1.  The mechanisms for those changes need 
further investigation.   
Chapter 7 represents the first study on the regulation of enterohepatic circulation of 
BAs by CR.  Individual BAs were quantified by UPLC-MS/MS in various compartments 
of the enterohepatic circulation, including serum, liver, gallbladder, small and large 
intestine, in order to systematically investigate the regulation of BA homeostasis by CR.  
CR increases the BA pool size (162%) and total BA concentrations/amounts in serum, 
gallbladder, and small intestine, which may be attributable to the increased expression of 
BA-synthetic (Cyp7a1) and conjugating enzyme (BAL) as well as ileal BA-binding 
protein.  The current finding of increased BAs by CR in mice is consistent with previous 
reports of the connections of BAs and longevity regulation in yeast (Goldberg et al., 
2010a), C. elegans (Gerisch et al., 2007), and long-lived Little mice (Amador-Noguez et 
al., 2007).  This evidence provides important support to the proposed roles of BAs as 
anti-aging molecules (Gems, 2007).  Quantification of various individual conjugated and 
unconjugated BAs by UPLC-MS/MS technique in Chapter 7 reveals that graded CR 
"dose-dependently" increases the concentrations of many individual BAs in serum, such 
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as TCA, TDCA, DCA, LCA, ωMCA, and HDCA.  Interestingly, many of these BAs are 
secondary BAs, which are generally thought to be more toxic than primary BAs due to 
increased hydrophobicity. It would be important to investigate whether this phenomenon 
has any functional significance.  For instance, this may be an example of the hormesis 
theory where a low dose of "toxic" compounds can activate stress defense mechanisms 
that ensure longevity.  This observation provides insight and clues to future directions of 
research and therapy, such as choosing some individual BAs as potential markers of 
aging and anti-aging process, and possibly developing BAs or BA-like compounds to 
increase longevity. 
Chapter 7 also reveals interesting alterations of BA composition by CR.  CR 
increases the proportions of BAs in the CA pathway (namely CA and DCA), and 
decreases the proportions of BAs in MCA pathway (namely α-, β-, and ωMCAs), which is 
exactly opposite to the BA composition changes observed during aging, which is 
increased proportion of βMCA and decreased proportion of DCA as shown in Chapter 7.  
This observation that CR regulates BA composition in an exactly opposite way to the 
regulation by aging suggests that the change in BA composition may be an overlooked 
marker for longevity regulation.  One major difference of BAs in the CA pathway 
compared to those in MCA pathway is that both CA and DCA have 12α-hydroxyl groups.  
The observation of a correlation of increased proportions of 12-hydroxylated BAs and 
improved insulin sensitivity and decreased lipid parameters in CR mice in Chapter 6 are 
consistent with a previous report that impaired generation of 12-hydroxylated BAs was 
associated with dyslipidemia and insulin resistance (Haeusler et al., 2012).  Therefore, 
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data in Chapter 7 provides important evidence for the role of BA composition (for 
instance the ratio of BAs in CA vs MCA pathways) in the regulation of glucose and lipid 
metabolism.   
The novel role of BAs as potential anti-aging molecules has been shown in yeast 
(Goldberg et al., 2010a; Goldberg et al., 2010b), and more studies are needed to 
investigate whether BAs are effective in increasing life span in higher organisms.  To 
address this question, BA feeding studies with life span as endpoints will provide 
important in vivo data.  Mouse models are a reasonable start for research in mammals.  
BAs are natural detergents with amphypathic properties, and high concentrations of BAs 
are cytotoxic and associated with various liver toxicity and diseases, as well as colorectal 
cancer.  Therefore, the dose of BA feeding is a critical aspect of the study design.  A 
previous report showed 2% CA feeding for 7 days up-regulated a largely overlapping set 
(close to 80%) of the XPGs up-regulated in long-lived Little mice (Amador-Noguez et al., 
2007).  Although this model has value in addressing the sequential events of increased 
BAs, and then increased XPG expression that appear to mediate beneficial roles in 
longevity in Little mice, the study design of feeding CA at this high concentration across 
the life span with the expectation to observe increased longevity is likely to be 
inappropriate.  This is because liver toxicity (ALT is about 500 IU/L) was induced by 1% 
CA feeding for 7 days in a previous BA feeding study in mice by our laboratory (Song et 
al., 2011).  Various individual BAs have different potencies in activating BA receptors 
FXR and TGR5, as well as regulating gene expressions.  Therefore, choosing correct 
individual BAs or combination of various BAs at the correct concentrations is of great 
 
 
191 
 
importance when performing BA feeding study across the life span in mice.  
Furthermore, life span studies in transgenic mice deficient or overexpressed with BA 
synthetic enzymes would provide valuable evidence for the possible role of BAs in 
longevity.  In addition, possible hormesis mechanisms of BAs that extend life span 
through up-regulation of XPGs need to be investigated as well.  
In summary, utilizing a "dose-response" model of CR, analytical tools, and molecular 
techniques, the present dissertation has investigated alterations of the expression of 
XPGs in liver and BA homeostasis with aging, and more importantly the regulation of 
XPG expression in liver, and the enterohepatic circulation of BAs by the best known 
anti-aging intervention, CR.  The current findings of CR-induced up-regulation of many 
XPGs and elevation of BAs provide further evidence for the detoxification theory of 
aging, and promote understanding the possible role of BAs as longevity signaling 
molecules, and also provide useful information on drug elimination pathways that one 
should monitor in the elderly as well as people on diets. 
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